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Skeletal muscle is one of the major organs involved in metabolism. It accounts for 
~50% of total body mass and is therefore one of the major contributors to whole-
body metabolic rate. In addition, skeletal muscle plays a central role in the 
regulation of whole-body glucose metabolism. By virtue of its mass, skeletal 
muscle is the primary tissue responsible for insulin-dependent glucose clearance, 
accounting for up to 80% of whole-body glucose uptake following meal ingestion.  
Aging and diseases like cancer and chronic obstructive pulmonary disease (COPD) 
are associated with a significant loss of muscle mass. For example, a 20-40% 
reduction in fat free mass has been reported in COPD patients. Muscle wasting in 
aging and these catabolic diseases eventually leads to muscle weakness and major 
disabilities in day-to-day life. The latter is accompanied by a reduction in physical 
performance, the loss of functional capacity and an increased likelihood of 
developing chronic metabolic diseases like obesity, type 2 diabetes and 
osteoporosis.  
Various interventions have been proposed to reduce or reverse the losses of 
muscle mass and function. It has been suggested that physical activity (i.e. 
resistance exercise) and nutritional interventions (i.e. protein and amino acids) 
could represent effective strategies to reduce or counteract the loss of muscle 
tissue that occurs with aging and disease. In this thesis we focus on the beneficial 
effects of resistance exercise and the potential of dietary supplementation with 
carbohydrate, protein and a specific amino acid to enhance muscle protein 
anabolism. 
Resistance exercise 
Resistance exercise or strength training involves a small number of muscle 
contractions against a heavy load (63). This kind of exercise has been demonstrated 
to result in an increase in muscle size and strength (34, 93, 113). Although the 
metabolic and morphological adaptations resulting from resistance and endurance 
exercise are quite different, both training methods have been shown to augment 
whole-body insulin sensitivity (16, 23, 29-31, 35, 55, 73, 82, 92). While endurance 
training can effectively increase mitochondrial density and oxidative capacity (51, 
52), resistance training should not be considered as a primary means of training for 
increasing VO2max. However, this type of exercise can effectively increase 
muscular strength, fat free mass and augment physical fitness. The latter is partly 
due to an increased amount of contractile protein within the muscle (113). This is 
particularly important in the elderly where the loss of muscle mass and strength are 
prominent deficits. As such, the American College of Sports Medicine currently 
recommends strength or resistance training as an important component of an 
overall fitness program (1).  
Resistance exercise and muscle protein synthesis 
Resistance exercise can provoke profound increases in muscle mass, or hyper-
trophy. However, it generally takes weeks or months before these changes become 
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apparent (89). This prolonged time course for hypertrophy is a reflection of the 
slow turnover rate of muscle proteins. The turnover rate of contractile protein in 
the fasted state in skeletal muscle, for example, is as low as 1% per day (7, 77, 105). 
Hypertrophy can only occur when protein synthesis is exceeding protein 
breakdown for an extended period. In conclusion, it is the balance between muscle 
protein synthesis and breakdown rates that determines net protein balance and the 
rate of net protein gain (89). 
Resistance exercise can effectively stimulate muscle protein synthesis (21, 68, 69, 
84). It has been shown that after a single session of resistance exercise, muscle 
protein synthesis is rapidly stimulated within 2 to 4h (84). Moreover, the 
stimulation of protein synthesis has been reported to last for at least 24h (21, 68), 
up to 48h (84). The increase in muscle protein synthesis or fractional synthetic rate 
(FSR), can be largely attributed to an increase in myofibrillar protein synthesis 
rates. Proteins, likely to be upregulated following resistance exercise are most likely 
myosin heavy chain (MHC) and actin, since those proteins are most abundant in 
skeletal muscle. This is supported by observations showing that synthesis rates of 
MHC are increased after a single resistance exercise session (11, 112, 119). 
Interestingly, muscle protein breakdown is also stimulated following resistance 
exercise; although, to a lesser extent than protein synthesis. The result is an 
increased net muscle-protein balance that persist up to 48h (84). On the other 
hand, net muscle protein balance is negative in the absence of nutrient intake, 
indicating that the muscle remains in a catabolic state. Therefore, muscle 
hypertrophy requires the interaction of exercise and nutrition, which will be further 
discussed in chapter 1.4. 
In addition to the acute effects of resistance exercise on muscle protein synthesis 
rates, prolonged resistance exercise training results in an elevated resting mixed 
muscle protein FSR (83, 85). This training induced elevation in muscle protein 
turnover indicates that the processes of protein synthesis and degradation are both 
increased. The latter may indicate that a more rapid protein remodeling is taking 
place (83).  
Muscle protein synthesis 
The primary determinant of skeletal muscle size attained during resistance training 
is the external load that is applied. Several animal models have shown that 
increased loading results in an increased muscle mass and protein content per 
muscle (6, 10, 90). Increased loading enhances muscle protein synthesis and 
breakdown and this training induced rise in muscle protein turnover leads to a 
more rapid protein remodeling (83).  
Factors that lead to muscle hypertrophy are: muscle cell stretch (56, 70), increases 
in intracellular calcium (56), as well as exercise-induced increases in circulating and 
locally produced growth-factors such as insulin-like growth factor-1 (IGF-1; 42) 
and muscle growth factor (MGF; 47, 49). An acute bout of resistance exercise has 
been shown to activate transcription factors like Myo-D and myogenin (115), and 
to increase the rate of mRNA formation encoding for myosin heavy chain (66, 
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115). However, interestingly, changes in the rate of protein synthesis occur before 
changes in mRNA accumulation (111). Therefore, activation of protein synthesis 
must be controlled by a post-transcriptional mechanism (64). The post-
transcriptional regulation of protein synthesis involves mRNA translation 
initiation, elongation, termination and post-translational modification. The 
initiation of mRNA translation is thought to be most important for the overall 
control of muscle protein synthesis (14). 
Translation initiation  
The initiation of mRNA translation is a complex multi-step process requiring more 
than a dozen eukaryotic initiation factors (eIFs) (59, 81). At least two steps in the 
initiation pathway are subject to regulation in vivo: 1) binding of initiator methionyl-
tRNA (met-tRNA) to the 40S ribosomal subunit, and 2) binding of mRNA to the 
43S pre-initiation complex (2). In the first step, met-tRNA binds to the 40S 
ribosomal subunit as a ternary complex with eIF2 and GTP. A second initiation 
factor, eIF2B, mediates guanine nucleotide exchange on eIF2 (figure 1.1). 
Inhibition of eIF2B activity results in a decrease in the amount of eIF2∙GTP 
available to form the ternary complex, thereby limiting translation initiation. The 
activity of eIF2B is reciprocally regulated in part by phosphorylation of the -
subunit of eIF2, as it converts eIF2 from a substrate to a competitive inhibitor of 
eIF2B (60). 
Another potential rate-controlling step in the process of translation initiation 
involves the recognition and unwinding of the mRNA to allow binding to the 40S 
ribosome (2). This step requires a group of proteins referred to as eIF4F (figure 
1.1), which is a multi-subunit complex (consisting of both eIF4E and eIF4G). The 
eIF4F complex collectively serves to recognize, unfold and guide the mRNA to the 
43S pre-initiation complex (81). Modulation of eIF4E availability for binding 
eIF4G and forming the active eIF4F complex can alter translation initiation. The 
availability of eIF4E for eIF4F complex formation appears to be regulated in part 
by 4E-BP1, which compete with eIF4G for binding eIF4E (46), and is able to 
sequester eIF4E into an inactive complex. The binding of 4E-BP1 to eIF4E is 
regulated by phosphorylation of 4E-BP1, with increased phosphorylation of the 
protein causing a decrease in the affinity of 4E-BP1 for eIF4E. 
Intracellular signaling pathways that regulate translation initiation 
It has been shown that the phosphatidylinositol-3 kinase (PI-3 kinase)/mam-
malian target of rapamycin (mTOR) signal transduction pathway plays a major role 
in the regulation of translation initiation. This signaling pathway includes several 
protein kinases, including PI-3 kinase, protein kinase B (PKB, or Akt), mTOR and 
p70/p85 ribosomal protein S6 protein kinase (S6K1). Akt, downstream of PI-3 
kinase, phosphorylates and inactivates another protein kinase, glycogen synthase 
kinase (GSK-3). Consequently GSK-3 phosphorylates eIF2B, resulting in 
inhibition of its guanine nucleotide exchange activity, thereby increasing protein 
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synthesis rates (figure 1.1). In addition to GSK-3, Akt also phosphorylates mTOR 
on Ser2448, which subsequently phosphorylates and activates 4E-BP1 and S6K1. 
This allows the eIF4F complex formation and the activation of ribosomal protein 
S6, resulting in enhanced mRNA translation (figure 1.1). 
Figure 1.1 Intracellular signaling and protein signaling. Details of the individual steps are discussed in the text. 
PI3-K, phosphatidylinositol-3 kinase; Akt, protein kinase B; mTOR, mammalian target of rapamycin protein 
kinase; eIF4E, eukaryotic initiation factor 4E; 4E-BP1, eIF4E binding protein 1; S6K1; p70/p85 ribosomal 
protein S6 protein kinase; eIF4F, eukaryotic initiation factor 4F; S6, ribosomal protein S6; GSK-3, glycogen 
synthase kinase 3; eIF2B, eukaryotic initiation factor 2B; eIF2∙GDP, inactive eukaryotic initiation factor 2; 
eIF2∙GTP, activated eukaryotic initiation factor 2. 
Chronic overloading of the plantaris muscle in rodents has been shown to increase 
phosphorylation of Akt/PKB and proteins downstream of mTOR, such as 4E-
BP1 and S6K1 (10). In addition, increased phosphorylation of Ser2448 on mTOR 
after overload has been reported in rats (90). Moreover, in other animal studies 
phosphorylation of both 4E-BP1 and S6K1 has been shown to be enhanced in 
response to muscle loading (6, 10, 75). However few studies have examined the 
impact of exercise on translation initiation factors in humans in vivo. A recent study 
in humans investigated the effects of a single session of resistance exercise on 
S6K1 activation (57). Although phosphorylation of S6K1 was increased following 
exercise, S6K1 activity was unaltered, as evidenced by unchanged S6 
phosphorylation. These data indicate that a single session of resistance exercise 
does not fully activate S6K1. Interestingly, Karlsson et al. (15) showed that post-
exercise ingestion of branched chain amino acids has a striking effect on S6K1 
phosphorylation, which was evident by site-specific phosphorylation at Thr389. 
These data indicate that intake of protein/amino acids is needed to fully activate 
skeletal muscle translation initiation. 
PI3-K
Akt
mTOR
Insulin / IGF-1
eIF4E∙4E-BP1 S6K1
S6eIF4F
Translation initiation
Protein synthesis
eIF2·GTP
eIF2·GDP
eIF2B
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Measuring protein synthesis 
Our knowledge of the regulation of protein metabolism at the whole-body, muscle 
and organ levels in various physiological conditions is based on direct and indirect 
measurements of protein synthesis and breakdown, and exchange rates of amino 
acids and amino acid tracers between tissues (109). In the studies that are described 
in this thesis we used amino acid tracers to study the effect of several exercise and 
nutritional interventions on whole-body and muscle protein turnover. 
Figure 1.2 General model of protein metabolism used in the whole-body methods. Q, whole-body amino acid 
turnover or flux; Ra, rate of appearance in the plasma free amino acid pool; Rd, rate of disappearance from the 
plasma free amino acid pool; phe, phenylalanine; tyr, tyrosine. Adapted from Wagenmakers (109). 
Measuring whole-body protein turnover 
Stable isotope tracers are widely used in biomedicine to study metabolic pathways 
in vivo, because they are functionally identical to the compound of interest (tracee), 
but distinct in some physical characteristics that enable their precise detection 
(116). Calculation of substrate kinetics traditionally measures the rate of 
appearance (Ra) which in steady state conditions equals the rate of disappearance 
(Rd) of the substrate (=flux). In a single pool model it is assumed that the infusion 
of tracer, sampling, and Ra of substrate occurs from a single, homogenous, 
instantly mixing pool (109). In metabolic studies, the blood compartment is usually 
viewed as a single pool, which implicates that blood sampling is allowed for the 
calculation of whole-body flux (109, 116). In this model the rate of disappearance 
of amino acids from the blood compartment equals the rate of oxidation + protein 
synthesis, whereas the rate of appearance of amino acids equals the rate of protein 
breakdown + the rate of appearance of meal protein from the gut (figure 1.2) 
(109). 
body protein
plasma
amino acids
synthesis
S
breakdown
B In steady-state:
Q = Ra = Rd
Ra = B + I
Rd = S + O
dietary amino acids
I
O
phe  tyr
oxidation
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The use of the (whole-body) tracer balance methodology to investigate the effect 
of post-exercise nutrition on protein metabolism has some important limitations, 
as it does not allow the direct measurement of muscle protein synthesis rates. As 
such, it does not provide information on the contribution of individual tissues to 
protein metabolism, their response to nutritional and/or exercise intervention and 
it does not enable the discrimination between active and inactive muscle. 
Measuring muscle protein synthesis 
To circumvent the limitation of whole-body tracer methodology, methods were 
introduced to measure tissue or protein-specific synthesis rates; the amino acid 
tracer incorporation method. In most of these studies the amino acid tracer is 
provided by a continuous intravenous infusion until a steady state is obtained in 
the precursor pool for protein synthesis. Repeated muscle samples are then taken 
at steady-state. The protein is precipitated from the biopsy samples, hydrolyzed 
and the amino acids, after derivatization are analyzed for tracer enrichment using 
gas chromatography-mass spectrometry (GC-MS) or gas chromatography-isotope 
ratio mass spectrometry (GC-IRMS) methodology. The rise in tracer enrichment in 
the protein-bound amino acid fraction, over a given sampling time, is divided by 
the steady-state tracer enrichment in the precursor pool to give the fractional 
synthetic rate (FSR) of the protein, which is the percentage of the existing pool 
that has been synthesized over that time period (109). Although there has been a 
lot of discussion in the literature on which amino acid pool represents the best 
reflection of the precursor pool for protein synthesis during continuous-infusion 
studies, the intracellular amino acyl-tRNA is generally regarded to be the true 
protein synthesis precursor pool (109). However, due to the large muscle sample 
size that is required to make an estimate of the enrichment in the amino acyl-tRNA 
pool and the inherent analytical complexity of such measurements, the plasma and 
free muscle amino acid enrichments are generally used as surrogates to provide an 
estimate of the lower boundary (based on plasma precursor enrichments) and the 
higher boundary (based on intracellular muscle precursor enrichments) for the true 
fractional synthetic rate of mixed muscle proteins. 
Nutrition and muscle protein synthesis 
Physical activity is the most powerful stimulus to promote net muscle protein 
anabolism. After a single bout of resistance exercise, muscle protein synthesis and 
degradation rates are elevated. As a result, net muscle protein balance will actually 
remain negative in the absence of food intake. Skeletal muscle hypertrophy can 
only take place when food is ingested during the early phases of post-exercise 
recovery (32). Consequently, the combined ingestion of carbohydrate and 
protein/amino acids during recovery from exercise forms an effective strategy to 
stimulate muscle protein synthesis, inhibit protein degradation and, as such, to 
obtain a positive muscle protein balance by optimizing circulating insulin and 
amino acid concentrations. 
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Carbohydrate 
The ingestion of glucose during the post-exercise recovery phase has been shown 
to significantly increase circulating plasma insulin levels (62, 95, 102, 103). The 
latter has been shown to result in a decrease in urinary 3-methylhistidine and urea 
excretion, suggesting that protein degradation is reduced (95). However, muscle 
protein synthesis rates are not affected following carbohydrate ingestion (17, 95). 
Although carbohydrate ingestion improves net leg amino acid balance compared 
with water or placebo intake, the net balance remains negative (17). The effects of 
carbohydrate supplementation on protein metabolism can be in part attributed to 
the increase in circulating insulin. The elevation of plasma insulin levels results in 
an increase in net muscle protein anabolism in vivo in humans (42, 45, 53). 
However, insulin should not be regarded as a primary regulator of muscle protein 
synthesis rates as insulin levels exert only a modest effect on muscle protein 
synthesis in the absence of elevated amino acid concentrations (8). These 
observations are further supported by measurements in rats, showing that 
increased circulating insulin concentrations alone (induced by glucose 
supplementation) do not stimulate translation initiation post-exercise in rats (44). 
In addition, a nutritionally complete meal was shown to be more effective than 
feeding carbohydrate alone for post-exercise stimulation of protein synthesis (44). 
It is therefore suggested that most probably the protein in the diet is necessary for 
full stimulation of translation initiation and thus protein synthesis in skeletal 
muscle during exercise recovery. 
Protein and amino acids 
Amino acids have more metabolic roles than to merely serve as the building blocks 
of proteins. In addition, amino acids have been shown to induce the secretion of 
insulin, glucagon, growth hormone, and IGF-1 (37). The infusion of free amino 
acids in vivo in humans was shown to result in a significant increase in plasma 
insulin levels (38-41). More recently, reports from our laboratory show that co-
ingestion of a protein hydrolysate and free leucine and phenylalanine with 
carbohydrate effectively increases the plasma insulin response in type 2 diabetes 
patients (101), healthy controls (104) and endurance trained athletes (102, 103). 
Amino acids, and leucine in particular, can act as potent stimuli for the secretion of 
insulin from the pancreatic β-cell. The various mechanisms by which amino acids 
promote and/or enhance insulin secretion are diverse and have not yet been fully 
elucidated (79). Similar to glucose mediated insulin secretion (28), intracellular 
catabolism of the metabolizable amino acids will increase substrate availability for 
the tricarboxylic acid (TCA) cycle. Increased TCA cycle activity and oxidative 
phosphorylation will result in an increased ATP/ADP ratio, which will lead to the 
closing of ATP-sensitive K+ channels. The latter will lead to the depolarization of 
the plasma membrane, thereby opening up voltage activated Ca2+-channels, 
resulting in Ca2+-activated insulin exocytosis. Leucine-induced insulin secretion is 
mediated by its oxidative decarboxylation as well as by its ability to allosterically 
activate glutamate dehydrogenase (79, 96, 117). Both the generation of acetyl-CoA 
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and -ketoglutarate are needed for leucine to fully stimulate mitochondrial activity 
in the pancreatic -cell. The metabolically linked secondary signals that 
subsequently lead to insulin exocytosis remain to be established, and also seem 
responsible for the leucine-induced activation of the mTOR signaling pathway 
(100, 117). 
There is a substantial amount of evidence that supplementation with 
protein/amino acids can effectively stimulate muscle protein synthesis rates. Biolo 
et al. (9) demonstrated that hyperaminoacidemia, resulting from intravenous 
infusion of amino acids, increases post-exercise muscle protein synthesis rates and 
prevent the exercise-induced increase in protein degradation. Moreover, amino 
acid infusion in the fasted state, without preceding (resistance) exercise, rapidly 
increased muscle protein synthesis (105). Since intravenous infusion of free amino 
acids is not a practical method for amino acid delivery, oral ingestion of protein 
and/or amino acids has been studied intensively. The oral ingestion of a large 
amount (30-40 g) of amino acids after exercise effectively stimulates muscle 
protein synthesis (99). Moreover, ingestion of a small amount of essential amino 
acids (EAAs) with and without carbohydrates has also been shown to increase 
post-exercise protein synthesis and improve net protein balance (18, 72, 87). Thus, 
post-exercise amino acid ingestion represents an effective method to maximize the 
anabolic effect of exercise. However, ingestion of only a small amount (6 g) of 
EAA 1h and 2h post-exercise resulted in a positive net protein balance for only 
two hours, after which net protein balance over the muscle became negative (18). 
This indicates that amino acid and/or energy delivery was not sufficient to 
maintain an anabolic state (enhanced protein synthesis).  
The precise mechanisms responsible for this amino acid-induced anabolic response 
have not yet been established. Amino acids play an important role in the control of 
mRNA translation and thus protein synthesis in skeletal muscle (58). Increased 
amino acid availability, particularly the branched-chain amino acid leucine, has 
been shown to activate several key-factors (mTOR, S6K1) of the mTOR signal 
transduction pathway, thereby increasing the rate of mRNA translation (61).  
Leucine 
The role of leucine as a regulator of protein metabolism has been studied 
extensively (43). In the 1970s, a number of laboratories performed in vitro 
investigations of the factors that control protein turnover in tissues (19, 65, 74). 
These studies showed that high concentrations of all amino acids stimulated 
protein synthesis and inhibited protein degradation. In particular, it was shown in 
isolated diaphragm muscle, that leucine alone could effectively stimulate protein 
synthesis (19). This group of studies, from several laboratories, initiated a 
continuing series of investigations into the role of leucine in the control of tissue 
protein mass, its mechanism of action, and its possible value for enhancing muscle 
protein deposition in healthy subjects or moderating muscle protein loss in 
catabolic states in patients.  
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In general, most animal studies support the findings by Buse and Reid (19) and 
report that leucine inhibits muscle protein breakdown and stimulates muscle 
protein synthesis. For example, Anthony et al. (3, 4) have reported a direct, 
stimulating effect of leucine ingestion on muscle protein synthesis in rodents. In 
line with those data, the same group showed that leucine supplementation 
enhances protein synthesis in skeletal muscle from diabetic rats through insulin-
independent mechanisms (5). These studies have increased the understanding of 
the mechanisms of nutritional regulation of protein synthesis at the molecular level 
and indicate that leucine ingestion could stimulate muscle anabolism in several 
ways, as it can further increase plasma insulin concentrations and also directly 
stimulate protein synthesis. Leucine has the ability to function as a nutritional 
signaling molecule that modulates muscle protein synthesis and/or breakdown 
following food intake. The stimulatory effect of leucine on protein synthesis occurs 
at the level of translation initiation and involves signaling through mTOR (61, 86), 
which is thought to serve as a convergence point for leucine- and insulin-mediated 
effects on translation initiation (61, 86). In addition, leucine has been shown to 
have the potential to affect muscle protein metabolism by decreasing the rate of 
protein degradation (78), most likely via an increase in circulating insulin, and 
phosphorylation of key proteins involved in the regulation of protein synthesis (57, 
67, 86). 
Though most in vitro and in vivo animal studies report that leucine administration 
can inhibit protein breakdown and stimulate protein synthesis, most in vivo human 
studies report that leucine and/or BCAA administration reduces muscle protein 
breakdown, without stimulating muscle protein synthesis (71). The apparent 
discrepancy between observations in humans and animal studies remains to be 
elucidated. Maximal rates of protein synthesis rates during post-exercise recovery 
probably require both leucine and insulin signaling and the anabolic signal of 
resistance exercise. However, under normal in vivo conditions in humans it is 
impossible to discriminate between the effects of leucine and insulin and resistance 
exercise (IGF-1 and MGF) on muscle protein synthesis. 
In conclusion, due to anabolic properties of insulin and amino acids (leucine in 
particular), it has been suggested that a dietary supplement containing free leucine, 
protein and carbohydrate could be an effective tool to further increase post-
exercise muscle protein synthesis and/or to inhibit protein degradation. 
Aging 
The progressive aging of our population imposes a major threat to welfare in the 
Western society. Population demographics in the Netherlands show that by 2025 
more than 20% of the entire Dutch population will be aged 65 years or older (91). 
This aging of our society is responsible for a major increase in population 
morbidity, which will put an increasing demand on our health care system. The 
increased morbidity in the elderly is associated with the progressive decline in 
skeletal muscle mass and function. This process of age-related loss of muscle mass 
and function, or sarcopenia, has substantial health consequences, as it is associated 
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with decreased basal metabolic rate, increased body fatness, loss of bone mass and 
reduced strength and functional capacity. Sarcopenia is facilitated by a combination 
of factors, which include a more sedentary lifestyle and sub-optimal diet. The age-
related changes in skeletal muscle mass are attributed to a disruption in the 
regulation of muscle protein turnover, which results in a chronic imbalance 
between muscle protein synthesis and degradation. 
Aging and muscle function 
It has been reported that both muscle cross-sectional area and fiber numbers 
decreased from as early as the fourth decade of life. Short et al. (97, 98) measured 
the cross-sectional area of muscle in the mid-thigh using computed tomography 
imaging in healthy human subjects (18 to 88 y) and observed an age-related 
decrease in muscle area starting from the fourth decade of life. In addition, a 
parallel decrease in muscle strength (knee extension) occurred with the decrease in 
muscle mass. Accordingly, data from our laboratory shows a similar an age-related 
decrease in muscle strength (figure 1.3, L. Verdijk, unpublished observations). 
Maximal oxygen uptake is another physical performance related factor which has 
been shown to decline with aging (97). As a result, the muscles of older individuals 
are thought to fatigue faster than those of young adults. 
Figure 1.3 Age-related decrease in knee extensor strength as observed in our laboratory. Knee extensor strength 
was determined on a leg-extentions machine. 1RM, one-repetition maximum or maximal strength.  
The observed decrease in muscle mass and muscle strength with aging, in 
combination with a reduced endurance capacity, is linked to reduced levels of 
physical activity (76), which results in a decrease in total energy expenditure in 
older persons. The latter is likely to attribute to an increased prevalence of obesity, 
especially abdominal fat accumulation. Such alterations in body composition can 
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cause insulin resistance and contribute to the development of type 2 diabetes, 
hyperlipidemia, and hypertension. The combined effect of these metabolic 
abnormalities is increased cardiovascular and other morbidities (76). 
Aging and muscle protein turnover 
The age-related changes in skeletal muscle mass are attributed to a disturbance in 
the regulation of muscle protein turnover, which results in a chronic imbalance 
between muscle protein synthesis and degradation. The concept of aging is 
strongly associated with a decrease in protein synthesis, including changes in 
genome integrity and gene expression (54), and in translation and post-translational 
modifications of proteins (88). Recently, it has been shown that muscles of elderly 
humans have significantly lower amounts of total mTOR, S6K1 and eIF2B, all key-
factors in the regulation of translation initiation (24). Many studies have reported 
either similar (80, 106-108), or reduced (7, 50, 94, 112, 113, 118, 119) skeletal 
muscle protein synthesis rates in the elderly compared with young adults. More 
specifically, the synthesis rates of myofibrillar proteins (112), but not of 
sarcoplasmic proteins (7) have been shown to be reduced in the elderly compared 
with young adults. The synthesis of myosin heavy chain was dramatically reduced 
(7), without any change in its rate of transcription (110). In addition to the reduced 
MHC synthesis, aging is also characterized by a reduced rate of mitochondrial 
protein synthesis, which may contribute to the depressed aerobic capacity and 
muscle performance (94). Restoring the balance between protein synthesis and 
breakdown should form the main therapeutic target in intervention programs 
designed to improve muscle mass and function in the elderly. 
Interventions to improve muscle protein synthesis in the elderly 
There is substantial evidence that the muscle protein synthesis rate is responsive to 
exercise (89). In studies performed in young and aged persons, resistance exercise 
(50) and endurance exercise (97) stimulate the synthesis rate of mixed muscle 
proteins. Resistance exercise training mainly affects muscle strength and muscle 
mass and can increase specific muscle proteins, such as MHC proteins, in the 
elderly (50). In contrast, endurance exercise improves many metabolic functions, 
including insulin-induced glucose disposal and mitochondrial function, which is 
likely to be mediated by changes in specific proteins/enzymes (15). The specific 
adaptations that occur depend on the frequency, intensity and the duration of the 
exercise regimen, as it has been shown that only modest increases in strength are 
achieved by elderly subjects when exercise intensity is low (33). 
In addition to exercise, it has been hypothesized that the ingestion of sufficient 
amounts of protein or specific mixtures of amino acids can effectively increase the 
anabolic response in older individuals. In accordance, infusion of amino acids has 
been shown to increase muscle protein synthesis in the elderly (105). However, 
intravenous infusion of amino acids is not a physiologic route for amino acid 
delivery, as it circumvents both intestinal absorption and first-pass splanchnic 
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processing. Interestingly, it has been shown that protein digestion rates can 
differentially affect the anabolic response in young and older adults (25). Slowly 
absorped protein (casein) stimulates protein anabolism in the young (12), whereas 
faster absorped proteins (whey protein) favor anabolism in the elderly (25). In 
addition, a percentage of the ingested amino acids will not be made available for 
muscle protein synthesis due to utilization in the splanchnic tissues. The latter has 
been suggested to increase with age (13, 107). Nevertheless, Volpi et al. (107) 
demonstrated that despite a greater first-pass extraction by the gut and liver of 
orally administered amino acids, the amino acid-induced muscle protein anabolism 
in older subjects is not different from that of younger individuals. 
In contrast to these finding, there are indications that the anabolic response to 
mixed meal, consisting of carbohydrate and protein (and fat), is substantially 
blunted in the elderly. For example, most interventions using nutritional 
supplements to attenuate muscle loss in older individuals were unsuccessful in 
humans (20, 36, 114). However, Esmarck et al. (32) showed that in the elderly the 
timing of protein ingestion following resistance exercise is crucial, as immediately 
post-exercise supplement ingestion resulted in significantly greater gains than when 
the supplement was ingested after several hours of recovery. Volpi et al. (106) 
reported a blunted anabolic response in older individuals to the combined 
ingestion of glucose and essential amino acids. The latter was confirmed using the 
hyperinsulinemic, hyperaminoacidemic clamp technique showing an impaired 
activation of S6K1 as a potential mechanism for the attenuated protein synthetic 
response in the elderly (48).  
Interestingly, recent studies in rodent have suggested a possible role for oral 
leucine supplementation to restore normal postprandial anabolism in aged animals 
(26, 27). When supplemented with leucine, muscle protein synthesis in old rats was 
stimulated and similar to that observed in mature rats. Therefore, it was concluded 
that meal supplementation with leucine was sufficient to restore postprandial 
stimulation of muscle protein synthesis (27) and inhibition of proteasome-
dependent proteolysis (22) in old rats. Whether leucine supplementation can 
effectively increase muscle protein synthesis and net muscle protein balance and 
quality under normal physiological conditions in humans remains to be established.  
Outline of this thesis 
This thesis describes a series of studies that investigate the effects of exercise and 
nutrition on muscle protein synthesis, substrate utilization and insulin sensitivity. 
In chapter 2, we first describe a study about the acute effects of a single session of 
resistance exercise on whole-body insulin sensitivity. Chapter 3 describes a study 
in which we focused on the use of intramyocellular substrate sources during a 
single session of resistance exercise. Based on the observed changes in muscle lipid 
and glycogen content we discuss possible interactions with the observed 
improvement in insulin sensitivity following such an exercise bout. In chapter 4, 
we describe the use of different amino acid tracers to determine whole-body 
protein metabolism and discuss which amino acid should be preferentially used as 
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a tracer in metabolic research. In addition, we investigated the effects of the 
ingestion of different nutritional supplements on whole-body protein metabolism. 
Chapters 5 and 6 describe the effects of amino acid and/or protein ingestion on 
muscle protein synthesis. In chapter 5, we investigated the effects of the ingestion 
of carbohydrate, protein and leucine on skeletal muscle protein synthesis rates after 
resistance exercise in young healthy males. Chapter 6 describes a study in which 
we compared muscle protein synthesis following activities of daily living between 
young and elderly subjects while ingesting carbohydrates. In addition we 
investigated the effects of the combined ingestion of protein and leucine with 
carbohydrate on muscle protein synthesis rates in the young and the elderly. In 
chapter 7, we provide information on the effect of a single session of resistance 
exercise on the phosphorylation status of several proteins that are involved in the 
regulation of muscle protein synthesis and investigate whether changes in 
phosphorylation are muscle fiber-type specific. Finally, chapter 8 discusses the 
results of the above described studies and provides an overview of the main 
conclusions. Based on these conclusions the practical implications of the 
performed research are discussed and subsequent aims for future research are 
provided. 
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Abstract 
The aim of the present study was to determine whether a single session of 
resistance exercise improves whole-body insulin sensitivity in healthy men for up 
to 24h. Twelve male subjects (23±1 y) were studied over a period of 4 days during 
which they consumed a standardized diet, providing 0.16±0.01 MJ∙kg-1∙day-1 
containing 15±0.1 Energy% (En%) protein, 29±0.1 En% fat and 55±0.3 En% 
carbohydrate. Insulin sensitivity was determined 24h before and 24h after a single 
resistance exercise session (8 sets of 10 repetitions at 75% of 1-repetition 
maximum for 2 leg exercise tasks) using an intravenous insulin tolerance test. 
Insulin sensitivity index was calculated by the decline in arterialized blood glucose 
concentration following intravenous administration of a single bolus of human 
insulin (0.075 IU∙kg-1 fat free mass). Basal glucose and insulin concentrations were 
not changed 24h after resistance exercise. However, a substantial 13±5% 
improvement in whole-body insulin sensitivity was observed 24h after resistance 
exercise (P<0.05). This study shows that even a single session of resistance exercise 
improves whole-body insulin sensitivity for up to 24h in healthy men, which is 
consistent with earlier observations following endurance exercise tasks. 
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Introduction 
Skeletal muscle tissue is responsible for most of the insulin stimulated glucose 
uptake in humans. The capacity for insulin-mediated glucose uptake is directly 
related to total muscle mass and inversely associated with fat mass (58). In type 2 
diabetes patients, insulin-stimulated glucose uptake is substantially impaired in liver 
and skeletal muscle tissue, leading to the development of a hyperinsulinemic 
and/or hyperglycemic state (9). The development of insulin resistance and/or type 
2 diabetes is strongly associated with the presence of obesity and physical inactivity 
(18, 31, 44). Weight loss (23, 30, 45), increased physical activity (27), as well as 
pharmacological interventions (33, 34, 49) have been shown to form effective 
strategies to improve insulin sensitivity.  
Studies investigating the role of physical activity as a means to improve insulin 
sensitivity generally apply endurance exercise as a model. Endurance exercise 
allows the use of a relatively large amount of muscle for a prolonged period of 
time, and, as such, forms a safe and effective means to elevate energy expenditure 
and promote weight loss (16). Prolonged endurance exercise training has been 
shown to improve insulin sensitivity in young (11), elderly (36) and/or insulin-
resistant subjects (4, 10, 12, 32, 46, 48). However, even a single bout of moderate-
to-high-intensity endurance exercise has been shown to acutely improve insulin 
sensitivity and/or glucose tolerance (14, 15, 26, 42, 46). This effect has been 
reported to persist for a period ranging from 2h (42), 4-6h (56), 12-16h (14, 15, 26) 
to up to 48h post-exercise (42, 46).  
In contrast to endurance exercise, limited information is available on the potential 
of resistance exercise to affect insulin sensitivity and/or glucose tolerance (51, 52). 
Some studies have demonstrated that 6-12 wk of progressive resistance training 
improves glucose tolerance (8, 19, 43). These changes are generally attributed to 
the concomitant gain in skeletal muscle mass. Unfortunately, the few studies that 
investigated the more acute effects of resistance exercise have provided 
contradictory findings. Whereas some have reported an improved glucoregulatory 
response 12-24h after a single bout of resistance exercise (19, 20), others have 
failed to observe any change in insulin sensitivity (6). The apparent discrepancy in 
the literature is likely due to the methods used to determine insulin sensitivity 
and/or glucose tolerance. Most studies have applied an oral glucose tolerance test 
(OGTT) as a surrogate measure of insulin sensitivity. However, the OGTT has 
been reported to have a questionable reproducibility (37). In contrast to the 
OGTT, the insulin tolerance test (ITT) directly measures insulin sensitivity (28) 
and has been validated using the euglycaemic hyperinsulinemic clamp (1). 
Therefore, in the present study we applied the ITT to investigate the short-term 
effects of a single resistance exercise session on whole-body insulin sensitivity. 
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Methods 
Subjects 
Twelve healthy male volunteers with no history of participating in any regular 
exercise program were recruited for the present study. Subject characteristics are 
shown in table 2.1. All subjects were informed on the nature and possible risks of 
the experimental procedures before their written informed consent was obtained. 
The latter after approval by the Medical Ethical Committee of the Academic 
Hospital Maastricht, The Netherlands.  
Table 2.1 Subjects’ characteristics 
         Mean ± SEM 
Age (yrs) 23.0 ± 1.0 
Weight (kg) 74.3 ± 2.8 
Height (m)  1.79 ± 0.02 
BMI (kg∙m-2) 23.1 ± 0.7 
% bodyfat (%) 17.1 ± 2.2 
Fat free mass (kg) 61.2 ± 1.8 
Fat mass (kg) 13.1 ± 1.9 
HbA1C (%)   5.23 ± 0.08 
1RM leg press (kg)              198 ± 8 
1RM leg press (kg∙BW-1)   2.67 ± 0.08 
1RM leg extension (kg)              108 ± 4 
1RM leg extension (kg∙BW-1)  1.46 ± 0.05 
Values are expressed as means±SEM. 
Pretesting  
All subjects reported to the laboratory in the morning after an overnight fast for 
measurement of body composition, assessed using the hydrostatic weighing 
method. Residual lung volume was measured by the helium-dilution technique 
using a spirometer (Volugraph 2000, Mijnhart, Bunnik, The Netherlands). Body 
weight was measured with a digital balance with an accuracy of 0.001 kg (E1200, 
August Sauter GmbH, Albstadt, Germany). Body fat percentage was calculated 
using Siri's equation (50). Fat Free mass (FFM) was calculated by subtracting fat 
mass from total body mass.  
Thereafter, subjects participated in an exercise trial to become familiarized with the 
exercise protocol and the equipment. Proper lifting technique was demonstrated 
and practiced for each of the 2 lower-limb exercises (leg press and leg extension) 
and for the 3 upper-body exercises (chest press, shoulder press and lat-pulldown). 
Thereafter maximum strength was estimated using the multiple repetitions testing 
procedure (41). In another session, at least 1 wk before the first experimental trial, 
subjects’ 1 repetition maximum (1RM) was determined (38). After warming up, the 
load was set at 90-95% of the estimated 1RM, and increased after each successful 
lift until failure. A 5 min resting period between subsequent attempts was allowed. 
 Insulin sensitivity and resistance exercise 
33 
A repetition was valid if the subject was able to complete the entire lift in a 
controlled manner without assistance.  
Standardization diet and activity prior to testing 
All subjects received a standardization diet for 4 days, i.e. the day prior to the 
Insulin Tolerance Test (ITT) (on day 1), the ITT (on day 2), the resistance exercise 
session (on day 3), and the second ITT (on day 4), which were performed at 
exactly 8.30 am in the morning after an overnight fast. Subjects were provided with 
a pre-weighed amount of food products, beverages, and instant meals and were 
allowed to drink water ad libitum. All main meals (breakfast, lunch, and dinner) 
and between-meal snacks were instructed to be taken at predetermined time inter-
vals during each day. Subjects were asked to record their food intake during the 
entire testing period. Energy intake averaged 0.16±0.01 MJ∙kg bodyweight-1∙day-1 
containing 15±0.1 Energy% (En%) of protein, 29±0.1 En% of fat and 55±0.3 
En% of carbohydrate. Energy intake did not differ significantly between days, even 
though subjects were free to increase or decrease portion size of all meals and 
snacks. All volunteers were instructed to refrain from any sort of heavy physical 
exercise during the entire period except for the resistance exercise session. 
Figure 2.1 Overview of the study design. All subjects received a standardization diet during the entire study 
period; prior to the day preceding the first Insulin Tolerance Test (ITT) (day 1), the ITT (day 2), the resistance 
exercise session (day 3), and the second ITT (day 4), which were performed at exactly 8.30 am in the morning 
after an overnight fast. All volunteers were instructed to refrain from any sort of heavy physical exercise during 
the entire period (6 days) except for the resistance exercise session. 
Experimental trials 
An overview of the study protocol is provided in figure 2.1. One week after the 
subjects completed their 1RM-test, insulin sensitivity was measured using a short 
Insulin Tolerance Test (ITT). 24h after the ITT, subjects exercised for ~1 h using 
Day -1 Day 0 Day 1 Day 2 Day 3 Day 4
ITT1 Exercise ITT2
No heavy physical activity (except for the single bout of resistance exercise)
Standardization diet:
0.16 MJ∙kg-1: 15En% protein, 29 En% fat and 55 En% carbohydrate
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the resistance exercise machines. The resistance exercise was followed 24h later 
with a second ITT. 
ITT 
The day before and after the resistance exercise session, subjects arrived at the 
laboratory by car or public transportation (to avoid disturbances in insulin 
sensitivity due to physical activity: i.e. cycling, stair walking) at 8.00 am after an 
overnight fast. A Teflon catheter was inserted into an antecubital vein for insulin 
infusion and a second Teflon catheter was inserted retrogradely in a dorsal vein of 
the contralateral hand, which was placed in a hot-box (60 C), for arterialised blood 
sampling. After 30 min of incline bed rest, a basal blood sample was collected    
(t=-5 min). Another blood sample (t=0 min) was obtained before administration 
of a single intravenous dose of human insulin (Actrapid®, Novo Nordisk A/S, 
Bagsværd, Denmark) of 0.075 IU∙kg-1 fat free mass. Thereafter, blood samples 
were collected every 2 min until t=16 min. Thereafter, the test was terminated and 
subjects consumed a standardised breakfast.  
Blood samples were taken for blood glucose measurement (see analyses section). 
In addition, blood glucose concentrations were directly monitored using a blood 
glucose monitor (Precision Xtra, MediSense, Amersfoort, The Netherlands) at t=0, 
6, 12, 16 min. If blood glucose <2.5 mmol∙L-1 at t=16 min a 10 ml bolus of 20% 
dextrose (Baxter B.V., Utrecht, The Netherlands) was injected, to prevent severe 
hypoglycaemia. Blood glucose was checked again at 22 and 30 min after insulin 
injection. No subjects reported symptoms of hypoglycaemia during the ITT, 
and/or during the 20-30 min after insulin administration. 
Resistance exercise 
The day after the first ITT subjects arrived at the laboratory by car or public 
transportation at 8.00 am, in an overnight fasted state. Subjects performed a 
general warm-up of 5 min using a Stairmaster, followed by 3 sets of 10 repetitions 
on 3 resistance exercise machines targeting the upper-body (chest-press, shoulder-
press and lat-pulldown, Jimsa Benelux BV, Rotterdam, The Netherlands). The 
latter were included to provide a whole-body warm-up and to reduce the risk of 
injury. Thereafter, the resistance exercise session targeted the legs, with 8 sets of 10 
repetitions on the horizontal leg press machine (Technogym BV, Rotterdam, The 
Netherlands) and 8 sets of 10 repetitions on the leg extension machine 
(Technogym). Both exercises were performed at 75% of the subjects’ individual 
1RM with 2 min rest intervals between sets and in total required ~40 min to 
complete. All subjects were verbally encouraged during the test to complete the 
entire protocol. At the end of the exercise session, subjects consumed a 
standardized breakfast. Energy expenditure during the exercise session was not 
measured. Based on indirect calorimetry measurements during similar resistance 
exercise protocols, others have shown energy expenditure rates ranging between 14 
and 27 kJ∙min-1 (2, 5, 47). 
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Analysis 
Blood samples (4 ml) were collected in tubes containing a glycolytic inhibitor 
(sodium fluoride) and anticoagulant (potassium oxalate) and placed on ice. After 
centrifugation at 1000∙g and 4ºC for 5 min aliquots of plasma were frozen 
immediately in liquid nitrogen and stored at –80ºC until analyses. Plasma glucose 
(Uni Kit III, 07367204, Roche, Basel, Switzerland) concentrations were analyzed 
with the COBAS FARA semi-automatic analyzer (Roche). Plasma insulin was 
measured by radioimmunoassay (HI-11K, Linco Research Inc., St. Charles, MO, 
USA). To determine basal fasting blood HbA1C content a 3 ml blood sample was 
collected in EDTA containing tubes and analyzed by high-performance liquid 
chromatography (Bio-Rad Diamat, Munich, Germany). 
Calculation of insulin sensitivity 
The decline in blood glucose between 4 and 16 min during the ITT was used to 
determine insulin sensitivity (ISindex) (4). Linear regression was used to calculate 
the slope of the decline in log transformed blood glucose concentration against 
time during the first 4-16 min (1, 4, 28). The slope was multiplied by –100 to 
derive the rate constant (KITT) which is equivalent to the percentage decline in 
blood glucose per min (28).  
Insulin sensitivity was also estimated by the homeostasis model assessment or 
HOMA-Insulin Resistance (IR) index which is calculated by dividing the product 
of fasting plasma glucose (mmol∙L-1) and insulin concentrations (mU∙L-1) by 22.5 
(40).  
Statistics 
All data are expressed as means ± SEM. ISindex (KITT) calculated from data 
obtained during ITT1 and ITT2 were compared using a two-tailed, paired t-test. In 
addition, simple regression analysis was performed to calculate correlations 
between basal insulin, glucose, ISindex and HOMA index. Statistical significance was 
set at P<0.05. 
Results 
Resistance exercise 
Mean 1 repetition maximum (1RM) measured during the pre-testing was 198±8 kg 
on the horizontal leg press and 108±4 kg on the leg extension. Therefore, average 
weights used during the resistance exercise were 148±6 and 81±3 kg for the leg 
press and leg extension, respectively. All subjects completed 8 sets with 10 
repetitions on the leg press. However, during the 6th set, 2 subjects could not finish 
all 10 repetitions, after which weight was reduced to 65% of the individual 1RM. 
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Ten subjects completed 8 sets of 10 repetitions on the leg extension. Two subjects 
were not able to finish the last 2 sets due to dizziness.  
Plasma analyses 
Table 2.2 Blood parameters 
                  ITT 1                      ITT 2 
Basal glucose (mmol∙L-1) 5.44 ± 0.12 5.45 ± 0.10 
Glucose at t=16 (mmol∙L-1) 3.00 ± 0.18    2.73 ± 0.19 * 
KITT (%∙min-1) 5.07 ± 0.37    5.77 ± 0.53 * 
Basal insulin 5.35 ± 0.43 5.51 ± 0.35    
HOMA-(IR) index 1.29 ± 0.11 1.33 ± 0.08 
Values are expressed as means±SEM. * Significantly different from ITT1, P<0.05.  
All subjects showed normal fasting plasma glucose (5.42 ± 0.13 mmol∙l-1) and 
insulin concentrations (5.35 ± 0.43 mU∙L-1) before the start of the first ITT. Basal 
plasma glucose concentrations were similar before the ITT1 and ITT2 trial (5.42 ± 
0.13 vs. 5.45 ± 0.10 mmol∙L-1, respectively). Basal plasma insulin concentrations 
did not differ between the ITT1 and ITT2 (5.35 ± 0.43 and 5.51 ±0.35 mU∙L-1, 
respectively). The HOMA-(IR) index before ITT1 and ITT2 averaged 1.29 ± 0.11 
and 1.33 ± 0.08, respectively (NS). An overview of the plasma data is presented in 
table 2.2.  
Intravenous insulin tolerance test 
Figure 2.2 Plasma glucose concentrations following injection of a bolus of insulin (0.075 IU∙kg-1 fat free mass) 
24h before and 24h after a single bout of resistance exercise. Values are expressed as means±SEM. * Significantly 
different from basal blood glucose concentrations during ITT1 and ITT2 (P<0.01) 
 Insulin sensitivity and resistance exercise 
37 
During the first ITT, the administration of insulin resulted in a decline in plasma 
glucose concentration from 5.27±0.11 mmol∙L-1 at t=4 min to 3.00±0.18 mmol∙L-1 
at t=16 min. During the ITT 24h after resistance exercise (ITT2), plasma glucose 
concentrations were reduced from 5.26 ± 0.10 mmol∙L-1 at t=4 min to 2.73 ± 0.19 
mmol∙L-1 at t=16 min. Plasma glucose levels at t= 16 min were significantly lower 
in ITT2 compared to ITT1 (P<0.05). The decline in blood glucose concentration 
is presented in figure 2.2.  
Calculated rate constants for the glucose disappearance (KITT, %∙min-1) between 
4-16 min following insulin injection during a short insulin tolerance test (ITT) 
before, and 24h after resistance exercise are shown in figure 2.3A. KITT values 
were significantly increased with 13.4 ± 4.8% 24h post-exercise compared to pre-
exercise values (5.1±0.4 vs. 5.8±0.5 %∙min-1, P<0.05). The individual KITT values 
of blood glucose after insulin administration during the ITT before and 24h after 
resistance exercise are shown in figure 2.3B. 
Figure 2.3 Insulin Sensitivity index presented as the mean rate constants for the disappearance (KITT) of blood 
glucose following insulin injection during a short insulin tolerance test (ITT) before, and 24h after resistance 
exercise (A). Values are expressed as means±SEM. * significantly different from values observed during ITT1 
(P<0.05). Individual results showing KITT values of blood glucose after insulin administration during the ITT 
before and 24h after resistance exercise (B). 
Discussion 
It has been well established that a single bout of endurance exercise improves 
whole-body insulin sensitivity for up to 24h. In the present study, we extend on 
those findings by showing that a single session of resistance exercise can also 
effectively increase whole-body insulin sensitivity for up to 24h in healthy males.  
Endurance exercise training has been reported to improve whole-body insulin 
sensitivity in young (11), elderly (36) and insulin-resistant subjects (4, 10, 12, 32, 46, 
48). The latter is attributed to the concomitant induction of weight loss (16) and 
the upregulation of skeletal muscle GLUT-4 expression (7). Besides the more 
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prolonged adaptive response to endurance training, it has been firmly established 
that even an acute bout of endurance exercise elevates whole-body insulin 
sensitivity for a prolonged period, ranging from 2 (42), 4-6 (56), 12-16 (14, 15, 26) 
to up to 48h following cessation of exercise (42, 46). The latter is generally 
attributed to attenuated muscle GLUT-4 translocation (53) as well as increased 
GLUT-4 expression in muscle tissue (39). Factors thought to play a major 
regulatory role in this process include muscle lipid content (54) in relation with 
physical inactivity, AMPK activation (21, 25, 55), muscle glycogen content and 
subsequent activation of glycogen synthase activity (3, 13, 22, 46, 56, 57), which 
enhance insulin signalling downstream of the receptor (24, 27). 
In addition to prolonged endurance training, resistance exercise interventions have 
also been reported to improve glucose tolerance and/or whole-body insulin 
sensitivity (8, 17, 19, 29, 35, 43). The latter is generally attributed to a concomitant 
gain in skeletal muscle tissue, which improves whole-body glucose disposal 
capacity (8, 19, 43). Besides this increase in lean muscle tissue, resistance exercise 
also improves functional capacity, thereby supporting a more active, healthy 
lifestyle. However, in the development of most exercise intervention programs, the 
focus generally lies on the implementation of endurance exercise because of its 
acute stimulating effect on whole-body insulin sensitivity. Consequently, endurance 
exercise sessions are generally implemented at the expense of resistance exercise 
when designing such intervention programs. In the present study, we speculated 
that a single resistance exercise session could also acutely improve whole-body 
insulin sensitivity. The latter would imply that there is no need to restrict the 
inclusion of resistance exercise when designing effective lifestyle intervention 
programs.  
So far, the few studies that investigated the acute effects of resistance exercise on 
insulin sensitivity have provided contradictory findings (6, 19, 20). In the present 
study, we show that a single resistance exercise session (mainly consisting of 16 
sets of leg-exercise using 75% of the individual 1RM) improves whole-body insulin 
sensitivity by as much as 13.4±4.8% when measured 24h after exercise. However, 
a large inter-subject variation was observed. Whereas 5 subjects did not show a 
measurable increase in plasma glucose clearance 24h after resistance exercise, the 7 
other subjects showed improvements in insulin sensitivity ranging between 13 and 
49%. The average increase in whole-body insulin sensitivity following resistance 
exercise seems to be of a similar magnitude as the ~20% improvement reported 
following an acute (~60 min) bout of endurance exercise (42, 46). Previous studies, 
investigating the acute effects of resistance exercise on insulin sensitivity, have 
applied either oral (19, 20) or intravenous (6) glucose tolerance tests (OGTT and 
IVGTT, respectively) to estimate insulin sensitivity. These studies, which use the 
glucose and/or insulin response following glucose administration as a 
representative of insulin action, have provided discrepant findings. Fluckey et al. 
(1994) reported no change in integrated glucose concentrations following glucose 
ingestion 18 h after resistance exercise, but observed a lower insulin response (20). 
Fenicchia et al. (2004) reported a lower glucose response 12-24h after resistance 
exercise in female type 2 diabetes patients, without observing any difference in 
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insulin levels. In that study as well as in a study by Chapman et al. (2002), no 
changes in glucose or insulin responses were observed 15h after a single bout of 
resistance exercise in the healthy, non-obese, normoglycaemic controls (6, 19). 
Clearly, in the literature the acute effects of resistance exercise on whole-body 
insulin sensitivity have always remained equivocal. 
The discrepancy in these earlier findings could likely be attributed to the use of 
glucose tolerance tests, which do not measure insulin sensitivity directly. In 
accordance, the OGTT has been reported to have a questionable reproducibility as 
a measure of whole-body insulin sensitivity (37). Therefore, in the present study, 
we applied an intravenous insulin tolerance test (ITT) 24h before and 24h after 
performing a resistance exercise session. We observed a greater arterial blood 
glucose clearance rate following an intravenous dose of insulin 24h after resistance 
exercise compared with pre-exercise values (figure 2.3). During the ITT, insulin 
sensitivity index was calculated by the observed decline in arterial blood glucose 
following insulin administration. In contrast to the OGTT, the ITT provides a 
reproducible method that more directly assesses insulin sensitivity (28), and has 
been validated using the euglycaemic hyperinsulinemic clamp (1). Other factors 
that might explain the discrepant findings in the literature include the intensity 
and/or duration of the resistance exercise session, the standardization of dietary 
intake and daily physical activity as well as the population studied. The resistance 
exercise protocol used both by Fluckey et al. (1994) and Chapman et al. (2002) may 
not have been of sufficient intensity to invoke a large significant improvement in 
whole-body insulin sensitivity as observed in the present study. Furthermore, many 
of the earlier studies did not standardize food intake and/or physical activity prior 
to the OGTTs (19, 20). In the present study, both food intake and physical activity 
were strictly standardized to reduce any confounding effects of diet on insulin 
sensitivity.  
In the present study we show that resistance exercise acutely stimulates insulin 
sensitivity. Similar to the reported effects of a single bout of endurance exercise, 
this is likely attributed to attenuated muscle GLUT-4 translocation (53) and/or 
elevated GLUT-4 expression (39). Though information on the metabolic demand 
imposed upon by resistance exercise is scarce, we speculate that resistance exercise 
activates AMPK and substantially reduces muscle glycogen and/or IMTG content. 
More research is warranted to elucidate the exact mechanisms responsible for the 
observed increase in insulin sensitivity following exercise. In conclusion, an acute 
bout of intense resistance exercise substantially improves whole-body insulin 
sensitivity for up to 24h after cessation of exercise. Therefore, the present data 
indicate that both endurance as well as resistance type exercise tasks stimulate 
insulin sensitivity. As such, there should be no restriction in combining the 
benefits of both types of exercise in future lifestyle intervention programs.  
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Abstract 
Resistance exercise has recently been shown to improve whole-body insulin 
sensitivity in healthy males. Whether this is accompanied by an exercise-induced 
decline in skeletal muscle glycogen and/or lipid content remains to be established. 
In the present study, we determined fiber-type specific changes in skeletal muscle 
substrate content following a single resistance exercise session. After an overnight 
fast, eight untrained healthy lean males participated in a ~45 min resistance 
exercise session. Muscle biopsies were collected before, following cessation of 
exercise, and after 30 and 120 min of post-exercise recovery. Subjects remained 
fasted throughout the test. Conventional light and (immuno)fluorescence 
microscopy were applied to assess fiber-type specific changes in intramyocellular 
triacylglycerol (IMTG) and glycogen content. A significant 27±7% net decline in 
IMTG content was observed in the type I muscle fibers (P<0.05), with no net 
changes in the type IIa and IIx fibers. Muscle glycogen content decreased with 
23±6, 40±7 and 44±7% in the type I, IIa and IIx muscle fibers, respectively 
(P<0.05). Fiber-type specific changes in intramyocellular lipid and/or glycogen 
content correlated well with muscle fiber-type oxidative capacity. During post-
exercise recovery, type I muscle fiber lipid content returned to pre-exercise levels 
within 120 min. No changes in muscle glycogen content were observed during 
recovery. We conclude that intramyocellular lipid and glycogen stores are readily 
used during resistance exercise and this is likely associated with the reported 
increase in whole-body insulin sensitivity following resistance exercise. 
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Introduction 
Fat and carbohydrate are the principal substrates that fuel ATP resynthesis in 
skeletal muscle tissue. Endogenous carbohydrates are mainly stored as muscle and 
liver glycogen and represent less than 5% of total energy storage. The vast majority 
of our energy reserves is stored as fat, mainly deposited as triacylglycerol (TG) in 
subcutaneous and deep visceral adipose tissue. Smaller quantities of TG are 
present as lipid droplets inside the muscle fibers, intramyocellular triacylglycerol 
(IMTG) (19). 
There has been much controversy on the actual contribution of the IMTG pool as 
a substrate source during exercise (47). The apparent discrepancy in the literature 
likely stems from the methodological difficulties that have been associated with the 
biochemical triacylglycerol extraction method that has been used to determine 
IMTG content in muscle biopsies collected before and after exercise (47). In 
accordance, more recent studies using stable isotope methodology, 1H-magnetic 
resonance spectroscopy, electron and/or immunofluorescence microscopy all 
support the contention that the IMTG pool can function as an important substrate 
source during submaximal exercise (45). Besides the intramyocellular lipid deposits, 
muscle glycogen stores represent another important substrate source. In 
accordance, substantial net reductions in both type I and II muscle fiber glycogen 
content have been reported following prolonged endurance exercise tasks (42). 
These intramyocellular lipid and glycogen stores play a major regulatory role in 
skeletal muscle metabolism. Muscle glycogen use and subsequent post-exercise 
glycogen synthesis rates have been shown to be functionally coupled to the 
exercise-induced increase in skeletal muscle insulin sensitivity in humans and 
rodents (2, 6, 14, 35, 48, 49). Furthermore, interventions known to improve insulin 
sensitivity, like weight loss in humans (15, 20), dietary lipid withdrawal (33), the use 
of thiazolidinediones in rodents (34) as well as an acute bout of endurance exercise 
in rodents and humans (33, 45) have all been associated with a reduction in skeletal 
muscle lipid content. Because of its capacity to reduce both intramyocellular lipid 
and glycogen content, endurance exercise is generally considered an effective 
interventional strategy to improve skeletal muscle insulin sensitivity. 
However, resistance exercise should also be regarded as an essential component of 
effective intervention programs designed to improve health. Resistance training 
increases skeletal muscle mass (22) and, as such, can augment whole-body glucose 
disposal capacity (5, 11, 31). In addition, resistance training also improves muscle 
strength, power and functional capacity, which facilitates the adaptation towards a 
more active lifestyle (10, 28). Though there is some discrepancy in the existing 
literature, we (24) as well as others (11, 12) have recently shown that even a single 
resistance exercise session can improve whole-body insulin sensitivity for up to 
24h after cessation of exercise. In line with the acute stimulating effects of 
endurance exercise on post-exercise insulin sensitivity (2), it has been speculated 
that the acute effects of resistance exercise on whole-body insulin sensitivity are 
also attributed to the reduction of the intramyocellular glycogen and/or lipid stores 
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(24). However, studies on the metabolic demands of resistance exercise are scarce, 
which is likely due to the methodological difficulties associated with the non-steady 
state conditions of this type of exercise. Therefore, in the present study, we 
determined fiber-type specific changes in intramyocellular glycogen and lipid 
content during and immediately after a single resistance exercise session. 
Methods 
Subjects 
Eight healthy untrained male volunteers with no history of participating in any 
regular exercise program were recruited for the present study. Subjects’ 
characteristics are shown in table 1. All subjects were informed on the nature and 
possible risks of the experimental procedures before their written informed 
consent was obtained, the latter after approval by the Medical Ethical Committee 
of the Academic Hospital Maastricht.  
Table 3.1 subjects’ characteristics 
                            Mean ± SEM 
Age (yrs) 22.5 ± 0.9 
Weight (kg) 74.9 ± 2.8 
Height (m)  1.80 ± 0.01 
BMI (kg.m-2) 23.3 ± 0.7 
% bodyfat (%) 17.8 ± 2.4 
Fat free mass (kg) 61.3 ± 2.1 
Fat mass (kg) 13.6 ± 2.1 
HbA1C (%)  5.3 ± 0.1 
1RM leg press (kg)  198 ± 7 
1RM leg extension (kg)  105 ± 3 
Values are expressed as means±SEM. 
Pretesting  
Body composition was assessed using the hydrostatic weighing method in the 
morning following an overnight fast. Residual lung volume was measured by the 
helium-dilution technique using a spirometer (Volugraph 2000, Mijnhart, Bunnik, 
The Netherlands). Body mass was measured with a digital balance with an accuracy 
of 0.001 kg (E1200, August Sauter GmbH, Albstadt, Germany). Body fat 
percentage was calculated using Siri's equation (39). Fat Free mass (FFM) was 
calculated by subtracting fat mass from total body mass.  
To familiarize subjects with the resistance exercise protocol and the equipment, a 
familiarization trial was performed. Proper lifting technique was demonstrated and 
practiced for each of the 2 lower-limb exercises (leg-press and leg-extension) and 
for the 3 upper-body exercises (chest-press, shoulder-press and lat-pulldown). 
Thereafter, maximum strength was estimated using the multiple repetitions testing 
procedure (29).  
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In an additional exercise session, at least 1 wk before the first experimental trial, 
the subjects’ 1 repetition maximum (1RM) was determined (26). After warming up, 
the load was set at 90-95% of the estimated 1RM, and increased after each 
successful lift until failure. A 5 min resting period between subsequent attempts 
was allowed. A repetition was valid if the subject was able to complete the entire 
lift in a controlled manner without assistance.  
Standardised diet and activity prior to testing 
All subjects received a strict standardized diet for 2 days prior to the resistance 
exercise test trial, which was performed in the morning after an overnight fast. 
Subjects were provided with a pre-weighed amount of food products, beverages, 
and instant meals and were allowed to drink water ad libitum. Subjects were 
instructed to take all main meals (breakfast, lunch, and dinner) and between-meal 
snacks at predetermined time intervals during each day. The standardized diet 
provided 0.15 MJ∙kg-1∙day-1 containing 15 Energy% (En%) of protein, 30 En% of 
fat and 55 En% of carbohydrate. All volunteers were instructed to refrain from any 
sort of heavy physical exercise during the 2 days prior to the test-trial. 
Experimental trial 
The day of the test, subjects arrived at the laboratory by car or public 
transportation at 8.00 am, following an overnight fast. A Teflon catheter was 
inserted into an antecubital vein for blood sampling. After 30 min of supine rest, a 
basal blood sample was collected and a muscle biopsy was taken from the m. 
vastus lateralis. Thereafter, subjects performed a 5 min low-intensity warm-up on a 
Stairmaster, followed by 3 sets of 10 repetitions on 3 resistance exercise machine 
targeting upper-body muscle groups (chest-press, shoulder-press and lat-pulldown, 
Jimsa Benelux BV, Rotterdam, The Netherlands). The latter were included to 
provide a whole-body warm-up to reduce the risk of injury. Thereafter, subjects 
performed 8 sets of 10 repetitions on the horizontal leg-press machine 
(Technogym BV, Rotterdam, The Netherlands) and 8 sets of 10 repetitions on the 
leg-extension machine (Technogym). Both exercises were performed at 75% of the 
individual 1RM with 2 min rest intervals between sets and required ~45 min to 
complete. All subjects were verbally encouraged during the exercise session to 
complete the entire protocol. Immediately after cessation of exercise, a second 
muscle biopsy sample was taken, after which subjects rested supine for 2h. After 
30 min and 2h of post-exercise recovery, additional muscle biopsies were taken. 
Blood samples were collected before, after 30 min of exercise, immediately after 
cessation of exercise and following 30, 60, 90 and 120 min of post-exercise 
recovery. Subjects remained fasted throughout the test. 
Muscle biopsy samples were collected from both legs. The first two biopsies were 
taken from the same incision in one leg; the last two were taken from the same 
incision in the contralateral leg. When biopsy samples were taken from the same 
incision, the first sample was taken from a different region (distal of the incision, 
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with the needle pointing inwards) than the second (proximal with the needle 
pointing outwards). Muscle biopsies were obtained from the middle region of the 
m. vastus lateralis (15 cm above the patella) and approximately 3 cm below entry 
through the fascia using the percutaneous needle biopsy technique (1). Muscle 
samples were dissected carefully, freed from any visible non-muscle material, 
embedded in Tissue-Tek (Sakura Finetek, Zoeterwoude, The Netherlands) and 
rapidly frozen in liquid nitrogen-cooled isopentane. 
Plasma sample analysis 
Blood samples (6 ml) were collected in EDTA-containing tubes and centrifuged at 
1000 g at 4°C for 10 min. Aliquots of plasma were frozen immediately in liquid 
nitrogen and stored at -80°C. Plasma glucose (Uni Kit III, Roche, Basel, 
Switzerland), lactate (Gutmann & Wahlefeld, 1974) and FFA (Wako NEFA-C test 
kit, Wako Chemicals, Neuss, Germany) concentrations were analysed with a 
COBAS FARA semi-automatic analyser (Roche). 
Muscle sample analysis  
Multiple serial sections (5 µm) from biopsy samples collected before, immediately 
after, 30 and 120 min after exercise were thaw-mounted together on uncoated, pre-
cleaned glass slides for each subject. To permit the determination of muscle fiber 
IMTG content stained by oil red O together with immunolabelled cellular 
constituents we used the protocol as previously described (25, 44-46). The 
proportion of type I, IIa, and IIx muscle fibers was determined by ATPase staining 
(27). To assess intramyocellular glycogen content we used the modified Periodic 
Acid Schiff reagent stain (PAS) as recently described (37), allowing direct, fiber-
type-specific determination of muscle glycogen content. Muscle fiber-type specific 
oxidative capacity was estimated by determining succinate dehydrogenase activity 
(SDH) in the muscle cross-sections using histochemical analyses (16). Histological 
techniques, like oil red O, PAS and SDH staining combined with either 
immunofluorescence or conventional light microscopy are semi-quantitative. As a 
consequence, the present study does not provide absolute measures of skeletal 
muscle lipid and/or glycogen concentrations. After 24h, glass slides were examined 
using a Nikon E800 fluorescence microscope (Uvikon, Bunnik, The Netherlands) 
coupled to a Basler A113 C progressive scan color CCD camera, with a Bayer 
color filter. Epifluorescence signal was recorded using a Texas red excitation filter 
(540-580 nm) for oil red O, a fluorescein isothiocyanate (FITC) excitation filter 
(465-495 nm) for muscle fiber-type, and a 4',6-diamidino-2-phenylindole (DAPI) 
UV excitation filter (340-380 nm) for laminin.  
Digitally captured images (240x magnification) with a minimum of six fields-of-
view per muscle cross-section (12±1 fibers per field-of-view), were processed and 
analyzed using Lucia 4.8 software (Nikon, Düsseldorf, Germany). The signal 
derived from the antibody against laminin was used to select single muscle fibers 
and with the antibody against human myosin heavy chain I, we were able to 
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differentiate between type I and II muscle fibers. To differentiate between type IIa 
and IIx fibers we used matching serial cross-section stained using routine ATPase 
staining. The oil red O epifluorescence signal was recorded for each muscle fiber, 
resulting in a total of 70±5 muscle fibers analyzed for each muscle cross-section 
(35±2 type I, 25±4 type IIa and 10±1 type IIx muscle fibers). An intensity 
threshold representing minimal intensity values corresponding to lipid droplets was 
set manually and uniformly used for all images. Total area measured and the area as 
well as the number of objects emitting oil red O epifluorescence signal were 
recorded. Fiber-type-specific IMTG content was expressed as the percentage of 
the measured area that was stained with oil red O. In a previous study, two 
different muscle samples from two different subjects were analysed; showing a 
coefficient of variance of 10.5 and 38.6% for the type I and II muscle fibers (45). 
Mixed muscle fiber lipid content, as determined by oil red O staining, has been 
shown to correlate significantly with measures of intramyocellular lipid content as 
assessed by 1H-magnetic resonance spectroscopy (46). Average lipid droplet size 
was calculated by dividing the total area lipid stained by total number of lipid 
droplets. Lipid droplet density was calculated by dividing the total number of lipid 
droplets by the total area measured.  
PAS and SDH stained sections were captured in full color using bright field light 
microscopy. Digitally captured images (120x magnification) with a minimum of 
four fields-of-view per muscle cross-section (37±2 fibers per field-of-view), were 
processed and analyzed using the Lucia 4.8 software package. The PAS and SDH 
signals were recorded for each muscle fiber, resulting in a total of 142±8 muscle 
fibers analyzed for each muscle cross-section (64±4 type I, 57±5 type IIa and 
21±2 typ IIx muscle fibers). The bright-field images of the PAS and SDH stains 
were converted post hoc to 8-bit grayscale values. The mean optical density of the 
PAS or SDH-raised signal per individual fiber was determined by averaging the 
optical density measured in every pixel in the cell, corrected for the mean optical 
density of the background stain measured in a field-of-view containing no muscle 
fibers. Mixed muscle glycogen content, as determined by PAS staining, correlates 
significantly with muscle glycogen content as measured using biochemical analyses 
(37).  
Statistics 
All data are expressed as means±SEM. Analyses of variance (ANOVA) for 
repeated measures were applied to determine differences in muscle lipid and 
glycogen content over time in type I, IIa and IIx fibers with time and muscle fiber-
type as factors. In case of a significant F-ratio, a Scheffé post-hoc test was applied 
to locate the differences. Statistical significance was set at P<0.05. Simple 
regression analysis was performed on mean muscle fiber-type oxidative capacity 
and glycogen/lipid content. 
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Results 
Resistance exercise 
Mean 1 repetition maximum (1RM) measured during the pre-test was 198±7 kg on 
the horizontal leg press and 105±3 kg on the leg extension. Therefore, average 
weight lifted during the resistance exercise was set at 148±5 and 79±3 kg for the 
leg press and leg extension respectively. All subjects completed 8 sets with 10 
repetitions on the leg press. One subject was unable to finish 10 repetitions during 
the 6th set, after which resistance was reduced to 65% of the individual 1RM. All 
subjects completed 8 sets of 10 repetitions on the leg extension machine. 
Plasma analyses 
Plasma glucose, lactate and FFA concentrations are presented in figure 3.1. Plasma 
glucose concentrations increased during exercise and peaked immediately post-
exercise (P<0.05), after which they returned to baseline values. Plasma lactate 
concentrations markedly increased during exercise (P<0.0001), and decreased 
during recovery. Plasma FFA concentrations tended to decrease during exercise 
(P=0.08), and markedly increased during recovery (P<0.001). 
Figure 3.1 Plasma glucose, lactate and free fatty acid concentrations at rest, during resistance exercise and 
subsequent recovery. Data provided are means±SEM. * Significantly different from pre-exercise values (P<0.05)  
Muscle glycogen content 
Representative images of muscle cross-sections obtained before (A) and 
immediately after (B) exercise following PAS staining for analyses of 
intramyocellular glycogen content are shown in figure 3.2. Muscle fiber glycogen 
content was similar at rest in all fiber-types. Mixed muscle glycogen content 
declined by 33±7% following the exercise session (P<0.0001). Glycogen content 
had declined by 23±6% in the type I fibers (P<0.01), 40±7% in the type IIa fibers 
(P<0.001), and 44±7% in the type IIx fibers (P<0.001) compared to pre-exercise 
values (figure 3.3). The observed decrease over time in glycogen content was 
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significantly greater in the type IIx fibers compared to the type I muscle fibers 
(P<0.05). During post-exercise recovery muscle glycogen content remained below 
pre-exercise levels, with no significant changes over time in the type I, IIa and IIx 
muscle fibers.  
 
 
 
Figure 3.2 Images (120x magnification) of representative cross-sections of vastus lateralis muscle obtained before 
(left) and immediately after exercise (right) with sections stained for glycogen content (A/B), and laminin and 
myosin heavy chains I (C/D). The muscle fibers are labeled as type I, type IIa, and type IIx. Differentiation 
between type IIa and IIx fibers was made based on ATPase staining (E/F). 
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Figure 3.3 The effect of resistance exercise on muscle glycogen content. Fiber-type specific glycogen content 
(expressed in arbitrary units) before and immediately after exercise, and following 30 and 120 min of post-exercise 
recovery as determined by brightfield microscopy on PAS-stained muscle cross-sections. Data provided are 
means±SEM. * Significantly lower than pre-exercise values (P<0.05); # significantly different over time compared 
to type I muscle fibers (P<0.05).  
IMTG content 
Representative images of muscle cross-sections obtained before (A) and 
immediately after (B) exercise stained for intramyocellular lipid content are shown 
in figure 3.4. Muscle tissue analyses for IMTG content applying fluorescence 
microscopy on oil red O stained muscle cross-sections showed that at rest IMTG 
content in type I fibers was higher compared with type II fibers (P<0.05). Mixed 
muscle IMTG content tended to decline with 25±10% following the exercise 
session (P=0.087). In addition, a substantial 27±7% decline in lipid content in the 
type I fibers (P<0.05) was found, with IMTG content in the type I muscle fibers 
being significantly lower both immediately post-exercise as well as following 30 
min of post-exercise recovery compared to pre-exercise values (figure 3.5). After 
2h of post-exercise recovery, IMTG content had returned to values similar to pre-
exercise values. The observed decrease in IMTG content was accounted for by a 
significant decrease in lipid droplet size (from 0.69±0.08 to 0.53±0.07 and 
0.53±0.07 µm2, P<0.01) without any changes in lipid droplet density (from 
0.049±0.003 to 0.045±0.004 and 0.041±0.003 droplets∙µm-2) as determined before, 
immediately after and after 30 min of post-exercise recovery exercise, respectively. 
Net changes in IMTG content over time in the type I fibers were significantly 
different compared to the type IIa and IIx fibers (P<0.05). No significant changes 
over time were observed in intramyocellular lipid content in the type IIa or IIx 
muscle fibers.  
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Figure 3.4. Images (240x magnification) of representative cross-sections of vastus lateralis muscle obtained 
before (left) and immediately after exercise (right) with sections stained for lipid content (A/B), and laminin and 
myosin heavy chains (C/D). The muscle fibers are labeled as type I, type IIa, and type IIx. Differentiation 
between type IIa and IIx fibers was made, based on standard ATPase staining.  
Muscle fiber oxidative capacity 
A histochemical analysis for succinate dehydrogenase (SDH) activity in muscle 
cross-sections was performed as a measure of muscle fiber oxidative capacity and 
results are shown in table 3.2. SDH activity was significantly greater in the type I 
versus the type II fibers (P<0.05). Type IIa muscle fiber SDH activity was 
substantially greater when compared to the IIx fibers (P<0.05). Positive 
correlations were observed between muscle fiber-type oxidative capacity and 
baseline muscle fiber lipid content (r=0.573, P<0.01), and muscle fiber-type 
oxidative capacity and the net reduction in muscle fiber lipid content observed 
following exercise (r=0.482, P<0.05). No significant correlation was observed 
between muscle fiber-type specific oxidative capacity and resting muscle fiber 
glycogen content. A significant negative correlation was observed between muscle 
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fiber-type oxidative capacity and the net reduction in muscle fiber glycogen 
content observed during exercise (r=-0.556, P<0.05). 
Figure 3.5 The effect of resistance exercise on muscle lipid content. Mean fiber-type-specific intramyocellular 
lipid content (expressed as percentage of area lipid stained) before exercise, immediately after exercise and 
following 30 and 120 min of post-exercise recovery as determined by fluorescence microscopy on oil red O 
stained muscle cross-sections Data provided are means±SEM. *: significantly lower than pre-exercise values 
(P<0.05); #: significantly different over time compared to type IIa fibers (P<0.05); ^: significantly different over 
time compared to type IIx fibers (P<0.05). 
Table 3.2 Muscle SDH activity, glycogen and lipid content at rest 
           Type I           Type IIa           Type IIx 
Fiber-type distribution (%) 46 ± 4 39 ± 3 15 ± 2 
SDH activity (AU) 73 ± 6 45 ± 5 *   27 ± 5 *# 
IMTGcontent (area fraction) 0.032 ± 0.004  0.017 ± 0.005 *   0.004 ± 0.001 *^ 
Glycogen content (AU) 0.122 ± 0.038 0.129 ± 0.032 0.129 ± 0.032 
Lipid content / SDH activity 0.47 ± 0.07 0.42 ± 0.13 0.19 ± 0.05 
Glycogen content / SDH activity 1.85 ± 0.41 3.41 ± 0.85 6.74 ± 1.87 *# 
Values are expressed as means ± SEM. * Significantly different from type I fibers (P<0.05), # significantly 
different from type IIa fibers (P<0.05), ^ different from type IIa fibers (P=0.07). AU Arbitrary Units. 
Discussion 
In the present study, we show that resistance exercise can substantially reduce 
skeletal muscle glycogen and lipid content. A single resistance exercise session 
reduces both type I and II muscle fiber glycogen content, with most pronounced 
changes located in the type IIx fibers. Furthermore, resistance exercise also reduces 
intramyocellular lipid content, which is restricted to the type I muscle fibers. Fiber-
type specific substrate utilisation during resistance exercise seems to be tightly 
coupled to muscle fiber-type oxidative capacity. 
Metabolic demands of resistance exercise 
57 
The exercise-induced reduction in skeletal muscle glycogen and/or lipid content 
has been associated with an increase in insulin sensitivity in humans (2, 35, 48, 49). 
Numerous studies have reported intramuscular substrate availability to play a key 
regulatory role in skeletal muscle insulin signaling (18, 50). For example, skeletal 
muscle glucose uptake and glycogen synthase activity strongly depend on muscle 
glycogen availability (32, 50). The mechanism for this phenomenon is related to 
increased GLUT4 translocation under reduced muscle glycogen availability, and is 
likely coupled to an increased activation of AMP-activated protein kinase (AMPK) 
(50). Furthermore, a decrease in muscle lipid content following exercise has also 
been linked to greater insulin sensitivity in rodents (33). Although a variety of 
mechanisms have been suggested, recent studies seem to indicate that the 
relationship between IMTG content and skeletal muscle insulin sensitivity is not 
functional (44).  
Aging, disability and functional incapacity often result in the inability/inefficacy to 
perform moderate-intensity endurance exercise. Therefore, resistance exercise 
training is now more frequently advocated as a necessary component of effective 
exercise intervention programs to augment muscle mass (22), strength, power and 
functional capacity (10, 28). However, only few studies have investigated the acute 
effects of resistance exercise on insulin sensitivity (4, 11, 12). Recently, we showed 
that a single resistance exercise session improves whole-body insulin sensitivity by 
~13% for up to 24h after exercise (24). The latter seems to be of a similar 
magnitude as the ~20% increase in whole-body insulin sensitivity that has been 
reported after ~60 min of endurance exercise (7, 8, 30, 35). It could be speculated 
that the increase in insulin sensitivity following resistance exercise is also associated 
with a net reduction in skeletal muscle glycogen and/or lipid content. However, 
literature on the metabolic demands of resistance exercise is scarce. Early reports 
suggest that energy needs during resistance exercise can be provided with only 
minor activation of glycogenolysis or lipolysis (23).  
In the present study, we investigated fiber-type specific changes in skeletal muscle 
glycogen and lipid content following resistance exercise and subsequent recovery 
by using semi-quantitative histological techniques. The latter provides an effective 
strategy to assess fiber-type specific changes in intramyocellular lipid and/or 
glycogen content, without the methodological limitations associated with 
biochemical extraction analyses. In accordance, we recently reported a good 
correlation between IMTG content as determined by 1H-magnetic resonance 
spectroscopy (MRS) and fluorescence microscopy (45). In addition, strong 
correlations between data on (mixed-muscle) glycogen content obtained by the use 
of both biochemical and histochemical methods have recently been reported (37). 
In the present study, mixed muscle glycogen content declined by 33±7% following 
the resistance exercise session. The latter seems to be in line with previous studies 
applying biochemical analysis on mixed muscle tissue (9, 41). We extent their 
findings by showing that these changes in muscle glycogen are fiber-type specific, 
and seem to be tightly coupled to (non-)oxidative capacity (table 3.2, figure 3.3). 
Linear regression revealed a negative correlation between the net reduction in 
muscle fiber-type glycogen content and fiber-type oxidative capacity (r=-0.556, 
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P<0.05). As such, net changes in muscle fiber glycogen content were more 
pronounced in type IIx fibers compared to type I muscle fibers, which can be 
attributed to the greater recruitment of these fibers during high-intensity resistance 
exercise (13). During post-exercise recovery no significant differences in muscle 
glycogen content were observed over time in the type I, IIa or IIx muscle fibers. 
Furthermore, we observed a significant 27±7% reduction in type I muscle fiber 
lipid content (P<0.05). No changes in IMTG content were observed in the type 
IIa and IIx fibers (figure 3.5). The net reduction in IMTG content was significantly 
different compared to the type II fibers (P<0.05). On average, type I muscle fiber 
lipid content was 2.5±0.3 and 8.8±1.4 times greater when compared to the type IIa 
and IIx fibers, respectively. Due to the many methodological difficulties with the 
biochemical triacylglycerol extraction analyses on mixed muscle biopsy samples 
(21), we applied (immuno)histochemical IMTG analyses on oil red O stained 
muscle cross section to enable fiber-type specific determination of intramyocellular 
lipid content. The latter might be the reasons why Essen-Gustavsson and Tesch 
(9) failed to detect a significant reduction in mixed muscle lipid content following 
resistance exercise. In accordance, we observed a non-significant 25±10% net 
decline in calculated mixed muscle lipid content (P=0.087).  
The reported net changes in muscle fiber-type specific lipid content following 
exercise were positively correlated with muscle fiber-type oxidative capacity (table 
3.2). Interestingly, within 120 min of post-exercise recovery, muscle fiber lipid 
content had returned to pre-exercise values. This could be attributed to the 
substantial increase in circulating plasma FFA concentrations during post-exercise 
recovery. Which is similar to reports on IMTG accumulation under conditions of 
elevated plasma FFA availability, like prolonged fasting (38, 40), prolonged 
endurance exercise in regard to inactive muscle tissue (38) and/or 48h of post-
exercise recovery on a relatively high-fat diet (46). The absence of a prolonged net 
reduction in skeletal muscle lipid content implies that the reported stimulating 
effects of resistance exercise on whole-body insulin sensitivity is unlikely to be 
attributed to a reduction in intramuscular lipid content. The latter is in line with the 
fact that the proposed relationship between IMTG deposition and insulin 
sensitivity does not appear functional (44). It has been suggested that the ratio 
between IMTG content and oxidative capacity likely represents a more appropriate 
parameter to assess the risk of developing insulin resistance and/or type 2 diabetes 
(43). This is especially important when evaluating the benefits of exercise 
intervention programs, as intervention studies have actually shown IMTG contents 
to remain stable or even increase despite substantial improvements in muscle 
oxidative capacity and/or whole-body insulin sensitivity (3, 17, 36).  
In conclusion, a single resistance exercise session substantially reduces 
intramyocellular lipid and glycogen content. These changes are fiber-type specific 
and are closely related to fiber-type oxidative capacity. The present data suggest 
that earlier reports on the acute improvements in whole-body insulin sensitivity 
following resistance exercise could, at least partly, be attributed to the net 
reduction in skeletal muscle glycogen content. 
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Abstract 
The aims of this study were to compare different tracer methods to assess whole-
body protein turnover during 6h of prolonged endurance exercise when 
carbohydrate was ingested throughout and to investigate whether the addition of 
protein can improve protein balance. Eight endurance trained athletes were studied 
on 2 different occasions at rest (4h), during 6h of exercise at 50% VO2max (in 
sequential order: 2.5h of cycling, 1h running and 2.5h of cycling) and during 
subsequent recovery (4h). Subjects ingested either carbohydrate (CHO trial; 0.7 g 
CHO∙kg-1∙h-1) or carbohydrate/protein beverages (CHO+PRO trial; 0.7 g 
CHO∙kg-1∙h-1and 0.25 g PRO∙kg-1∙h-1) at 30 min intervals during the entire study. 
Whole-body protein metabolism was determined by infusion of L-[1-13C]leucine, 
L-[2H5]phenylalanine and [15N2]urea tracers with sampling of blood and expired 
breath. Leucine oxidation increased from rest to exercise (CHO: 27±2.5 vs. 
74±8.8; CHO+PRO: 85±9.5 vs. 200±16.3 mg protein∙kg-1∙h-1; P<0.05), whereas 
phenylalanine oxidation and urea production did not increase with exercise. 
Whole-body protein balance during exercise with carbohydrate ingestion was 
negative (-74±8.8; -17±1.1; -72±5.7 mg protein∙kg-1∙h-1, when using L-[1-
13C]leucine, L-[2H5]phenylalanine and [15N2]urea as tracer). Addition of protein to 
the carbohydrate drinks resulted in a positive or less negative protein balance        
(-32±16.3; 165±4.6; 151±13.4 mg protein∙kg-1∙h-1, when using L-[1-13C]leucine, L-
[2H5]phenylalanine and [15N2]urea as tracer). We conclude that even during 6h of 
exhaustive exercise in trained athletes using carbohydrate supplements; net protein 
oxidation does not increase, compared with the resting state and/or post-exercise 
recovery. Furthermore, the combined ingestion of both protein and carbohydrate 
improves net protein balance at rest as well as during exercise and post-exercise 
recovery. 
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Introduction 
In the nineteenth century, skeletal muscle protein was thought to be the main fuel 
used to generate energy for muscle contractions (33). However, controlled 
nitrogen balance studies invalidated the proposed hypothesis as they showed no 
substantial increase in nitrogen loss during and/or following prolonged exercise (9, 
14). Since then various methods have been applied to investigate the effects of 
exercise on protein metabolism. This has resulted in many discrepant findings in 
the literature, which are due in part to differences in the methodology employed 
and in part to the conditions under which different exercise interventions have 
been performed. 
Since the introduction of stable isotope tracers in metabolic research, various 
methods have been applied to study whole-body protein metabolism. Most studies 
have used plasma L-[1-13C]leucine kinetics as a model for whole-body protein 
metabolism. Whereas several studies have reported increases in whole-body 
protein degradation during exercise (23, 25, 39, 40), others have failed to observe 
such changes (6, 26). Wolfe et al. (39) measured the rate of appearance of 13CO2 in 
the expired breath from infused 13C-labeled leucine and reported a 3-fold increase 
in leucine oxidation rates during exercise. The latter was shown to occur in the 
absence of a change in total leucine flux, which implies that the observed increase 
in protein breakdown was accompanied by a reduction in the rate of protein 
synthesis. Another tracer method that has been developed to determine whole-
body protein metabolism, without the necessity of analyzing breath gasses, is the 
use of L-[2H5]phenylalanine according to the model of Clarke and Bier (10) and 
Thompson et al (27). However, that method has not yet been applied to investigate 
the effect of prolonged endurance exercise. Studies applying [15N]urea to 
determine the rate of urea production as a measure of the amount of amino acids 
that are liberated by net protein degradation (degradation – synthesis) and oxidized 
(with conversion of the amino group to urea) during exercise, have not confirmed 
the catabolic nature of prolonged endurance exercise (7, 39).  
The reports using urea as a tracer, indicate that protein synthesis and degradation 
rates do not change during endurance type activities. However, nitrogen balance 
data from field studies suggest that prolonged endurance exercise, leading to 
glycogen depletion, is accompanied by a substantial increase in net protein 
breakdown (13). In accordance, activation of the branched-chain -keto acid 
dehydrogenase complex, the enzyme responsible for leucine oxidation in the 
muscle, has been shown to increase during exercise when glycogen stores are low 
(34, 35). During competition many endurance athletes (e.g. cyclists, triathletes and 
ultra-marathon runners) exercise for more than 5h at relatively high workloads and 
deplete their glycogen stores to a large extent. However, whole-body protein 
turnover measurements using multiple amino acid tracers have not yet been 
performed during such prolonged exhaustive exercise activity. 
Endurance trained athletes try to optimize carbohydrate availability through 
carbohydrate ingestion before, during and after exercise. However, most studies 
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measuring protein turnover during exercise have been performed following an 
overnight fast and with nutritional interventions generally applied during the post-
exercise recovery phase. Little information is available about the effects of 
carbohydrate or carbohydrate and protein supplementation on protein metabolism 
during exercise. The available literature indicates that combined ingestion of 
carbohydrate and protein in the post-exercise recovery phase improves net protein 
balance (12, 22), at least after resistance exercise (2, 3, 24, 28, 29). Ingestion of such 
a substrate mixture during exercise could possibly also affect protein balance 
during and after prolonged endurance exercise.  
In the present study, we determined whole-body protein synthesis and degradation 
rates at rest, during prolonged exhaustive exercise and during subsequent recovery. 
A multiple tracer approach, applying L-[1-13C]leucine, L-[2H5]phenylalanine and 
[15N2]urea infusions was chosen to investigate whether there are differences in 
outcome depending on the applied tracer model. These studies were performed in 
a laboratory setting that resembles real-life endurance exercise competition in elite 
triathletes, combining 6h of exercise with regular carbohydrate supplementation. In 
addition, we investigated whether the addition of protein to carbohydrate ingestion 
can improve net protein balance during exercise and subsequent recovery 
compared with the ingestion of only carbohydrate.  
Methods 
Subjects 
Eight well-trained male subjects (age: 31±3 y; height: 1.84±0.03 m; weight: 
72.4±2.3 kg; body mass index (BMI): 21.4±0.3 kg∙m-2;% bodyfat: 9.6±0.8%, fat 
free mass: 65.7±1.3 kg; maximal workload capacity (Wmax): 383±13 W; maximal 
oxygen uptake capacity (VO2max): 4.9±0.2 L∙min-1) participated in this study. 
Subjects trained around 15h a week (3h swimming, 7h cycling and 5h running) and 
had a training history > 5y. Subjects were informed about the nature and risks of 
the procedures before their written informed consent was obtained. This study was 
approved by the local medical ethical committee of the Academic Hospital 
Maastricht. 
Pre-testing 
VO2max and Wmax were measured on an electronically braked cycle ergometer 
(Lode Excalibur, Groningen, The Netherlands) during an incremental exhaustive 
exercise test (17) one week before the first trial to determine the 45% Wmax 
workload (179±8.6 W; ~50% VO2max), which was applied in these studies. 
Maximum running velocity was determined on a motor driven treadmill with a 1% 
incline (to represent outdoor running) using an incremental exhaustive exercise test 
to determine the 45% maximal running velocity (Vmax) (11.0±0.3 km∙h-1; ~50% 
VO2max). After a 5 min warm-up at 10 km∙h-1, speed was increased every 3 
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minutes by 2 km∙h-1, and from a heart rate of 85% of maximal heart rate with 1 
km∙h-1 every 3 minutes until the subject was unable to continue. 
Diet and activity prior to testing 
All subjects were instructed not to consume any products with a high natural 
abundance of 13C (carbohydrates derived from C4 plants: corn, sugar cane) one 
week before the first trial and during the entire test period. This has been shown to 
minimize possible shifts in background enrichment due to changes in endogenous 
substrate utilization (36). All subjects were also instructed to refrain from heavy 
physical exercise and to maintain normal dietary habits for 3 days prior to each 
trial. In addition, we asked subjects to record their food intake for 48h before the 
start of the first experimental trial and to consume exactly the same food 48h 
before the start of the second test. 
Studies 
All subjects were studied on two different occasions. Each test day consisted of 
three parts during which whole-body protein turnover and whole-body urea 
production rate, were measured at rest, during prolonged exercise and subsequent 
recovery. Via a randomized cross-over design, subjects received beverages 
containing either carbohydrate (CHO) or carbohydrate with protein hydrolysate 
(CHO+PRO) during each trial. An outline of the study design is presented in 
figure 4.1. 
Figure 4.1 Schematic outline of the study protocol. Cycling and running exercises were performed at 50% 
VO2max. Every 30 min throughout the entire test, subjects received a beverage volume of 4 ml∙kg-1 to ensure a 
given dose of 0.7 g∙kg-1∙h-1 carbohydrates (maltodextrin) in the control trial (CHO) and 0.7 g∙kg-1∙h-1 carbohydrate 
and 0.25 g∙kg-1∙h-1 protein hydrolysate in the CHO+PRO trial. 
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Protocol 
The subjects reported at the laboratory at 7.00 am after an overnight fast. A Teflon 
catheter (Baxter BV, Utrecht, The Netherlands) was inserted into an antecubital 
vein of one arm for blood sampling; another catheter was inserted in the 
contralateral arm for isotope infusion. A resting blood sample was drawn and 
expired breath samples were collected into vacutainer tubes (Becton Dickinson, 
Meylan, France) to measure baseline enrichments. Thereafter, a single intravenous 
dose of NaH13CO3 (5.9 µmol∙kg-1) was administered to prime the bicarbonate pool, 
which was followed by a L-[1-13C]leucine (7.6 µmol∙kg-1), L-[2H5]phenylalanine (3.0 
µmol∙kg-1), [15N2]urea (88 µmol∙kg-1) and L-[2H4]tyrosine (0.46 µmol∙kg-1) prime. 
Thereafter (t=0), continuous infusion of L-[1-13C]leucine (7.6 µmol∙kg-1∙h-1), L-
[2H5]phenylalanine (3 µmol∙kg-1∙h-1), [15N2]urea (88 µmol∙kg-1∙h-1) was started via a 
calibrated IVAC 560 pump (San Diego, CA, USA) and continued for 14h. After 
the start of the tracer infusion, subjects rested for 4h (resting period). 
Subsequently, subjects exercised for 6h at a moderate intensity (45% Wmax), 
starting with 2.5h of cycling, followed by 1h of treadmill running, and another 2.5h 
of cycling exercise. Subjects were not allowed to rest between the different exercise 
bouts apart from the time necessary to change from ergometer to treadmill and 
back. After cessation of exercise, subjects rested for 4h (recovery). During the pre-
exercise resting period and during the post-exercise recovery phase breath and 
blood samples were obtained every 30 and 60 minutes, respectively. During cycling 
exercise periods blood and breath samples were collected every 30 minutes and 
VO2 and VCO2 were measured (Oxycon- , Mijnhardt, Bunnik, The Netherlands) 
at 30 min intervals for 5 min.  
Beverages 
Directly after the start of the stable isotope infusion and every 30 min throughout 
the entire trial (before, during and after exercise), subjects received a beverage 
volume of 4 ml∙kg-1 to ensure a given dose of 0.7 g∙kg-1∙h-1 carbohydrates 
(maltodextrin) in the control trial (CHO) and 0.7 g∙kg-1∙h-1 carbohydrate and 0.25 
g∙kg-1∙h-1 protein hydrolysate in the CHO+PRO trial. The drinks were prepared by 
Quest International (Naarden, The Netherlands). L-[2H5]phenylalanine and L-[1-
13C]leucine enrichment in the beverages was measured using GC-MS and did not 
differ from the L-[2H5]phenylalanine and L-[1-13C]leucine enrichment in the 
plasma background samples. Therefore, beverage ingestion did not alter plasma 
enrichment and corrections were not required. The beverages contained per liter: 
80 g maltodextrin, 25 g glucose syrup, 0.3 g sodium-benzoaat, 2.25 g citrus 
compound, 1 g citric acid and 0.2 g ascorbic acid with or without the addition of 
30 g rice hydrolysate (Hyprol Dev 8115, Quest International). Amino acid profile 
of the rice hydrolysate is listed in table 4.1.  
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Table 4.1 Amino acid composition of the protein hydrolysate 
Amino acids Rice hydrolysate 
L-Arginine (Arg) 5.6 
L-Histidine (His) 1.5 
L-Asparagnine (Asn) 4.1 
L-Glutamine (Gln) 7.7 
L-Lysine (Lys) 2.8 
L-Glycine (Gly) 2.7 
L-Alanine (Ala) 3.5 
L-Tryptophan (Trp) 0.6 
L-Serine (Ser) 3.4 
L-Proline (Pro) 2.4 
L-Valine (Val) 3.9 
L-Threonine (Thr) 2.4 
L-Cysteine (Cys) 0.6 
L-Isoleucine (Ile) 2.8 
L-Leucine (Leu) 5.2 
L-Aspartate (Asp) 2.4 
L-Glutamate (Glu) 4.5 
L-Methionine (Met) 1.4 
L-Phenylalanine (Phe) 3.6 
L-Tyrosine (Tyr) 3.3 
Values expressed in g∙100g dry product-1. 
Plasma analyses 
Blood samples were collected in EDTA containing tubes and centrifuged at 1000 g 
and 4°C for 5 min. Aliquots of plasma were frozen in liquid nitrogen and stored at 
–80°C. Plasma [1-13C]alpha-Ketoisocaproate (KIC) enrichment was measured 
using a quinoxalinoltrimethylsilyl derivate (31), whereas L-[2H5]phenylalanine and 
L-[2H4]tyrosine enrichments were measured using their t-butyldimethylsilyl 
derivates on a gas chromatography mass spectrometer (GC-MS) (Finnigan: Incos 
XL, Bremen, Germany) (27). Plasma [15N2]urea enrichment was measured using 
the N,N’-bistrimethylsilyl derivate of urea on a GC-MS (39). Breath 13CO2 
enrichment in the expired air was measured by GC continuous flow-IRMS 
(Finnigan, MAT-252). 
Calculations 
The rate of protein turnover was calculated as described previously (20). Briefly, 
leucine turnover (flux, Q) was measured from the dilution of L-[1-13C]leucine 
infusion in plasma alpha-KIC at isotopic steady state:  
where i is the [1-13C]leucine infusion rate ( mol∙kg body weight-1∙h-1), Ei is the 
enrichment of the [1-13C]Leucine infused (expressed in atom percent excess; APE) 
1
Ep
Ei
iQ
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and Ep is the [1-13C]alpha-KIC enrichment in the plasma at steady state (APE). 
The background enrichment of expired 13CO2 was measured before the start of 
tracer infusions. This background enrichment was subtracted from the isotopic 
plateau value for the calculation of leucine oxidation. Leucine oxidation rates were 
also corrected for bicarbonate retention. In endurance trained subjects, employed 
bicarbonate retention factors were 83.1% for rest and 98.9% for exercise (11). The 
rate of leucine oxidation is calculated using, 
where F13CO2 is the rate of 13CO2 production and release in the expired breath 
(µmol 13CO2∙kg-1∙h-1). At isotopic steady state, protein flux (Q) equals the sum of 
protein synthesis (S) and oxidation (O) as well as the sum of the rate of appearance 
of meal protein from the gut (I) and protein breakdown (B), whole-body protein 
synthesis rate was calculated as flux minus oxidation.  
The leucine parameters mentioned above were converted to corresponding 
estimates of whole-body protein turnover by multiplying the leucine values by the 
constant 1/(590 µmol leucine∙g-1protein) to give values of g protein∙kg-1∙h-1 (20). 
The 590 µmol leucine∙g protein-1 factor corresponds to a protein leucine content of 
7.8% and was derived from averaged values for leucine content of protein of 
human and other mammal muscles (20).  
In addition, we used the phenylalanine balance model as described by Thompson 
et al (27). In this model, phenylalanine flux (Qp) can be calculated by isotope 
dilution using equation 1, where i is the L-[2H5]phenylalanine infusion rate 
(µmol∙kg-1∙h-1), Ei is the enrichment of the L-[2H5]phenylalanine infused (expressed 
in APE) and Ep is the L-[2H5]phenylalanine in the plasma at steady state (APE). At 
isotopic steady state, whole-body phenylalanine oxidation can be determined from 
the conversion (hydroxylation) of L-[2H5]phenylalanine to L-[2H4]tyrosine. The rate 
of hydroxylation (Qpt) was calculated (27) using the formula 
where Pt/Pp (=0.73) is the molar ratio of the fluxes of tyrosine and phenylalanine 
arising from protein catabolism (27), Qp is the phenylalanine flux, Et is the L-
[2H4]tyrosine enrichment, and ip is the L-[2H5]phenylalanine infusion rate (µmol∙kg-
1∙h-1). Protein synthesis and degradation using this approach was calculated using  
Rates of protein synthesis and degradation (g protein∙kg bodyweight-1∙h-1) are 
calculated using the phenylalanine content of protein of 280 µmol∙g-1protein (27). 
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The 280 µmol phenylalanine∙g protein-1 factor was derived from protein 
composition measurements in animals (21).  
The net protein balance (table 4.2) was calculated from the difference between 
whole-body protein synthesis (S) and degradation (B) determined using the leucine 
and phenylalanine model as described above. 
The rate of urea production was calculated using equations described previously 
(38). In short, at isotopic steady state during the constant infusion of [15N2]urea, 
two enrichments (expressed in tracer tracee ratio; TTR) were measured, A and B 
The rate of urea production was calculated using 
where F is the [15N2]urea infusion rate (µmol∙kg-1∙h-1). 
The net balance of the amount (g∙kg-1∙h-1) of protein that was broken down in the 
CHO trial and converted to urea was calculated by converting urea production 
rates to mg N produced per kg per h and multiplying with 6.25 (1 g of protein 
contains 160 mg of nitrogen). The positive protein net balance (protein synthesis – 
protein degradation) reported in table 4.2 was calculated in this case by again 
converting the observed urea production rate to protein oxidation rates and then 
taking the difference between protein ingestion and protein oxidation (both in g 
protein∙kg-1∙h-1). 
Statistics 
All data are expressed as mean±SEM. To compare tracer kinetics, protein 
synthesis and degradation rates between the different interventions over time, a 
two way repeated measures ANOVA was used with both subject and treatment as 
factors. A Scheffé’s post-hoc test was applied in case of a significant F-ratio to 
locate specific differences. Student’s t-tests for paired observations were used to 
compare differences in protein synthesis, breakdown, oxidation, net balance and 
urea production between the CHO and CHO+PRO trial. Significance was set at 
the 0.05 level of confidence.  
urea unlabeled
urea labeledsingly 
A
BA
F
Q
2
2
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Results 
Tracer kinetics 
Figure 4.2 Tracer data. A, plasma L-[ 2H5]phenylalanine (Phe) and L-[ 2H4]tyrosine (Tyr) enrichment; B, plasma 
[13C]alphaKIC; C, breath 13CO2 enrichment; D, plasma [15N2]urea enrichment. APE, atom percent excess. Data 
are means±SEM. * Significantly different between studies (P<0.05); ^ significantly different from rest (P<0.05); # 
significantly different from recovery (P<0.05) 
Plasma L-[2H5]phenylalanine and L-[2H4]tyrosine enrichment, plasma [1-13C]alpha-
KIC enrichment, breath 13CO2 enrichment and plasma [15N2]urea enrichment are 
shown in figure 4.2A, B, C and D, respectively. Plasma L-[2H5]phenylalanine, L-
[2H4]tyrosine, [1-13C]alpha-KIC reached a steady state after 2h of infusion. Breath 
13CO2 enrichment was significantly lower during exercise (P<0.05) compared with 
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both resting conditions and post-exercise recovery. Plasma [15N2]urea enrichment 
slightly increased over time during the CHO trial, with significantly higher plasma 
[15N2]urea enrichment during recovery compared with pre-exercise resting values 
(P<0.05). In contrast, during the CHO+PRO trial plasma [15N2]urea enrichment 
remained constant throughout the entire trial. During the CHO+PRO trial plasma 
L-[2H5]phenylalanine, L-[2H4]tyrosine, [1-13C]alpha-KIC and [15N2]urea enrich-
ments were significantly lowered compared with the CHO trial (P<0.05). Breath 
13CO2 enrichment was elevated during the CHO+PRO trial compared with the 
CHO trial (P<0.05). 
Phenylalanine model 
Protein flux was similar at rest, during exercise 1 and 2 and during post-exercise 
recovery (176±6, 170±6, 172±7 and 162±15 mg protein∙kg-1∙h-1respectively) in the 
CHO trial and (303±26, 294±14, 264±14 and 293±21 mg protein∙kg-1∙h-1 
respectively) in the CHO+PRO trial. However, in the CHO+PRO trial, protein 
flux was ~70% increased at rest, during exercise and in the post-exercise recovery 
phase, when compared with the CHO trial (P<0.01). 
Figure 4.3 Whole-body protein synthesis (A) and degradation (B) calculated on basis L-[ 1-13C]leucine and         
L-[ 2H5]phenylalanine at rest, during exercise 1 and 2 and during recovery. Data are means±SEM; ^ significantly 
different from rest (P<0.01); # significantly different from recovery (P<0.01); * significantly different between 
studies (P<0.05). 
Whole-body protein synthesis (mg protein∙kg-1∙h-1) during the CHO and 
CHO+PRO trials is shown in figure 4.3A. No differences were found in protein 
synthesis rates during exercise compared to rest and recovery phase. However, 
under all conditions protein synthesis rates were higher in the CHO+PRO trial, 
when compared with the CHO trial (P<0.01). 
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Protein degradation rates (mg protein∙kg-1∙h-1) did not change during exercise 
(figure 4.3B). A marked decrease in protein breakdown was observed throughout 
the CHO+PRO trial, when compared with the CHO trial (P<0.01). 
Whole-body protein oxidation (mg protein∙kg-1∙h-1) is shown in figure 4.4. Whole-
body protein oxidation was similar at rest, during exercise and during post-exercise 
recovery (13±1, 17±1, 19±2 and 15±2 mg protein∙kg-1∙h-1 respectively) in the 
CHO trial and (31±4, 30±3, 25±2 and 27±3 mg protein∙kg-1∙h-1 respectively) in the 
CHO+PRO trial. During the CHO+PRO trial protein oxidation rates were higher 
at rest, during exercise and recovery when compared with the CHO trial (P<0.05). 
During exercise, whole-body protein balance (mg protein∙kg-1∙h-1) was not different 
from resting conditions and post-exercise recovery (figure 4.5). In the CHO+PRO 
trial, protein balance was positive whereas protein balance was negative in the 
CHO trial. 
Figure 4.4 Whole-body protein oxidation calculated on basis L-[1-13C]leucine and L-[2H5]phenylalanine at rest, 
during exercise 1 and 2 and during recovery. Data are means±SEM; ^ significantly different from rest (P<0.01); # 
significantly different from recovery (P<0.01); * significantly different between studies (P<0.05). 
Leucine model 
Protein flux (mg protein∙kg-1∙h-1) was not different during exercise compared with 
fluxes at rest and during post-exercise recovery. Protein flux was ~50% higher at 
rest, during exercise and in the post-exercise recovery phase (P<0.01) in the 
CHO+PRO trial, when compared with the CHO trial. 
Whole-body protein synthesis (mg protein∙kg-1∙h-1) in the CHO and CHO+PRO 
studies is shown in figure 4.3A. Protein synthesis rates were decreased during 
exercise compared with rates at rest and during post-exercise recovery (P<0.01). 
Whole-body protein synthesis tended to be increased at rest (P=0.09), but was 
similar during exercise and post-exercise recovery in the CHO+PRO trial, when 
compared with the CHO trial. 
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Protein degradation rates (mg protein∙kg-1∙h-1) did not change during exercise 
(figure 4.3B). A marked decrease in protein breakdown was observed throughout 
the CHO+PRO trial, when compared with the CHO trial (P<0.01). 
Whole-body protein oxidation (mg protein∙kg-1∙h-1) is shown in figure 4.4. Protein 
oxidation rates were 2-3 fold higher during exercise than at rest and during post-
exercise recovery (P<0.01) in the CHO and CHO+PRO trial. In the CHO+PRO 
trial, protein oxidation was increased at rest, during exercise and recovery when 
compared with the CHO trial (P<0.05). 
During the CHO trial whole-body protein balance (mg protein∙kg-1∙h-1) was 
negative at rest, during exercise and during subsequent recovery. Protein balance 
was more negative during exercise compared with the rest and recovery period 
(P<0.01) (figure 4.5). During the CHO+PRO trial, protein balance was less 
negative at rest, during exercise and during post-exercise recovery, when compared 
with the CHO trial (P<0.01), however protein balance during exercise remained 
negative. 
Figure 4.5 Net whole-body protein balance calculated on basis L-[1-13C]leucine and L-[2H5]phenylalanine at rest, 
during exercise 1 and 2 and during recovery. Data are means±SEM; ^ significantly different from rest (P<0.01); # 
significantly different from recovery (P<0.01); * significantly different between studies (P<0.05). 
Phenylalanine model vs. leucine model 
The relative increase in protein flux in the CHO+PRO trial compared with the 
CHO trial was similar for both applied tracers (L-[2H5]phenylalanine, +70±14%; 
L-[1-13C]leucine, +48±12%). 
Protein synthesis was 69±14% increased in the CHO+PRO trial compared with 
the CHO trial when phenylalanine was used as a tracer. The leucine model showed 
no differences in protein synthesis rates between trials. 
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The relative decrease in protein degradation in the CHO+PRO trial compared 
with the CHO trial was similar for both applied amino acid tracers (L-
[2H5]phenylalanine, -55±11%; L-[1-13C]leucine, -62±8%). 
Protein oxidation was increased with both tracer models during the CHO+PRO 
trial when compared with the CHO trial. The relative increase in protein oxidation 
in the CHO+PRO trial compared with the CHO trial was higher when measured 
with L-[1-13C]leucine than with L-[2H5]phenylalanine (190±30% vs. 82±22%, 
P<0.05). 
Protein balance was improved with both tracer models during the CHO+PRO trial 
when compared with the CHO trial (P<0.05). The relative increase in protein 
balance in the CHO+PRO trial compared with the CHO trial was higher when 
measured with L-[2H5]phenylalanine than with L-[1-13C]leucine (P<0.01).  
Urea model and comparison with other tracers 
Urea kinetics were calculated using a [15N2]urea tracer and results are illustrated in 
figure 4.6. During the CHO trial urea production decreased during exercise and 
recovery compared with resting values, whereas during the CHO+PRO trial urea 
production remained constant. Urea production was higher during the 
CHO+PRO trial compared with the CHO trial (P<0.05).  
Figure 4.6 Urea production calculated on basis [15N2]urea data at rest, during exercise 1 and 2 and during 
recovery. Data are means±SEM; ^ significantly different from rest (P<0.01); # significantly different from 
recovery (P<0.01); * significantly different between studies (P<0.05). 
Net protein balance calculated from urea production rates was less negative during 
exercise and recovery compared with resting values in the CHO trial (P<0.05). No 
changes in net protein balance were observed in the CHO+PRO trial. Calculated 
net protein balance was positive in the CHO+PRO trial, whereas during the CHO 
trial net protein balance was negative.  
Chapter 4 
78 
In the CHO trial, whole-body protein oxidation did not change in time with L-
[2H5]phenylalanine applied as a tracer, increased during exercise with L-[1-
13C]leucine used as a tracer to return to resting values in the recovery period, and 
gradually decreased in time with [15N2]urea as tracer. In the CHO+PRO trial, 
whole-body protein oxidation did not change in time with the L-[2H5] 
phenylalanine and [15N2]urea as tracer and increased during exercise with L-[1-13C] 
leucine as tracer to return to resting values in the recovery period. 
Protein balance was improved with all tracer models applied in this trial during the 
CHO+PRO trial when compared with the CHO trial. The phenylalanine model 
and the urea model both indicate that the net protein balance is positive in the 
CHO + PRO trial at rest, during exercise and during recovery.  
Discussion 
In the present study we show that whole-body estimates of protein metabolism 
during exercise are highly dependent on the specific tracermethod that is applied. 
Using L-[1-13C]leucine as a tracer to study the effects of exercise on protein 
metabolism shows that protein oxidation is increased 2-3 fold during exercise. 
However, when using L-[2H5]phenylalanine as a tracer, protein oxidation, synthesis 
and degradation rates were not affected by exercise. In addition, urea production, 
measured using [15N2]urea, decreased in time during the CHO trial. Thus, two of 
the three methods indicate that prolonged exhaustive exercise does not lead to 
increased protein oxidation and/or a more negative protein balance. Although the 
application of different tracer methods produce different outcomes upon the effect 
of exercise on protein metabolism, each method shows that protein balance is 
negative when only carbohydrates are ingested. The addition of protein to 
carbohydrate ingestion improves whole-body protein balance, when measured 
using both the phenylalanine and the leucine model used in the present study.  
Urea production in subjects not ingesting any protein is generally considered a 
reflection of the amount of amino acids that are released by net protein 
degradation (degradation - synthesis) and subsequently oxidized with conversion of 
the amino group to urea. Studies on the effect of exercise on urea production have 
consistently found no significant change from the basal rate (7, 39, 40), leading to 
the conclusion that the rate of net protein catabolism (degradation – synthesis) and 
amino acid oxidation was not changed. However, data obtained using another 
approach to determine whole-body protein turnover, involving the infusion of L-
[1-13C]leucine and the determination of leucine turnover and 13CO2 appearance in 
the expired air, indicated that leucine oxidation was markedly increased during 
exercise (4, 5, 39, 40). Because of this discrepancy between methods, we applied 
both tracer methods in the same study. In addition, we also applied a third tracer, 
L-[2H5]phenylalanine, which has been successfully applied at rest (10, 27), but not 
during exercise conditions. In contrast to most studies we used an experimental 
setup, which included exercise and the continuous ingestion of carbohydrate 
(CHO) or carbohydrate and protein supplements (CHO+PRO) as athletes always 
ingest carbohydrates during exercise (training or competition) of this duration and 
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intensity. With leucine as tracer, protein oxidation was 2 to 3-fold higher during 
exercise than in the resting or recovery period (figure 4.4). The widely used L-[1-
13C]leucine model for the calculation of whole-body protein synthesis and 
breakdown therefore suggests that exercise inhibits protein synthesis (figure 4.3A). 
However, with phenylalanine used as tracer, protein oxidation, synthesis and 
degradation were similar at rest, during exercise and recovery (figure 4.4, 4.3A and 
B, respectively). Moreover, urea production and the amount of protein oxidation 
calculated from it also did not increase during exercise (figure 4.6). Thus, both the 
phenylalanine model and urea data show that prolonged moderate intensity 
exercise does not lead to an imbalance between protein synthesis and degradation 
and subsequent oxidation of the liberated amino acids. This is in line with tracer 
incorporation studies (8, 30), which reported no change in muscle protein synthesis 
both during moderate endurance exercise and recovery. However, results from 
both the phenylalanine model and the leucine model in the present study show that 
whole-body protein balance is negative at rest, during exercise and during post-
exercise recovery when only carbohydrates are ingested (figure 4.5). 
A several fold increase in leucine oxidation without changes in urea production 
during exercise has been previously observed (39, 40). Moreover, other studies also 
showed no effect of exercise on plasma urea concentration (26), production (7) or 
urinary excretion (6, 18, 23). An explanation for the discrepancy between the 
leucine and urea data is that leucine metabolism during exercise is not 
representative of the fate of the other amino acids that are present in proteins. The 
stochastic leucine model, therefore, cannot be used to investigate whole-body 
protein metabolism during exercise. A difference in time response of leucine and 
urea kinetics theoretically also leads to an apparent absence of an increase in urea 
production during high rates of leucine oxidation. The urea pool is large and turns 
over with a half-life of 8-10h (16, 19, 37). This implies that any increase in urea 
production due to an accelerated protein oxidation rate during exercise should 
have become apparent either during or following the 6h exercise period. However, 
in the CHO trial we observed a gradual decrease instead of an increase in urea 
production over time. Such a decrease in urea production in time has previously 
been reported in studies at rest after an overnight fast (37). The latter can be 
attributed to the delayed response of the urea production following changes in 
protein intake (16, 37).  
In the present study, we also investigated phenylalanine metabolism. We 
determined the rate of conversion (hydroxylation) of L-[2H5]phenylalanine to L-
[2H4]tyrosine at rest, during exercise and during recovery. This is the first step of 
phenylalanine oxidation and we found that its rate did not change during exercise 
and/or recovery in comparison to the resting state. This is in line with findings 
reported by Wolfe et al. (40) using a lysine tracer. In the latter study the increase in 
lysine oxidation during exercise was small compared with the increase in leucine 
oxidation. In addition, a discrepancy existed between the [15N]- and [13C]lysine flux 
data and the [13C]- and [15N]leucine flux data, which is similar to the discrepancy 
between phenylalanine and leucine observed in the present study. 
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One of the likely causes of the discrepancy between the lysine and/or 
phenylalanine tracer and the leucine tracer methods is the fact that during exercise, 
uptake (1, 32) and oxidation (32, 34, 35) of branched chain amino acids (leucine, 
isoleucine and valine) are increased several fold in contracting muscle. As such, the 
leucine tracer does not seem to be representative of the fate of the other essential 
amino acids during exercise. The latter means that the stochastic leucine model of 
whole-body protein metabolism (20) becomes invalid during exercise and cannot 
be used to estimate qualitative or quantitative changes in whole-body protein 
synthesis and/or degradation. 
Most studies measuring protein turnover during exercise were performed in the 
morning after an overnight fast, which does not represent every day practice in the 
competitive athletes. Athletes optimize carbohydrate availability before and during 
exercise to enhance endurance performance capacity. During subsequent recovery 
they ingest mixed meals or carbohydrate/protein recovery drinks. The present 
study demonstrates that net protein degradation does not increase during moderate 
intensity exercise when carbohydrate is ingested. This implies that net protein 
breakdown and oxidation is minimal during athletic events such as 
(ultra)marathons and prolonged cycling races when carbohydrate is ingested. 
Although protein degradation and synthesis are unaltered by exercise when CHO 
(0.7 g∙kg-1∙h-1) are ingested, whole-body protein balance measured with L-
[2H5]phenylalanine was slightly negative during exercise and during recovery in the 
present study. However, the imbalance between protein synthesis and degradation 
and the amount of protein oxidized was not larger than in the resting state (figure 
4.5). 
It has previously been shown that infusion or ingestion of amino acids alone or in 
combination with carbohydrate increases protein synthesis and reduces protein 
degradation both at a whole-body level and in skeletal muscle tissue under resting 
conditions (12, 15, 22) and after resistance exercise (2, 3, 24, 28, 29), resulting in a 
positive protein balance. We aimed to investigate whether the addition of protein 
to a carbohydrate supplement can improve whole-body protein balance during and 
following prolonged endurance exercise leading to a (more) positive protein 
balance, as previously observed in the resting state. Combined ingestion of protein 
and carbohydrate resulted in an increased whole-body protein synthesis rate at rest, 
during exercise and recovery when compared with carbohydrate supplementation 
only. Although protein oxidation was increased ~2 fold at rest, during exercise and 
recovery with the protein supplement, whole-body protein degradation decreased 
by ~60%. Thus, the present study shows that the combined ingestion of protein 
and carbohydrate improves net protein balance at rest, during prolonged moderate 
intensity exercise and subsequent recovery in elite endurance athletes. With 
phenylalanine and urea as tracer a positive net protein balance was achieved, 
whereas ingestion of only carbohydrate resulted in a negative protein balance.  
The L-[2H5]phenylalanine tracer method indicate that protein flux and oxidation 
rates are increased as expected when protein is orally ingested. In addition, co-
ingestion of protein with carbohydrate results in a decreased rate of protein 
degradation and improved protein balance. The [15N2]urea tracer provides a similar 
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outcome upon the effect of exercise on net protein balance as the L-
[2H5]phenylalanine tracer. Urea production slightly increases when protein is 
ingested (figure 4.6). This is due to the fact that more protein is ingested than is 
used for protein synthesis. The excess is directly oxidized or used for 
gluconeogenesis and/or lipogenesis with the aminogroup being disposed as urea. 
The balance between protein synthesis and degradation calculated from the 
difference between urea production observed and the urea equivalent of the 
ingested amount of protein (table 4.2) indicates that there is net positive protein 
balance, which is quantitatively similar to the estimates made from the figures 
generated by the phenylalanine tracer both at rest, during exercise and during 
recovery. This implies that the information generated by the phenylalanine tracer 
and urea tracer on the effect of protein ingestion is similar in all time periods 
studied, while the leucine data generate a different message during exercise 
(positive balance at rest and during recovery and negative balance during exercise).  
In summary, this study shows that the L-[2H5]phenylalanine, L-[1-13C]leucine and 
[15N2]urea tracers models reveal the same qualitative effect of the combined 
ingestion of protein and carbohydrate on whole-body protein balance at rest and 
during recovery. However, the L-[1-13C]leucine model for measurements of whole-
body protein turnover overestimates protein oxidation rates and underestimate 
protein synthesis rates during exercise. We conclude that prolonged exhaustive 
moderate intensity exercise does not result in increased protein degradation and/or 
a decrease in protein synthesis compared with resting situations in endurance-
trained athletes. Whereas whole-body protein balance remains negative when only 
carbohydrates are ingested, co-ingestion with protein improves protein balance by 
increasing synthesis and decreasing breakdown, resulting in a positive net protein 
balance both at rest, during prolonged moderate intensity exercise and during 
recovery. 
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Abstract 
The present study was designed to determine post-exercise muscle protein 
synthesis and whole-body protein balance following the combined ingestion of 
carbohydrate with or without protein and/or free leucine. Eight male subjects were 
randomly assigned to 3 trials in which they consumed drinks containing either 
carbohydrate (CHO), carbohydrate and protein (CHO+PRO), or carbohydrate, 
protein and free leucine (CHO+PRO+leu) following 45 min of resistance exercise. 
A primed, continuous infusion of L-[ring-13C6]phenylalanine was applied, with 
blood samples and muscle biopsies collected to assess fractional synthetic rate 
(FSR) in the m. vastus lateralis as well as whole-body protein turnover during 6h of 
post-exercise recovery. Plasma insulin response was higher in the CHO+PRO+leu 
compared to the CHO and CHO+PRO trials (+240±19% and +77±11%, 
respectively, P<0.05). Whole-body protein breakdown rates were lower, and 
whole-body protein synthesis rates were higher in the CHO+PRO and 
CHO+PRO+leu trials compared to the CHO trial (P<0.05). Addition of leucine in 
the CHO+PRO+leu trial resulted in a lower protein oxidation rate compared to 
the CHO+PRO trial. Protein balance was negative during recovery in the CHO 
trial, but positive in the CHO+PRO and CHO+PRO+leu trials. In the 
CHO+PRO+leu trial, whole-body net protein balance was significantly greater 
compared to values observed in the CHO+PRO and CHO trials (P<0.05). Mixed 
muscle fractional synthetic rate, measured over a 6h period of post-exercise 
recovery, was significantly greater in the CHO+PRO+leu trial compared to the 
CHO trial (0.095 0.006 %∙h-1 vs. 0.061 0.008 %∙h-1, respectively; P<0.05), with 
intermediate values observed in the CHO+PRO trial (0.0820±0.0104 %∙h-1). We 
conclude that the co-ingestion of protein and leucine stimulates muscle protein 
synthesis and optimizes whole-body protein balance when compared to the intake 
of carbohydrate only.  
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Introduction 
Resistance training can substantially augment skeletal muscle size and it has been 
shown that after resistance exercise, mixed muscle protein synthesis is stimulated 
for up to 48h (12, 35). Simultaneously, the rate of muscle protein degradation is 
also increased after exercise (7, 35). However, in the absence of food intake net 
muscle protein balance remains negative (7, 35, 36). Carbohydrate supplementation 
in the post-exercise recovery phase has been shown to result in a decrease in 
urinary 3-methylhistidine and urea excretion, suggesting that protein degradation is 
reduced (40). However, muscle protein synthesis does not seem to be affected 
following carbohydrate ingestion (10, 40). Although carbohydrate ingestion 
improves net leg amino acid balance compared with water or placebo intake, the 
net balance remains negative (10). It has been shown using different tracer 
methods/models (e.g. tracer incorporation measurements in muscle, leg amino 
acid exchange methods or whole-body measurements) that the combined infusion 
or ingestion of carbohydrate and protein/amino acids is needed to increase protein 
synthesis rate, to reduce protein degradation, and thus to elicit a positive net 
protein balance under resting conditions (13, 33) and during recovery from 
resistance exercise (8, 11, 39, 43, 44). Moreover, in a recent study (25), we have 
shown that the combined ingestion of protein and carbohydrate leads to a positive 
protein balance during ultra endurance exercise and subsequent recovery. The 
combined ingestion of carbohydrate and protein/amino acids in the post-exercise 
recovery phase can stimulate protein metabolism in several ways. Besides 
providing amino acids as precursors for protein synthesis, combined ingestion of 
carbohydrate and protein/amino acids can elicit a strong insulinotropic response 
(34, 38, 49).  
Combined ingestion of carbohydrate with protein and/or free amino acids (34, 38, 
47-49), as well as intravenous infusion of free amino acids (16, 17) has been shown 
to further elevate plasma insulin levels. It has been speculated that such elevated 
insulin concentrations can stimulate the uptake of selected amino acids (6) and 
muscle protein synthesis rate (6, 20). In addition, insulin has been reported to 
effectively inhibit proteolysis (9, 18, 19). Nonetheless, the exact mechanisms 
responsible for the stimulatory effects of carbohydrate and protein/amino acid 
ingestion on muscle protein synthesis during recovery from resistance exercise 
have not yet been established in detail. For example, in animal models, free leucine 
has been shown to stimulate protein synthesis by an insulin-independent 
mechanism (2, 3). Consequently, it has been speculated that a nutritional 
supplement containing carbohydrate, protein and free leucine could represent an 
effective tool to further increase post-exercise muscle protein synthesis and/or to 
inhibit protein degradation. 
The main aim of the present study was to investigate the effect of carbohydrate 
(CHO), carbohydrate and protein (CHO+PRO) as well as carbohydrate, protein 
and leucine (CHO+PRO+leu) ingestion on the anabolic response to resistance 
exercise. By measuring the incorporation rate of labeled amino acids in the skeletal 
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muscle protein pool, mixed muscle protein synthesis rates were directly measured 
during 6h of recovery from strenuous resistance exercise. A primed constant 
infusion of L-[ring-13C6]phenylalanine was combined with plasma and muscle 
tissue sampling to simultaneously measure mixed muscle fractional protein 
synthetic rate and whole-body protein turnover.  
Methods 
Subjects 
8 healthy, untrained male volunteers (age: 22.3±0.9 y; weight: 74.1±3.5 kg; height: 
1.81±0.02 m; BMI: 22.5±0.9 kg∙m-2; % body fat: 16.0±3%), with no history of 
participating in any regular exercise program, were recruited for the present study. 
All subjects were informed on the nature and possible risks of the experimental 
procedures before their informed consent was obtained. The latter after approval 
by the Medical Ethical Committee of the Academic Hospital Maastricht, The 
Netherlands. 
Pretesting  
All subjects participated in an orientation trial to become familiarized with the 
exercise protocol and the equipment. Proper lifting technique was demonstrated 
and practiced for each of the 2 lower-limb exercises (leg press and leg extension). 
Thereafter maximum strength was estimated using the multiple repetitions testing 
procedure (29). In another session, at least 1 wk before the first experimental trial, 
subjects’ 1 repetition maximum (1RM) was determined (26). After warming up, the 
load was set at 90-95% of the estimated 1RM, and increased after each successful 
lift until failure. A five-minute resting period between the subsequent attempts was 
allowed. A repetition was valid if the subject was able to complete the entire lift in 
a controlled manner without assistance. The average 1RM for the leg press was 
185±9 kg and the mean 1RM for the leg extension was 106±4 kg. 
Diet and activity prior to testing  
All subjects consumed a standardized meal (66.1±2.7 kJ∙kg-2, consisting of 72 
Energy% (En%) carbohydrate, 23 En% protein and 5 En% fat) the evening before 
the trials. All volunteers were instructed to refrain from any sort of heavy physical 
exercise and to keep their diet as constant as possible 3 days before the trials. In 
addition, subjects were asked to record their food intake for 48h before the start of 
the first experimental trial and to consume the same diet 48h before the start of the 
second and third test. 
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Experimental trials 
Each subject participated in 3 trials, separated by at least 7 days, in which recovery 
drinks containing either carbohydrate (CHO), carbohydrate and protein 
(CHO+PRO) or carbohydrate, protein and leucine (CHO+PRO+leu) were tested 
in a randomized and double-blind fashion. Each trial lasted ~8 h. Repeated boluses 
of a given test-drink were ingested following the exercise protocol to ensure a 
continuous supply of ample glucose and amino acids to the muscle. Plasma and 
muscle samples were collected during a 6 h post-exercise period. These trials were 
designed to simultaneously assess whole-body amino acid kinetics and fractional 
synthetic rate (FSR) of mixed muscle protein by the incorporation of L-[ring-
13C6]phenylalanine in the m. vastus lateralis. 
Protocol 
At 8.00 am, after an overnight fast, subjects reported at the laboratory and a Teflon 
catheter was inserted into an antecubital vein for stable isotope infusion. A second 
Teflon catheter was inserted in a heated dorsal hand vein of the contralateral arm, 
which was placed in a hot-box (60 C) for arterialized blood sampling. After 
collection of a resting blood sample, a single intravenous dose of L-[ring-
13C6]phenylalanine (2 mol∙kg-1) was administered to prime the phenylalanine pool. 
Thereafter, tracer infusion was started with subjects resting in a supine position. 
After 75 min of infusion, a second blood sample was collected and subjects started 
the resistance exercise protocol. The exercise session consisted of 8 sets of 8 
repetitions on the horizontal leg press machine (Technogym BV, Rotterdam, The 
Netherlands) and 8 sets of 8 repetitions on the leg extension machine 
(Technogym). Both exercises were performed at 80% of the subjects’ individual 
1RM with 2 min rest intervals between the sets and in total required ~45 min to 
complete. All subjects were verbally encouraged during the test to complete the 
whole protocol. At the end of the resistance exercise protocol (t=0 min), subjects 
rested supine and a arterialized blood sample from the heated hand vein as well as 
a muscle biopsy from the m. vastus lateralis muscle were collected. Subjects then 
received an initial bolus (3 ml∙kg-1) of a given test drink. Repeated drinks (3 ml∙kg-1) 
were taken every 30 min until t=330 min post-exercise. Blood samples were 
subsequently taken from the heated hand vein at t= 15, 30, 45, 60, 75, 90, 120, 150, 
180, 210, 240, 270, 300, 330 and 360 min with an additional muscle biopsy taken at 
360 min post-exercise. 
Muscle biopsies 
Muscle biopsies were obtained from the middle region of the m. vastus lateralis (15 
cm above the patella) and approximately 2 cm below entry through the fascia using 
the percutaneous needle biopsy technique (5). Muscle samples were immediately 
freed from blood, visible fat and connective tissue, and rapidly frozen in liquid 
nitrogen, and stored at –80ºC for measurement of the amino acid enrichment in 
the muscle free amino acid pool and in mixed muscle protein.  
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Beverages 
Subjects received a beverage volume of 3 ml∙kg-1 every 30 minutes to ensure a 
given dose of 0.3 g carbohydrate∙kg-1 (50% as glucose and 50% as maltodextrin) 
and 0.2 g∙kg-1of a protein hydrolysate every h, with or without the addition of 0.1 
g∙kg-1∙h-1 leucine. The total amount of protein (0.2 g∙kg-1∙h-1) provided in both the 
CHO+PRO and CHO+PRO+leu trials by far exceeded the calculated amount of 
protein that was estimated to provide sufficient precursor substrate to sustain 
maximal protein synthesis rates for at least 6h (50). Repeated boluses were 
administered to enable a continuous ample supply of amino acids in the 
circulation, preventing perturbations in L-[ring- 13C6]phenylalanine enrichments. 
The whey protein hydrolysate used in the present study contained 9.95% leucine 
and consequently the total amount of leucine administered in the CHO+PRO and 
CHO+PRO+leu trial was 0.02 vs. 0.12 g∙kg-1∙h-1, respectively. 
The compositions of all test drinks are listed in table 5.1. Glucose and maltodextrin 
were obtained from AVEBE (Veendam, The Netherlands). Whey protein 
hydrolysate was prepared by Numico Research (Wageningen, The Netherlands). 
Leucine was purchased from BUFA (Uitgeest, The Netherlands). To make the 
taste comparable in all trials, beverages were uniformly flavored by adding 0.2 g 
sodium-saccharinate solution (25% w/w), 1.8 g citric acid solution (50% w/w) and 
5 g of cream vanilla flavor (Numico Research) for each liter of beverage. Trials 
were performed in a randomized order, with test-drinks provided in a double-blind 
fashion. 
Table 5.1 Composition of beverages 
Test drink                CHO          CHO+PRO     CHO+PRO+leu 
Whey protein - 33.3 33.3 
Leucine - - 16.6 
    
Glucose 25 25 25 
Maltodextrin 25 25 25 
    
Sodium saccharinate 0.2 0.2 0.2 
Citric acid 1.8 1.8 1.8 
Cream vanilla 5 5 5 
    
Water up to 1.00 L   
Values expressed in g∙L-1 beverage. 
Tracer infusion 
L-[ring-13C6]phenylalanine (99% enriched, Cambridge Isotopes, Andover, MA, 
USA) was dissolved in 0.9% saline before infusion. The phenylalanine pool was 
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primed with an infusion dose of 2 mol∙kg-1. Thereafter, continuous intravenous 
infusion of the isotopes was performed using a calibrated IVAC 560 pump (San 
Diego, CA, USA) with an average infusion rate of 0.046±0.001 mol∙kg-1∙min-1. 
Analysis 
Blood samples were collected in EDTA containing tubes and centrifuged at 1000 g 
and 4°C for 5 min. Aliquots of plasma were frozen in liquid nitrogen and stored at 
–80°C. Insulin was analyzed by radio immunoassay (Insulin RIA kit, LINCO 
Research Inc., St. Charles, MO, USA). Plasma (500 µL) for amino acid analysis was 
deproteonized on ice with 100 µL of 24% (w/v) 5-sulphosalicylic acid, mixed 
(vortexing) and the clear supernatant was collected after centrifugation. Plasma 
amino acid concentrations were analyzed on an automated dedicated amino acid 
analyzer (LC-A10, Shimadzu Benelux, Den Bosch, The Netherlands), using an 
automated precolumn derivatization procedure and a ternary solvent system (15). 
The exact phenylalanine concentration in the infusates (8.06±0.21 mmol∙L-1) was 
measured using the same method. Plasma phenylalanine and tyrosine were 
derivatized to their tert-butyldimethylsilyl (TBDMS) derivatives and their 13C 
enrichments were determined by electron ionization gas chromatography-mass 
spectrometry (GC-MS, Finnigan Incos XL) using selected ion monitoring of 
masses 336 and 342 for unlabeled and labeled phenylalanine respectively and 
masses 466 and 472 for unlabeled and labeled tyrosine (51). 
For measurement of L-[ring- 13C6]phenylalanine enrichment in the free amino acid 
pool and mixed muscle protein, 55 mg of wet muscle was freeze-dried. Collagen, 
blood and other non-muscle fiber material were removed from the muscle fibers 
under a light microscope. The isolated muscle fiber mass (2-3 mg) was weighed 
and 2 ml of ice-cold 2% perchloric acid (PCA) was added. The tissue was then 
homogenized and centrifuged. The supernatant was collected and processed in the 
same manner as the plasma samples, such that intracellular free L-[ring- 
13C6]phenylalanine and L-[ring- 13C6]tyrosine enrichments could be measured using 
their t-butyldimethylsilyl derivatives on a GCMS. The protein pellet was washed 
with 3 additional 2 ml washes of 2% PCA, dried and the proteins were hydrolyzed 
in 6M HCl at 120 C for 15-18h. The hydrolyzed protein fraction was dried under a 
nitrogen stream while heated to 120 C, then dissolved in a 50% acetic acid solution 
and passed over a Dowex exchange resin (AG 50W-X8, 100-200 mesh hydrogen 
form, Biorad, Hercules, CA, USA) using 2M NH4OH. Thereafter, the eluate was 
dried and the purified amino acid fraction was derivatized into the N-acetyl-methyl 
(NAM)-esters to determine the 13C-enrichment of protein bound phenylalanine 
enrichment using GC-IRMS (Finnigan, MAT 252). 
Calculations 
Infusion of L-[ring-13C6]phenylalanine with muscle and arterialized blood sampling 
was used to simultaneously assess whole-body amino acid kinetics and FSR of 
mixed muscle protein. Whole-body rates of appearance (Ra) and disappearance 
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(Rd) of phenylalanine were calculated using the non-steady state Steele equations 
adapted for stable isotope methodology (41). 
where F is the infusion rate (µmol∙kg-1∙min-1); V= distribution volume for 
phenylalanine (125 ml∙kg-1) (14); C1 and C2 are the phenylalanine concentrations 
(mmol∙L-1) in arterialized plasma at time 1 (t1) and 2 (t2), respectively and E1 and 
E2 are the plasma L-[ring- 13C6]phenylalanine enrichments (expressed in tracer-
tracee ratio; TTR). As whole-body Ra comprise phenylalanine rate of appearance 
arising from protein breakdown (B) and protein intake (I), whole-body protein 
breakdown can be calculated as follows. 
As whole-body Rd comprise the rate of phenylalanine disappearance from the free 
amino acid pool in the blood due to protein synthesis (S) and oxidation, whole-
body protein synthesis can be calculated as Rd minus oxidation. The rate of 
phenylalanine oxidation was calculated using the phenylalanine balance model 
from Thompson et al. (42). Whole-body phenylalanine oxidation (Qpt) can be 
determined from the conversion (hydroxylation) of L-[ring- 13C6]phenylalanine to 
L-[ring- 13C6]tyrosine, without the necessity to measure 13CO2 enrichment in breath 
gasses (42). The rate of hydroxylation can be calculated using the formula, 
where Pt/Pp (=0.73) is the molar ratio of fluxes of tyrosine and phenylalanine 
arising form protein catabolism (31); Qp equals Rd under the steady state 
conditions that we observed. Ep and Et are the L-[ring- 13C6]phenylalanine and L-
[ring- 13C6]tyrosine enrichments (expressed in Atom Percent Excess; APE). Whole-
body protein synthesis was calculated using 
Fractional rate of mixed muscle protein synthesis was calculated by dividing the 
increment in enrichment in the product, i.e. protein-bound L-[ring- 
13C6]phenylalanine (TTR), by the enrichment of the precursor. Due to the large 
muscle sample size that is required to make an estimate of the enrichment in the 
aminoacyl-tRNA pool (generally regarded to be the true protein synthesis 
precursor pool) and the inherent analytical complexity of such measurements, we 
used plasma L-[ring-13C6]phenylalanine (TTR) and free muscle L-[ring-13C6]phenyl-
alanine (TTR) enrichments as surrogates to provide an estimate of the lower 
boundary (based on plasma precursor enrichments) and the higher boundary 
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(based on intracellular muscle precursor enrichments) for the true fractional 
synthetic rate of mixed muscle proteins. Muscle FSR’s were calculated as follows, 
where Ep is the delta increment of protein bound L-[ring- 13C6]phenylalanine 
during incorporation periods. Eprecursor is (I) the average plasma L-[ring-
13C6]phenylalanine enrichment during the time period for determination of amino 
acid incorporation; (II) the free muscle L-[ring-13C6]phenylalanine enrichment in 
muscle biopsy taken at 6h post-exercise; (III) the free muscle L-[ring- 
13C6]phenylalanine enrichment in muscle biopsy taken at 6h post-exercise corrected 
for the contribution of extra-cellular water, as previously described (50). t indicates 
the time interval (h) between biopsies and the factor 100 is needed to express the 
FSR in percent per hour (%∙h-1). The factor 2 arises because in the NAM-ester of 
L-[ring-13C6]phenylalanine molecule six of a total of twelve carbon atoms are 
labeled.  
Statistics 
All data are expressed as means±SEM. The plasma essential amino acid, insulin 
and glucose responses were calculated as area under the curve above pre-drink 
values. Statistical analysis of the data was performed using a one factor repeated 
measures analysis of variance (ANOVA) for non-time dependent variables. A two-
factor repeated measures ANOVA with time and treatment as factors was used to 
compare differences between treatments over time. In case of significant 
difference between trials, a Tukey’s post hoc test was applied to locate these 
differences. Statistical significance was set at P<0.05. 
Results 
Plasma insulin levels increased in all trials during the first 15-30 min after initial 
beverage ingestion. After this strong initial increase, insulin concentrations 
plateaued after 3-4h of recovery. Plasma insulin concentrations in the CHO+PRO 
and CHO+PRO+leu trials increased more compared to the CHO trial (figure 
5.1A). The insulin response, expressed as area under the curve (above baseline 
values) during the entire 6h post-exercise period (figure 5.1B), was substantially 
greater in the CHO+PRO+leu trial compared to the CHO and CHO+PRO trials 
(12.6±1.2 vs. 3.7±0.4 and 7.4±0.9 U∙6h∙L-1, respectively; P<0.01, which represent a 
+240±19 and +77±11% increase, respectively). The observed insulin response 
during the recovery period in CHO+PRO trial was increased with +98±17% 
compared to the CHO trial (P<0.05). Plasma glucose levels significantly increased 
following administration of the first beverage, after which they tended to decrease. 
The glucose response, expressed as area under the curve above baseline values, was 
significantly lower in the CHO+PRO+leu trial compared with the CHO trial 
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(96±62 vs. 320±65 mmol∙6h∙L-1, P<0.05), with an intermediate value for the 
CHO+PRO trial (216±48 mmol∙6h∙L-1). 
Figure 5.1 A, Plasma insulin concentration (expressed in mU∙L-1); B, plasma insulin response (expressed as area 
under the curve minus baseline values) during the different trials, while ingesting carbohydrate (0.3 g∙kg-1∙h-1; 
CHO), carbohydrate and protein (0.3 and 0.2 g∙kg-1∙h-1, respectively; CHO+PRO), or a carbohydrate and protein 
plus leucine mixture (0.3, 0.2 and 0.1 g∙kg-1∙h-1, respectively; CHO+PRO+leu). Values are means±SEM; * 
significantly different from CHO; # significantly different from CHO+PRO. 
Plasma leucine, phenylalanine and tyrosine concentrations are reported in figure 
5.2. Plasma essential amino acid (EAA) responses (area under the curve above 
baseline) are reported in figure 5.3. Resting plasma phenylalanine concentration 
averaged 53.6±1.4 mol∙L-1. After ingestion of the first bolus plasma phenylalanine 
concentrations increased in the CHO+PRO and CHO+PRO+leu trials (P<0.05), 
whereas a slight non-significant decrease was observed in the CHO trial during the 
first 2h of post-exercise recovery (figure 5.2B).  
The plasma phenylalanine response (figure 5.3) was negative in the CHO trial, 
whereas it was positive in the CHO+PRO and CHO+PRO+leu trials (-2.92 1.00 
vs. 3.25 0.72 and 1.47 0.81 mmol∙6h∙L-1, respectively; P<0.01). Plasma leucine 
concentrations (figure 5.2A) strongly increased after ingestion of the first bolus 
(P<0.01) in the CHO+PRO+leu and CHO+PRO trials whereas a slight decrease 
(P<0.05) was observed in the CHO trial during the first 2h of recovery. The 
plasma leucine response (figure 5.3) was negative in the CHO trial, positive in the 
CHO+PRO trial and significantly higher in the CHO+PRO+leu trial compared to 
both other trials (-9 5, 46 12 and 468 62 mmol∙6h∙L-1, respectively; P<0.05). The 
observed plasma insulin response was strongly correlated with the observed plasma 
leucine concentration (r=0.77; P<0.001). Basal plasma tyrosine concentrations 
averaged 65.3±0.8 mol∙L-1 in all trials. Plasma tyrosine concentrations increased 
after ingestion of the first bolus in the CHO+PRO and CHO+PRO+leu trials 
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(P<0.05). In the CHO trial the concentration decreased (P<0.05) during the first 
2h after exercise (figure 5.2C). Whereas plasma tyrosine responses were negative in 
the CHO trial, they were positive in the CHO+PRO and CHO+PRO+leu trials  (-
5.0 1.5 vs. 11.2 2.3 and 4.3 0.8 mmol∙6h∙L-1, respectively; P<0.01). 
Figure 5.2 Plasma leucine (A); phenylalanine (B); plasma tyrosine (C) concentration (µmol∙L-1), during the CHO, 
CHO+PRO and CHO+PRO+leu trials. Values are means±SEM. * significantly different from CHO; # 
significantly different from CHO+PRO. 
The time course of the plasma L-[ring-13C6]phenylalanine and L-[ring-13C6]tyrosine 
enrichments are shown in figure 5.4. Plasma L-[ring-13C6]phenylalanine enrich-
ment increased after exercise in the CHO trial. In the CHO+PRO and 
CHO+PRO+leu trials, plasma L-[ring-13C6] phenylalanine enrichment slightly 
decreased to reach plateau values at t=60 min. Plasma L-[ring-13C6]phenylalanine 
enrichment was significantly greater in the CHO trial compared to the CHO+PRO 
and CHO+PRO+leu trials (P<0.05). Plasma L-[ring-13C6]tyrosine enrichment 
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increased after exercise in the CHO trial, but remained unchanged in the 
CHO+PRO and CHO+PRO+leu trials. Plasma L-[ring-13C6]tyrosine enrichment 
was significantly higher in the CHO compared to the CHO+PRO and 
CHO+PRO+leu trials (P<0.05). Mean plasma amino acid enrichment, plasma 
phenylalanine rate of appearance (Ra) and rate of disappearance (Rd), muscle free 
amino acid enrichment and the increment in muscle protein enrichment are 
presented in table 5.2.  
Figure 5.3 Plasma essential amino acid response (expressed as area under the curve minus baseline values) during 
the CHO, CHO+PRO and CHO+PRO+leu trials. Values are means±SEM; * significantly different from CHO; 
# significantly different from CHO+PRO.  
 
Figure 5.4 Plasma L-[ring-13C6]phenylalanine enrichment (A) and plasma L-[ring-13C6]tyrosine enrichment (B) 
during the CHO, CHO+PRO and CHO+PRO+leu trials. Values are means±SEM; * significantly different from 
CHO+PRO and CHO+PRO+leu.  
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Whole-body protein breakdown (figure 5.5), calculated over the 6h of post-
exercise recovery, was lower in the CHO+PRO and CHO+PRO+leu trials 
compared to the CHO trial (P<0.05). Whole-body protein synthesis (figure 5.5), as 
calculated by Rd - Rox, was increased in the CHO+PRO and CHO+PRO+leu 
trial compared to the CHO trial (P<0.05). The rate of post-exercise whole-body 
phenylalanine oxidation (figure 5.5), as calculated from the conversion of 
phenylalanine to tyrosine, was decreased in the CHO+PRO+leu trial compared to 
the CHO+PRO and CHO trials (P<0.05). Whole-body protein balance (figure 5.5) 
was negative in the CHO trial, whereas protein balance was positive in the 
CHO+PRO and CHO+PRO+leu trials. In addition, whole-body protein balance 
was higher in CHO+PRO+leu than in CHO+PRO (P<0.01). Whole-body protein 
breakdown correlated with the plasma insulin and leucine responses (r=-0.670 and 
r=-0.647, respectively; P<0.01). Whole-body net protein balance was positively 
correlated with the plasma insulin and leucine response (r=0.678 and r=0.626, 
respectively; P<0.01). 
Figure 5.5 The rate of whole-body protein breakdown, synthesis, oxidation and net balance (expressed as µmol 
phenylalanine.kg.min-1) during the CHO, CHO+PRO and CHO+PRO+leu trials. Values are means+SEM; * 
significantly different from CHO; # significantly different from CHO+PRO. 
Mixed muscle protein fractional synthesis rates (FSR) were calculated using the 
precursor-product equation outlined in the methods section. FSR, with the mean 
plasma L-[ring-13C6]phenylalanine enrichment as precursor (figure 5.6), was 
significantly higher in the CHO+PRO+leu trial compared to the CHO trial 
(0.095 0.005 vs. 0.061 0.009 %∙h-1, respectively; P<0.05), with intermediate values 
observed in the CHO+PRO trial (0.0820±0.0104 %∙h-1). When the free 
intracellular L-[ring-13C6]phenylalanine enrichment was used as the precursor, FSR 
values were higher then when calculated with plasma L-[ring-13C6]phenylalanine 
enrichment as precursor, but revealed the same intervention effect (P=0.052). FSR 
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values averaged 0.089 0.012, 0.110±0.013, and 0.128 0.007 %∙h-1 for the CHO, 
CHO+PRO and CHO+PRO+leu trial, respectively. When these values were 
corrected for the contribution of extracellular water to the measured free muscle 
L-[ring-13C6]phenylalanine enrichment (50), FSR values averaged 0.097 0.013, 
0.117±0.014, and 0.136 0.007 %∙h-1 for the CHO, CHO+PRO and 
CHO+PRO+leu trial, respectively, with the same intervention effect (P=0.073). 
Significant correlations were observed between FSR and the amount of leucine 
ingested (r=0.471; P<0.05), phenylalanine Rd (r=0.531; P<0.01), whole-body 
protein synthesis (r=0.548; P<0.01), and whole-body protein balance (r=0.507; 
P<0.02). 
Figure 5.6 Fractional synthetic rate (FSR) of mixed muscle protein during the recovery phase from resistance 
exercise during the CHO, CHO+PRO and CHO+PRO+leu trials. Values are means±SEM; * significantly 
different from CHO. 
Discussion 
In the present study we simultaneously assessed whole-body protein turnover as 
well as the fractional synthetic rate (FSR) of mixed muscle protein by the 
incorporation of labeled phenylalanine in the m. vastus lateralis after resistance 
exercise. The co-ingestion of leucine and protein with carbohydrate significantly 
increased whole-body net protein balance compared to carbohydrate intake only 
and the combined ingestion of carbohydrate and protein. In addition, muscle 
protein synthesis rates were higher when protein and free leucine were co-ingested 
compared to the ingestion of carbohydrate only. Ingestion of carbohydrate and 
protein resulted in intermediate muscle protein synthesis rates, which were not 
significantly different from rates observed after co-ingestion of protein and leucine 
and carbohydrate ingestion only. Thus, the present study shows that the combined 
ingestion of protein and leucine with carbohydrate stimulates protein anabolism, 
measured using both tracer incorporation and whole-body tracer methodology.  
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It has been shown that both muscle protein synthesis (7, 35, 44) as well as protein 
breakdown rates (7, 35) are accelerated following resistance exercise. Resistance 
exercise exerts its effect either via the increased local production of IGF-1 in the 
muscle (21) and/or other contraction induced signaling events. Although muscle 
protein synthesis is stimulated during the post-exercise recovery phase (35), net 
muscle protein balance remains negative in the absence of food intake (7, 35, 36). 
It has been shown that the administration of amino acids with or without 
carbohydrate results in a rapid increase in muscle protein synthesis rate, whereas 
protein degradation rate is decreased (8, 11, 39, 44, 45). This results in an improved 
(positive) net muscle protein balance at rest and/or during post-exercise recovery.  
The combined intake of free leucine and protein with carbohydrate has been 
shown to increase the plasma insulin response (47-49). Increased amounts of 
circulating insulin have been reported to increase net muscle protein balance 
during conditions of hyperaminoacidemia (18, 19, 22), which occurs primarily by 
inhibition of muscle protein breakdown, rather than by stimulating protein 
synthesis. Furthermore, leucine ingestion has been reported to stimulate muscle 
protein synthesis, independent of circulating plasma insulin levels, by increasing 
the phosphorylation (activation) of key proteins involved in the regulation of 
protein synthesis in rat (1, 4) and human skeletal muscle (23, 28). An insulinotropic 
mixture containing carbohydrate, protein and leucine could therefore likely 
represent an efficient nutritional intervention to optimize net muscle accretion 
during post-exercise recovery. 
Using whole-body tracer balance methodology we observed that protein 
breakdown rates exceeded protein synthesis rates in the CHO trial, leading to a 
negative net protein balance (figure 5.5). The latter is in line with data from 
Borsheim et al. (2004) who showed that protein balance over the (leg) muscle 
remains negative after resistance exercise when only carbohydrate is ingested (10). 
However, measurements over the muscle do not necessarily account for all of the 
changes observed on a whole-body level. Whole-body protein breakdown rates 
were significantly suppressed in the CHO+PRO and CHO+PRO+leu trials 
compared to the CHO trial, whereas protein synthesis rates were increased (figure 
5.5). Co-ingestion of protein or protein and leucine with carbohydrate resulted in a 
50±2% and 62±2% reduction in protein degradation, respectively, when compared 
to carbohydrate ingestion only. In addition, protein synthesis was 54±5% and 
45±5% increased in the CHO+PRO and CHO+PRO+leu trials, respectively, 
compared to the CHO trial. When whole-body protein synthesis rates were 
expressed as a percentage of the rate of disappearance (Rd) of phenylalanine, we 
found the highest values in the CHO+PRO+leu trial (95.6±0.1% compared to 
92.0±0.4% and 94.2±0.4% in the CHO and CHO+PRO trials respectively; 
P<0.05), which could be attributed to a decreased rate of phenylalanine oxidation 
in the CHO+PRO+leu compared to the CHO+PRO trial, with intermediate 
values found in the CHO trial. Such a reduction in amino acid oxidation after 
administration of leucine has previously been established (32). Our findings are in 
accordance with earlier reports (27, 30, 39) showing that the combined ingestion of 
a single bolus of protein/amino acids and carbohydrate improves protein balance 
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in the post-resistance exercise period. In the present study we extend on these 
findings by investigating whether additional leucine could further promote protein 
anabolism. Therefore, in both the CHO+PRO and CHO+PRO+leu trials we 
provided an ample supply of protein (0.2 g∙kg-1∙h-1). This amount by far exceeds 
the amount of protein that was estimated to allow sustained maximal protein 
synthesis rates (50), and was selected to ensure that precursor substrate availability 
would not be limiting. Repeated boluses were administered, as opposed to a single 
bolus approach, to ensure a continuous supply of amino acids. Consequently, we 
show that the co-ingestion of leucine even further increases the net protein balance 
compared to carbohydrate and protein ingestion (figure 5.5). 
Most studies have applied the (whole-body) tracer balance methodology to 
investigate the effect of post-exercise nutrition on protein metabolism. 
Unfortunately, whole-body tracer methods have some important limitations, as 
they do not allow the direct measurement of muscle protein synthesis rates. As 
such, they do not provide information on the contribution of individual tissues to 
protein metabolism, their response to nutritional and/or exercise intervention and 
do not enable the discrimination between active and inactive muscle. Therefore, 
we also measured the incorporation rate of labeled phenylalanine in skeletal muscle 
tissue after resistance exercise to determine FSR of mixed muscle protein in the 
active m. vastus lateralis. We used plasma L-[ring-13C6]phenylalanine and free 
muscle L-[ring-13C6]phenylalanine enrichments to provide an estimate of the lower 
boundary (based on plasma precursor enrichments) and the higher boundary 
(based on intracellular muscle precursor enrichments) for the true fractional 
synthetic rate of mixed muscle proteins. Both methods provided similar results. As 
we observed a higher variation in intracellular muscle precursor enrichment, we 
based the FSR values on plasma precursor enrichments. Mixed muscle FSR 
averaged 0.0605 ± 0.0085 %∙h-1 during 6h of post-exercise recovery while ingesting 
carbohydrate. Combined ingestion of leucine and protein with carbohydrate 
resulted in a significantly increased FSR compared to carbohydrate ingestion alone 
(figure 5.6). The combined ingestion of protein and carbohydrate without free 
leucine resulted in an intermediate value, and was not significantly different from 
the lower values in the CHO trial nor the higher values reported in the 
CHO+PRO+leu trials (figure 5.6). Therefore our data on the muscle level also 
show that the combined ingestion of leucine and protein with carbohydrate can 
effectively stimulate muscle protein synthesis.  
The presented FSR data are in line with our observations using whole-body tracer 
methods, showing that co-ingestion of leucine and protein with carbohydrate 
accelerates protein synthesis and improves net protein balance when compared to 
carbohydrate ingestion only. Using whole-body tracer methodology, our data 
indicate that the combined ingestion of leucine and protein with carbohydrate can 
reduce protein breakdown. The latter seems to be in line with earlier reports by 
Nair et al (1992), who showed that leucine infusion significantly decreases protein 
breakdown as well as amino acid oxidation rate. In addition, data from the same 
study showed a decrease in the plasma concentrations of the other essential amino 
acids (EAA) during leucine infusion. In the present study we also observed a 
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reduced plasma EAA response in the CHO+PRO+leu trial compared to the 
CHO+PRO trial, although the same amount of EAA (with the exclusion of the 
supplemented leucine) was consumed. However, no differences were observed in 
phenylalanine Rd between the CHO+PRO+leu and CHO+PRO trials. This 
diminished plasma EAA response following leucine supplementation could be 
attributed to a reduced release from the muscle, and indicating a reduced protein 
breakdown and/or reduced protein oxidation rate (figure 5.5). 
We recently reported that co-ingestion of leucine, phenylalanine and protein with 
carbohydrate results in an increased plasma insulin response in the post-absorptive 
resting state (46, 49) and during recovery from endurance exercise (47, 48). In the 
present study we demonstrate that combined ingestion of leucine and protein with 
carbohydrate (without phenylalanine) can substantially increase the insulin 
response by ~250% when compared to the ingestion of only carbohydrate. 
Circulating insulin concentrations play an important role in regulating protein 
metabolism. The mechanism by which insulin mediates muscle hypertrophy is still 
a subject of debate as some reports (9, 18, 19) indicate that insulin infusion reduces 
protein breakdown while others (6, 20) have reported an enhanced muscle protein 
synthesis rate when sufficient amino acids were made available. However, in the 
absence of an ample supply of amino acids, insulin does not seem to stimulate 
muscle protein synthesis (9). In the present study, we found plasma insulin 
responses to be negatively correlated with whole-body protein degradation (r=-
0.641; P<0.01), whereas whole-body protein synthesis was positively correlated 
with plasma insulin response (r=0.451; P<0.05). Muscle protein synthesis rates 
(FSR) did not correlate with the plasma insulin response, whereas mixed muscle 
protein FSR did correlate with the amount of leucine that was ingested (r=0.471; 
P<0.05). Whether the observed differences can be attributed to the insulin or non-
insulin dependent stimulatory effects of leucine remains to be established.  
The combined ingestion of leucine and protein with carbohydrate in the recovery 
period from resistance exercise could stimulate muscle protein synthesis in several 
ways. It provides amino acids as precursors for muscle protein synthesis and the 
added leucine further increases plasma insulin concentrations and could also 
directly stimulate protein synthesis. Leucine has been shown to have the potential 
to affect muscle protein metabolism by decreasing the rate of protein degradation 
(32), most likely via increases in circulating insulin, and the phosphorylation of key 
proteins involved in the regulation of protein synthesis (23, 28, 37). The latter has 
been shown to occur even in the absence of an increase in circulating insulin 
concentrations. These studies indicate that leucine has the ability to function as a 
nutritional signaling molecule that modulates muscle protein synthesis and/or 
breakdown following food intake. The stimulatory effect of leucine on protein 
synthesis occurs at the level of translation initiation and involves signaling through 
mTOR (24, 37). This protein kinase referred to as mammalian target of rapamycin  
is thought to serve as a convergence point for leucine- and insulin-mediated effects 
on translation initiation (24, 37). Maximal rates of protein synthesis rates probably 
require both leucine and insulin signaling and the anabolic signal of resistance 
exercise. However, under normal in vivo conditions it is impossible to discriminate 
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between the effects of leucine and insulin and resistance exercise (IGF-1 and 
MGF) on muscle protein synthesis as all these signals are substantially elevated in 
the CHO+PRO+leu trial.  
In conclusion, the combined ingestion of protein and leucine with carbohydrate 
improves whole-body protein balance during recovery from resistance exercise 
when compared to the ingestion of carbohydrate or carbohydrate with protein. 
The combined ingestion of both leucine and protein with carbohydrate augments 
post-exercise mixed muscle protein synthesis when compared to the ingestion of 
only carbohydrate. The present data indicate that the additional ingestion of free 
leucine in combination with protein and carbohydrate likely represents an effective 
strategy to increase muscle anabolism following resistance exercise.  
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Abstract 
The progressive loss of skeletal muscle mass with aging is attributed to a disruption 
in the regulation of skeletal muscle protein turnover. We investigated the response 
to the ingestion of carbohydrate with or without protein and free leucine following 
simulated activities of daily living (ADL) on whole-body protein balance and mixed 
muscle protein synthesis rates. Eight elderly (75±1 y) and eight young (20±1 y) 
lean men were randomly assigned to 2 cross-over experiments in which they 
consumed either carbohydrate (CHO) or carbohydrate, protein and free leucine 
(CHO+PRO+leu) after performing 30 min of standardized ADL activities. 
Primed, continuous infusions with L-[ring-13C6]phenylalanine and L-[ring-
2H2]tyrosine were applied, and blood and muscle samples were collected to assess 
whole-body protein turnover as well as protein fractional synthetic rate (FSR) in 
the vastus lateralis muscle over a 6h period. Whole-body phenylalanine and 
tyrosine flux were significantly higher in the young versus the elderly (P<0.01). 
Protein balance was negative in the CHO, but positive in the CHO+PRO+leu 
experiment in both groups. Mixed muscle protein synthesis rates (FSR) were 
significantly lower in the elderly compared with the young subjects (P<0.05). FSR 
values were significantly greater in the CHO+PRO+leu compared with the CHO 
experiment in both the young (0.082 0.005 %∙h-1 vs. 0.060 0.005 %∙h-1, 
respectively; P<0.01), and elderly subjects (0.072 0.006 %∙h-1 vs. 0.043 0.003   
%∙h-1, respectively; P<0.01). Co-ingestion of protein and leucine with carbohydrate 
following ADL activities improves whole-body protein balance and increases 
muscle protein synthesis rates to the same extent in lean, young and elderly men.  
 
 Stimulation of protein anabolism in the elderly 
111 
Introduction 
Aging is associated with a slow progressive loss of skeletal muscle mass, which is 
also called sarcopenia (1). Sarcopenia is generally accompanied by a reduction in 
strength, the loss of functional capacity and an increased risk of developing 
chronic metabolic diseases like obesity, type 2 diabetes and osteoporosis. 
Sarcopenia is facilitated by a combination of factors, which include a sedentary 
lifestyle and a less than optimal diet (2). The age-related changes in skeletal muscle 
mass are attributed to a disruption in the regulation of skeletal muscle protein 
turnover (3), which results in a chronic imbalance between muscle protein 
synthesis and breakdown rates. It has been reported that basal protein synthesis 
rates are either similar (4-7), or reduced (8-14) in the elderly compared with young 
adults. Furthermore, muscle protein breakdown rates tend to be greater in the 
elderly, resulting in a gradual loss of skeletal muscle mass (6). 
Protein turnover in skeletal muscle tissue is highly responsive to nutrient intake in 
healthy, young individuals (15). In contrast, the anabolic effect of food intake on 
muscle protein synthesis seems to be substantially blunted in the elderly (5, 16-18). 
The latter has been proposed to represent a key-factor in the etiology of 
sarcopenia. In addition to food intake, physical activity can also effectively 
modulate protein metabolism, as it stimulates both protein synthesis and 
breakdown (19). However, in the absence of food intake net muscle protein 
balance will remain negative under these conditions (19, 20), leading to net muscle 
protein loss. Carbohydrate ingestion effectively reduces the activity-induced 
stimulation of muscle protein degradation, but does not affect protein synthesis 
(21, 22). As a consequence, the protein balance will remain negative (21, 22) unless 
protein and/or amino acids are co-administered (23-25). Interestingly, 
supplementation with leucine has been proposed as an effective strategy to reduce 
muscle protein breakdown and to further stimulate muscle protein synthesis (24, 
26-29). The latter could be attributed to the potential of leucine to stimulate 
protein anabolism by activating the mRNA translational machinery through the 
mammalian target of rapamycin (mTOR) in an insulin-dependent and independent 
manner (30-32). As a result, it has been suggested that the co-ingestion of a 
mixture of protein and additional free leucine with carbohydrate, could represent 
an effective strategy to augment muscle protein synthesis and/or to inhibit protein 
degradation (24). 
Under normal living conditions, ADL activities in the morning or afternoon are 
generally followed by food intake. As such, it is important to determine the 
combined effects of food intake and physical activity on skeletal muscle protein 
balance, when studying the proposed changes in skeletal muscle protein 
metabolism with aging. In the present study, we investigated the differential effects 
of carbohydrate and carbohydrate with protein and free leucine ingestion on 
skeletal muscle protein synthesis rates following simulated ADL type activity in 
young (~20 y) and elderly (~75 y) lean men. Infusions of L-[ring- 
13C6]phenylalanine and L-[ring-2H2]tyrosine were combined with plasma and 
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skeletal muscle tissue sampling to simultaneously measure whole-body protein 
turnover as well as mixed muscle protein fractional synthetic rates in vivo in men. 
Methods 
Subjects 
Eight healthy, elderly men (75±1 y) and eight weight-matched, young controls 
(20±1 y), with no history of participating in any regular exercise training program, 
were selected to participate in the present study. Subjects’ characteristics are shown 
in table 6.1. All subjects were informed about the nature and risks of the 
experimental procedure before their written informed consent to participate was 
obtained. This study was approved by the local Medical Ethical Committee. 
Table 6.1 Subjects’ characteristics 
 Young (n=8) Elderly (n=8) 
Age (yrs) 20 ± 1 75 ± 1.2 * 
Weight (kg) 73.7 ± 3.2 75.5 ± 2.1 
Height (m) 1.81 ± 0.03 1.72 ± 0.01 * 
BMI (kg∙m-2) 22.5 ± 1.1 25.7 ± 0.8 * 
Leg volume (L) 9.43 ± 0.39 8.23 ± 0.32 * 
HbA1C (%) 5.03 ± 0.17 5.71 ± 0.11 * 
Basal glucose (mmol∙L-1) 5.26 ± 0.12 5.51 ± 0.10 
Basal insulin (mU∙L-1) 11.15 ± 0.75 10.15 ± 0.85 
HOMA-(IR)  2.61 ± 0.19 2.48 ± 0.20 
1RM leg press (kg)  203.8 ± 7.4 151.3 ± 7.6 * 
1RM leg press (kg∙BW-1)  2.80 ± 0.17 2.00 ± 0.06 * 
1RM leg extension (kg)  107.5 ± 3.8 78.1 ± 4.3 * 
1RM leg extension (kg∙BW-1)  1.48 ± 0.09 1.03 ± 0.04 * 
Values are expressed as means ± SEM. HOMA-IR, Homeostasis model assessment of insulin resistance (22); 
1RM, one-repetition maximum. * Significantly different from young, P<0.05. 
Pretesting  
Before selection in the study, all volunteers were subjected to an oral glucose 
tolerance test (33, 34). Leg volume was determined as described previously (35), 
after which all subjects participated in an orientation trial to become familiarized 
with the physical activity protocol and the equipment. Proper lifting technique was 
demonstrated and practiced for each of the 2 lower-limb exercises (leg press and 
leg extension). Subsequently, maximal strength (one-repetition maximum, 1RM) 
was estimated using the multiple repetitions testing procedure (36). 
Diet and activity prior to testing  
All subjects consumed a standardized meal (64.1±2.0 kJ∙kg-1 body weight, 
consisting of 65 Energy% (En%) carbohydrate, 15 En% protein and 20 En% fat) 
the evening before the trials. All volunteers were instructed to refrain from any 
 Stimulation of protein anabolism in the elderly 
113 
sort of heavy physical exercise and to keep their diet as constant as possible 3 d 
before the trials. In addition, subjects were asked to record their food intake for 
48h before the start of the first experimental trial and to consume the same diet 
48h before the start of the second trial. 
Experimental trials 
Each subject participated in 2 experiments, separated by 7 d, in which drinks 
containing carbohydrate (CHO) or carbohydrate, protein and leucine 
(CHO+PRO+leu) were administered in a randomized and double-blind fashion. 
Each experiment lasted ~8h. Repeated boluses of a given test-drink were ingested 
following the physical activity protocol to ensure a continuous supply of glucose 
and amino acids. Plasma and muscle samples were collected during a 6h period. 
These experiments were designed to simultaneously assess whole-body amino acid 
kinetics and FSR of mixed muscle protein by the incorporation of L-[ring-
13C6]phenylalanine in the mixed protein of muscle biopsies collected from the 
vastus lateralis muscle. 
Protocol 
At 8.00 am, after an overnight fast, subjects arrived at the laboratory by car or 
public transportation and a Teflon catheter was inserted into an antecubital vein 
for stable isotope infusion. A second Teflon catheter was inserted in a heated 
dorsal hand vein of the contra-lateral arm, placed in a hot-box (60 C), for 
arterialized blood sampling. After basal blood sample collection, a single 
intravenous dose of L-[ring-13C6]phenylalanine (2 mol·kg-1) and L-[ring-
2H2]tyrosine (0.775 mol·kg-1) was administered to prime the phenylalanine and 
tyrosine pool. Thereafter, tracer infusion (average infusion rate (IR) of 
0.049±0.001 mol·kg-1·min-1 for L-[ring-13C6]phenylalanine and 0.019±0.001 
mol·kg-1·min-1 for L-[ring-2H2]tyrosine) was started and subjects rested in a 
supine position for 1h, before engaging in the standardized physical activity 
protocol. The protocol was designed to simulate 30 min of moderate intensity 
physical activity (for example garden tasks as lawn mowing) as has been 
recommended by several public health authorities (37, 38). The energy 
consumption during such an activity pattern is estimated to be ~650 kJ·30 min-1 
(39), and was simulated by combining low-intensity cycling and light resistance-
type exercise. After 5 min of self-paced cycling, subjects performed 6 sets of 10 
repetitions on the horizontal leg press machine (Technogym BV, Rotterdam, The 
Netherlands) and 6 sets of 10 repetitions on the leg extension machine 
(Technogym BV). The first 2 sets of both resistance exercises were performed at 
40% of the subjects’ 1RM. Sets 3-4, and 5-6 were performed at 55% and 75% of 
1RM, respectively, with 2 min rest intervals between sets. As such, the young and 
elderly, lean men performed exercise at the same relative intensity. At the end of 
the exercise protocol (t=0 min), subjects rested supine and an arterialized blood 
sample and a muscle biopsy from the vastus lateralis muscle were collected. 
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Subjects then received an initial bolus (1.33 ml·kg-1) of a given test drink. Repeated 
boluses (1.33 ml·kg-1) were ingested every 30 min until t=330 min. Arterialized 
blood samples were collected at t= 15, 30, 45, 60, 75, 90, 120, 150, 180, 210, 240, 
270, 300, 330 and 360 min with a second muscle biopsy taken at t=360 min from 
the contralateral limb. 
Table 6.2 Beverage composition 
Test drink                    CHO          CHO+PRO+leu 
Whey protein - 60 
Leucine - 10 
   
Glucose 92 92 
Maltodextrin 92 92 
   
Sodium saccharinate 0.2 0.2 
Citric acid 1.8 1.8 
Cream vanilla 5 5 
   
Water up to 1.00 L 
Values expressed in g∙L-1 beverage. 
Beverages 
Subjects received a beverage volume of 1.33 ml·kg-1 every 30 min to ensure a given 
dose of 0.49 g carbohydrate·kg-1 (50% as glucose and 50% as maltodextrin) with or 
without the addition of 0.16 g·kg-1 of a whey protein hydrolysate and 0.03 g·kg-1 
leucine every h. The total amount of protein provided in the CHO+PRO+leu 
experiment by far exceeds the calculated amount of protein needed to provide 
sufficient precursor substrate to sustain maximal protein synthesis rates for at least 
6 h (40). Repeated boluses were administered to enable a continuous supply of 
amino acids in the circulation, preventing perturbations in L-[ring-
13C6]phenylalanine and L-[ring-2H2]tyrosine enrichments. The whey protein 
hydrolysate (68.8% protein) contained 10.3% leucine and consequently the total 
amount of leucine administered in the CHO and CHO+PRO+leu experiment was 
0 vs. 0.041 g·kg-1·h-1, respectively. 
The compositions of all test drinks are listed in table 6.2. Glucose and maltodextrin 
were obtained from AVEBE (Veendam, The Netherlands). Whey protein 
hydrolysate was prepared by DSM Food Specialties (Delft, The Netherlands). 
Leucine was purchased from BUFA (Uitgeest, The Netherlands). To make the 
taste comparable in all experiments, beverages were uniformly flavored by adding 
0.2 g sodium-saccharinate solution (25% w/w), 1.8 g citric acid solution (50% 
w/w) and 5 g of cream vanilla flavor (Numico Research, Wageningen, The 
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Netherlands) for each liter of beverage. Experiments were performed in a 
randomized order, with test-drinks provided in a double-blind fashion. 
Analysis 
Blood samples were collected in EDTA containing tubes and centrifuged at 1000 g 
and 4°C for 5 min. Aliquots of plasma were frozen in liquid nitrogen and stored at 
–80°C. Plasma glucose (Uni Kit III, 07367204, Roche, Basel, Switzerland) 
concentrations were analyzed with the COBAS-FARA semi-automatic analyzer 
(Roche). Insulin was analyzed by radio immunoassay (Insulin RIA kit, LINCO 
Research Inc., St. Charles, MO, USA). Plasma (500 µL) for amino acid analyses 
was deproteinized on ice with 100 µL of 24% (w/v) 5-sulphosalicylic acid, mixed 
and the clear supernatant was collected after centrifugation. Plasma amino acid 
concentrations were analyzed on an automated dedicated amino acid analyzer (LC-
A10, Shimadzu Benelux, Den Bosch, The Netherlands), using an automated 
precolumn derivatization procedure and a ternary solvent system (14). The exact 
phenylalanine and tyrosine concentrations in the infusates (4.442±0.005 and 
1.762±0.003 mmol∙L-1, respectively) were measured using the same method. 
Plasma phenylalanine and tyrosine were derivatized to their tert-butyldimethylsilyl 
(TBDMS) derivatives and their 13C and/or 2H enrichments were determined by 
electron ionization gas chromatography-mass spectrometry (GC-MS, Agilent 
6890N GC/5973N MSD Little Falls, USA) using selected ion monitoring of 
masses 336 and 342 for unlabeled and labeled phenylalanine respectively and 
masses 466, 468 and 472 for unlabeled and labeled tyrosine (46). 
For measurement of L-[ring-13C6]phenylalanine enrichment in the free amino acid 
pool and mixed muscle protein, 55 mg of wet muscle was freeze-dried. Collagen, 
blood and other non-muscle fiber material were removed from the muscle fibers 
under a light microscope. The isolated muscle fiber mass (2-3 mg) was weighed 
and 8 volumes (8x dry weight of isolated muscle fibers x wet/dry ratio) of ice-cold 
2% perchloric acid (PCA) were added. The tissue was then homogenized and 
centrifuged. The supernatant was collected and processed in the same manner as 
the plasma samples, such that intracellular free L-[ring-13C6]phenylalanine, L-[ring-
2H2]tyrosine and L-[ring-13C6]tyrosine enrichments could be measured using their t-
butyldimethylsilyl derivatives on a GCMS. The free amino acid concentration in 
the supernatant was measured using an HPLC technique, after precolumn 
derivatization with o-phthaldialdehyde (35). The protein pellet was washed with 3 
additional 1.5 ml washes of 2% PCA, dried and the proteins were hydrolyzed in 
6M HCl at 120 C for 15-18h. The hydrolyzed protein fraction was dried under a 
nitrogen stream while heated to 120 C, then dissolved in a 50% acetic acid 
solution, and passed over a Dowex exchange resin (AG 50W-X8, 100-200 mesh 
hydrogen form, Biorad, Hercules, CA, USA) using 2M NH4OH. Thereafter, the 
eluate was dried and the purified amino acid fraction was derivatized into the N-
acetyl-methyl (NAM)-esters to determine the 13C-enrichment of protein bound 
phenylalanine enrichment using GC-IRMS (Finnigan, MAT 252). 
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Calculations 
Infusion of L-[ring-13C6]phenylalanine and L-[ring-2H2]tyrosine with muscle and 
arterialized blood sampling was used to simultaneously assess whole-body amino 
acid kinetics and fractional synthetic rate (FSR) of mixed muscle protein. Whole-
body kinetics for phenylalanine and tyrosine were calculated using the equations 
described by Thompson et al. (34) and Short et al. (32). Briefly, phenylalanine and 
tyrosine turnover (flux, Q) was measured from the isotope dilution at isotopic 
steady state:  
where i is the isotope infusion rate ( mol∙kg body weight-1∙h-1) and Ei and Ep 
correspond to the enrichments of infusate and plasma amino acids, respectively. At 
isotopic steady state, protein flux (Q) equals the sum of protein synthesis (S) and 
oxidation (O) as well as the sum of the rate of appearance of meal protein from the 
gut (I) and protein breakdown (B), whole-body protein synthesis rate was 
calculated as flux minus oxidation.  
At isotopic steady state, whole-body phenylalanine oxidation can be determined 
from the conversion (hydroxylation) of L-[ring-13C6]phenylalanine to L-[ring-
13C6]tyrosine. The rate of hydroxylation (Qpt) was calculated (32) using the 
formula, 
where Qt and Qp are the flux rates for L-[ring-2H2]tyrosine and labeled 
phenylalanine, respectively. Et and Ep are the L-[ring-13C6]tyrosine and L-[ring-
13C6]phenylalanine enrichments in plasma, respectively and ip is the infusion rate of 
the phenylalanine tracer. 
Fractional rate of mixed muscle protein synthesis (FSR) was calculated by dividing 
the increment in enrichment in the product, i.e. protein-bound L-[ring-
13C6]phenylalanine, by the enrichment of the precursor. Plasma L-[ring-
13C6]phenylalanine and free muscle L-[ring-13C6]phenylalanine enrichments were 
used to provide an estimate of the lower boundary (based on plasma precursor 
enrichments) and the higher boundary (based on intracellular muscle precursor 
enrichments) for the true fractional synthetic rate of mixed muscle proteins. 
Muscle FSR’s were calculated as follows (20): 
IBOSQ
S Q O
Qpt Qt
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Ep
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Where Ep is the delta increment of protein bound L-[ring-13C6]phenylalanine 
during incorporation periods. Eprecursor is (I) the average plasma L-[ring-
13C6]phenylalanine enrichment during the time period for determination of amino 
acid incorporation; (II) the free muscle L-[ring-13C6]phenylalanine enrichment in 
muscle biopsy taken at 6h post-exercise; (III) the free muscle L-[ring-
13C6]phenylalanine enrichment in muscle biopsy taken at 6h post-exercise corrected 
for the contribution of extra-cellular water, as previously described (41). t indicates 
the time interval (h) between biopsies and the factor 100 is needed to express the 
FSR in percent per hour (%∙h-1). The factor 2 arises because in the NAM-ester of 
L-[ring-13C6]phenylalanine molecule 6 of a total of 12 carbon atoms are labeled.  
Statistics 
All data are expressed as means±SEM. The plasma essential amino acid, insulin 
and glucose responses were calculated as area under the curve above baseline 
values. A three-factor repeated measures ANOVA with age-group, time and 
treatment as factors was used to compare differences between treatments over 
time between groups. For non-time dependent variables, a two-factor ANOVA 
with age-group and treatment as factors was used to compare differences in 
treatment effects between groups. In case of significant difference between 
experiments, a Scheffé post-hoc test was applied to locate these differences. 
Statistical significance was set at P<0.05. All calculations were performed using 
StatView 5.0 (SAS Institute inc., Cary, NC, USA). 
Results 
Figure 6.1 Plasma insulin response (expressed as area under the curve minus baseline values) in lean young (n=8) 
and elderly (n=8) men while ingesting carbohydrate (0.49 g·kg-1·h-1; CHO), or carbohydrate with protein and 
leucine (0.49, 0.16 and 0.1 g·kg-1·h-1, respectively; CHO+PRO+leu). Values are means±SEM. Data were analyzed 
with ANOVA (age-group x treatment): age-group effect, P=0.423; treatment effect, P<0.001; interaction of age-
group and treatment, P=0.636. 
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Plasma analyses 
The insulin response, expressed as area under the curve above baseline values 
(AUC) during the entire 6h post-exercise period is shown in figure 6.1. The 
glucose response (AUC), was significantly lower in the young subjects compared 
with the elderly (estimated marginal means: 587±42 vs. 869±39 mmol·6h·L-1, 
respectively, P<0.01). 
Plasma leucine, phenylalanine and tyrosine concentrations over time are reported 
in figure 6.2. Basal (t=-120 min) plasma leucine concentrations were significantly 
lower in the elderly compared with the young (99.0±3.8 vs. 119.7±2.7 µmol·L-1, 
respectively, P<0.05). No differences were observed between the young and 
elderly in basal (t=-120 min) plasma phenylalanine and tyrosine concentrations. 
The plasma leucine response (AUC) was negative in the CHO and positive in the 
CHO+PRO+leu experiment (estimated marginal means: -13.9 2.9 vs. 137.2 2.9 
mmol·6h·L-1, respectively, P<0.01. The observed plasma insulin responses were 
positively correlated with the observed plasma leucine concentration (r=0.675, 
P<0.001). The plasma phenylalanine response (AUC) was negative in the CHO, 
whereas it was positive in the CHO+PRO+leu experiment (estimated marginal 
means: -3.24 0.34 vs. 1.87 0.34 mmol·6h·L-1, respectively; P<0.01). Plasma 
tyrosine responses (AUC) were negative in the CHO and positive in the 
CHO+PRO+leu experiment in the young (-5.8 0.5 vs. 3.1 0.6 mmol·6h·L-1, 
respectively; P<0.01) and elderly (-5.6 0.3 vs. 5.7 0.8 mmol·6h·L-1, respectively; 
P<0.01). The plasma tyrosine response in the CHO+PRO+leu experiment was 
significantly greater in the elderly compared with the young (P<0.05). The plasma 
essential amino acid (EAA) response (area under the curve above baseline, with the 
exception of the supplemented leucine) was negative in the CHO and positive in 
the CHO+PRO+leu experiment in the young (-67.8 3.7 vs. 61.6 4.9 mmol·6h·L-
1, respectively, P<0.01) and in the elderly (-57.1 5.0 vs. 74.1 8.1 mmol·6h·L-1, 
respectively, P<0.01), with no differences between the young and elderly. 
The time course of the plasma L-[ring-13C6]phenylalanine, L-[ring-2H2]tyrosine and 
L-[ring-13C6]tyrosine enrichments are shown in figure 6.3. Plasma L-[ring-
13C6]phenylalanine and L-[ring-2H2]tyrosine enrichments increased in the CHO 
experiment in both the young and elderly. In the CHO+PRO+leu experiment, 
plasma L-[ring-13C6] phenylalanine and L-[ring-2H2]tyrosine enrichments did not 
change. Plasma L-[ring-13C6]phenylalanine and L-[ring-2H2]tyrosine enrichments 
were significantly greater in the CHO compared with the CHO+PRO+leu 
experiment (P<0.05). Plasma L-[ring-13C6]phenylalanine and L-[ring-2H2]tyrosine 
enrichments were significantly higher in the elderly in the CHO and 
CHO+PRO+leu experiments compared with the young subjects (P<0.05). Plasma 
L-[ring-13C6]tyrosine enrichment increased in the CHO, but remained unchanged 
in the CHO+PRO+leu experiment in the young and the elderly subjects. Plasma 
L-[ring-13C6]tyrosine enrichment was significantly higher in the CHO compared 
with the CHO+PRO+leu experiment (P<0.05). 
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Figure 6.2 Plasma leucine (A), phenylalanine (B), and tyrosine (C) concentrations (µmol.L-1) and responses, 
expressed as area under the curve (AUC) above baseline, during the CHO and CHO+PRO+leu experiments in 
lean young (n=8) and elderly (n=8) men. Values are means±SEM. AUC data were analyzed with a two-factor 
ANOVA (age-group x treatment). Plasma leucine response: age-group effect, P=0.10; treatment effect, P<0.001; 
interaction of age-group and treatment, P=0.186. Plasma phenylalanine response: age-group effect, P<0.05; 
treatment effect, P<0.001; interaction of age-group and treatment, P=0.596; Plasma tyrosine response: age-group 
effect, P<0.05; treatment effect, P<0.001; interaction of age-group and treatment, P<0.05; # significantly 
different from CHO experiment (Scheffé’s test, P<0.05); * significantly different compared to the young within 
the CHO+PRO+leu experiment (Scheffé’s test, P<0.05). 
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Figure 6.3 Plasma L-[ring-13C6]phenylalanine (A), L-[ring-2H2]tyrosine (B), and L-[ring-13C6]tyrosine enrichment 
(TTR) (C) during the CHO and CHO+PRO+leu experiments in lean young (n=8) and elderly (n=8) men. Values 
are means±SEM. Data were analyzed with ANOVA repeated measures (age-group x treatment x time). Plasma L-
[ring-13C6]phenylalanine enrichment: age-group effect, P<0.001; treatment effect, P<0.001; time effect, P<0.001; 
interaction of age-group and treatment, P=0.191; interaction of age-group and time, P<0.001; interaction of 
treatment and time, P<0.001; interaction of age-group, treatment and time, P=0.339. Plasma L-[ring-2H2]tyrosine 
enrichment: age-group effect, P<0.001; treatment effect, P<0.001; time effect, P<0.001; interaction of age-group 
and treatment, P=0.081; interaction of age-group and time, P<0.001; interaction of treatment and time, P<0.001; 
interaction of age-group, treatment and time, P<0.001. Plasma L-[ring-13C6]tyrosine enrichment: age-group effect, 
P=0.053; treatment effect, P<0.001; time effect, P<0.001; interaction of age-group and treatment, P=0.053; 
interaction of age-group and time, P=0.415; interaction of treatment and time, P<0.001; interaction of age-group, 
treatment and time, P=0.478. * significant differences between young and elderly (Scheffé’s test, P<0.05); # 
significantly different between treatments (Scheffé’s test, P<0.05). 
Muscle analysis 
No differences in free leucine and tyrosine concentrations in the muscle biopsies 
taken at t=0 min were observed between the young and elderly. Muscle free 
phenylalanine concentrations were lower in the elderly compared with the young 
(77±7 vs. 160±32 µmol∙L-1, respectively, P<0.05). At t=360 min muscle leucine 
concentrations were significantly higher during the CHO+PRO+leu trial 
compared with the CHO trial in the young (322±35 vs. 83±11 µmol∙L-1, 
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respectively, P<0.05) and elderly (232±38 vs. 103±10 µmol∙L-1, respectively, 
P<0.05). Muscle free tyrosine concentrations were significantly higher in the 
CHO+PRO+leu trial when compared with the CHO trial in the young only (44±4 
vs. 57±4 µmol∙L-1, respectively, P<0.05). No differences were observed in muscle 
free phenylalanine concentrations between trials and between the young and 
elderly at t=360 min. 
 
Table 6.3 Plasma and muscle tracer enrichments in young and elderly lean men  
                   Experiment              P values 
 CHO CHO+PRO+leu Age/treatment/interaction 
Plasma AA enrichment     
L-[ring-13C6]phenylalanine   <0.001 / <0.001 / 0.109 
Young 0.0817±0.0012 0.0614±0.0009  
Elderly 0.1002±0.0003 0.0731±0.0008  
L-[ring-2H2]tyrosine   <0.001 / <0.001 / 0.214 
Young 0.0420±0.0006 0.0289±0.0002  
Elderly 0.0524±0.0013 0.0347±0.0004  
L-[ring-13C6]tyrosine   <0.01 / <0.01 / <0.05 
Young 0.0131±0.0004 0.0046±0.0001 *  
Elderly 0.0098±0.0004 
# 
0.0045±0.0002 *  
Muscle AA enrichment     
L-[ring-13C6]phenylalanine   <0.001 / <0.001 / 0.573 
Young 0.0556±0.0010 0.0429±0.0020  
Elderly 0.0639±0.0036 0.0537±0.0013  
L-[ring-2H2]tyrosine   0.105 / <0.050 / <0.050 
Young 0.0226±0.0026 0.0218±0.0014  
Elderly 0.0297±0.0016 
# 
0.0209±0.0010 *  
L-[ring-13C6]tyrosine   0.858 / 0.070 / <0.05 
Young 0.0214±0.0024 0.0153±0.0043  
Elderly 0.0214±0.0020 0.0163±0.0021  
∆ enrichment muscle 
protein  
   
L-[ring-13C6]phenylalanine   0.398 / 0.149 / 0.442 
Young 0.0556±0.0010 0.0429±0.0020  
Elderly 0.0639±0.0036 0.0537±0.0013  
Values are means±SEM. n=8 elderly and 8 young persons. CHO, carbohydrate; CHO+PRO+leu, carbohydrate, 
protein and leucine; enrichments are expressed as tracer/tracee ratio (TTR). Data were analyzed with ANOVA 
(age x treatment). Mean plasma amino acid (AA) enrichments during the last 4h of recovery. Muscle free amino 
acid enrichments in the 6h post-exercise biopsy. Increments in muscle protein enrichment from 0 to 6h following 
ADL. * Significantly different from CHO experiment (Scheffé’s test, P < 0.05). # Significantly different from 
values observed in the young (Scheffé’s test, P < 0.05). 
Mean plasma amino acid enrichment during the last 4h of recovery, muscle free 
amino acid enrichment in the 6h post-exercise biopsy and the increment in muscle 
protein enrichment are presented in table 6.3. Free L-[ring-13C6]phenylalanine 
enrichments in the 6h post-exercise biopsy were significantly higher in the elderly 
compared with the young in both trials (P<0.05), while L-[ring-2H2]tyrosine 
enrichments were higher in the elderly in the CHO trial only (P<0.05). No 
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differences in muscle free L-[ring-13C6]tyrosine enrichments were observed 
between the young and elderly in the CHO and CHO+PRO+leu trials and 
between trials. Free L-[ring-13C6]phenylalanine enrichments in the 6h post-exercise 
biopsy were significantly higher in the CHO trial compared with the 
CHO+PRO+leu in both the young and elderly (P<0.05), while L-[ring-
2H2]tyrosine enrichments were lower in the CHO+PRO+leu trial in the elderly 
only (P<0.05). No differences were observed in the increase in protein-bound L-
[ring-13C6]phenylalanine enrichment during the CHO and CHO+PRO+leu trials 
between the young and elderly.   
Figure 6.4 The rate of whole-body protein breakdown, synthesis, oxidation and net protein balance (expressed as 
µmol phenylalanine∙kg∙h-1) during the CHO and CHO+PRO+leu experiments in lean young (n=8) and elderly 
(n=8) men. Values are means+SEM. Data were analyzed with ANOVA (age-group x treatment). Breakdown: age-
group effect, P<0.001; treatment effect, P<0.001; interaction of age-group and treatment, P=0.483. Synthesis: 
age-group effect, P<0.001; treatment effect, P<0.001; interaction of age-group and treatment, P=0.202. 
Oxidation: age-group effect, P<0.001; treatment effect, P=0.225; interaction of age-group and treatment, 
P=0.092. Net balance: age-group effect, P<0.001; treatment effect, P<0.001; interaction of age-group and 
treatment, P=0.092. 
Whole-body protein metabolism 
Both phenylalanine and tyrosine fluxes were higher in the CHO+PRO+leu trial 
compared with the CHO trial in the young (59.2±1.8 vs. 43.2±1.5 µmol 
phenylalanine∙kg-1∙h-1, respectively, P<0.01) and elderly subjects (48.7±1.35 vs. 
34.6±0.6 µmol phenylalanine∙kg-1∙h-1, respectively, P<0.01). Phenylalanine and 
tyrosine fluxes in the CHO trial were 20-25% higher in the young compared with 
the elderly subjects (P<0.01). In the CHO+PRO+leu trial, phenylalanine and 
tyrosine fluxes were 30-40% higher in the young compared with the elderly 
subjects (P<0.01). Whole-body protein breakdown (figure 6.4), calculated over the 
6h of post-exercise recovery, was lower in the CHO+PRO+leu trial compared 
with the CHO trial (P<0.05) in the young and elderly. Whole-body protein 
synthesis (figure 6.4), as calculated by Qp-Qpt, was increased in the CHO+PRO+ 
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leu trial compared with the CHO trial (P<0.01) in both groups. The rate of post-
exercise whole-body phenylalanine oxidation (figure 6.4), as calculated from the 
conversion of phenylalanine to tyrosine, was decreased in the CHO+PRO+leu 
trial compared with the CHO trial (P<0.05) in the young but not in the elderly. 
Whole-body protein balance (figure 6.4) was negative in the CHO trial, whereas 
protein balance was positive in the CHO+PRO+leu trial in the young and elderly. 
Protein breakdown, synthesis and oxidation rates were higher in the young 
compared with the elderly (P<0.05). Protein synthesis efficiency (whole-body 
protein synthesis as a percentage from phenylalanine flux) was significantly higher 
in the elderly compared with the young subjects in the CHO trial (P<0.01), but not 
in the CHO+PRO+leu trial (P=0.10). Protein synthesis efficiency was increased in 
the CHO+PRO+leu trial compared with the CHO trial in the young (91.9±0.7 vs. 
86.0±1.1%, respectively, P<0.01), but not in the elderly subjects. 
Figure 6.5 Fractional synthetic rate (FSR) of mixed muscle protein following the ingestion of carbohydrate 
(CHO) or carbohydrate with protein and leucine (CHO+PRO+leu) in lean young (n=8) and elderly (n=8) men 
using plasma phenylalanine enrichment as a precursor. Values are means±SEM. Data were analyzed with 
ANOVA (age-group x treatment). Age-group effect, P < 0.05; treatment effect, P < 0.001; interaction of age-
group and treatment, P = 0.583. 
Mixed muscle protein synthesis rates 
Mixed muscle protein fractional synthesis rates (FSR), with the mean plasma L-
[ring-13C6]phenylalanine enrichment as precursor (figure 6.5), was significantly 
higher in the CHO+PRO+leu trial compared with the CHO trial in the young 
(0.082 0.005 %∙h-1 vs. 0.060 0.005 %∙h-1, respectively; P<0.01), and in the elderly 
(0.072 0.006 %∙h-1vs. 0.043 0.003 %∙h-1, respectively; P<0.01). The observed FSR 
values in the elderly subjects were significantly lower than those in the young 
(P<0.05). Net differences in the mixed muscle protein synthesis rates between 
trials were not different between young and elderly subjects (0.022±0.007 %∙h-1 vs. 
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0.029 0.004 %∙h-1, respectively; NS). When the free intracellular L-[ring-
13C6]phenylalanine enrichment was used as the precursor, FSR values were higher, 
but revealed the same intervention effect. FSR values in the young subjects 
averaged 0.088 0.008 and 0.124 0.011 %∙h-1 for the CHO and CHO+PRO+leu 
trial, respectively (P<0.05). In the elderly, FSR values averaged 0.068 0.005 and 
0.097 0.008 %∙h-1 for the CHO and CHO+PRO+leu trial respectively (P<0.01). 
When these values were corrected for the contribution of extra-cellular water to 
the measured free muscle L-[ring-13C6]phenylalanine enrichment (41), FSR values 
averaged 0.095±0.009 and 0.135±0.014 %∙h-1 for the CHO and CHO+PRO+leu 
trial, respectively (P<0.05). In the elderly, FSR values averaged 0.076 0.007 and 
0.102 0.008 %∙h-1 for the CHO and CHO+PRO+leu trial respectively (P<0.01). 
Discussion 
In the present study, we assessed whole-body protein turnover and determined 
mixed muscle protein synthesis rates by measuring the incorporation of labeled 
phenylalanine in the vastus lateralis muscle following the ingestion of carbohydrate 
with or without protein and free leucine in young and elderly men. Co-ingestion of 
protein and leucine is shown to improve whole-body protein balance in both the 
young and elderly when compared with the ingestion of carbohydrate only. Direct 
measurement of mixed muscle protein synthesis rates reveals that protein synthesis 
rates are lower in the elderly compared with the young when ingesting only 
carbohydrate. However, co-ingestion of protein and leucine substantially increases 
muscle protein synthesis rates to the same extent in both young and elderly men.  
It has been reported that basal muscle protein synthesis rates are similar (25, 38-40) 
or reduced in the elderly (6, 16, 30, 42, 43, 48, 49), while protein degradation rates 
are increased (40). In addition, there are indications that the stimulating effect of 
food intake on muscle protein synthesis is blunted in the elderly (38, 44, 45). 
Besides food intake, physical activity can also effectively modulate protein 
metabolism. Under normal living conditions, activities of daily living (ADL) are 
generally followed by food intake. Therefore, determining the combined effects of 
food intake and physical activity on skeletal muscle protein metabolism is of crucial 
importance when investigating the proposed changes in skeletal muscle protein 
metabolism with aging. In the present study, we investigated the anabolic response 
to carbohydrate (CHO) ingestion following simulated ADL type activities in vivo in 
young (~20 y) and elderly men (~75 y). Consequently, we show that muscle 
protein synthesis rates are significantly lower in the elderly (~75 y) compared with 
the young (~20 y) under such conditions. The observed mixed muscle FSR values 
following ADL activities were ~30% lower in the elderly compared with the young 
subjects (figure 6.5), which would represent a ~5% decline per decade. These 
observations are in line with previous reports showing muscle protein synthesis 
rates to be 20-30% lower in elderly humans (60-84 yrs) than in young adults in a 
basal, fasted state (16, 33, 44). Our findings on the muscle level are in line with our 
observations using the whole-body tracer methods showing whole-body 
phenylalanine and tyrosine turnover to be 20-25% lower in the elderly compared 
 Stimulation of protein anabolism in the elderly 
125 
with the young. Thus, on a whole-body level, protein synthesis, oxidation and 
breakdown are reduced in the elderly compared with the young subjects. In 
accordance to our earlier findings (20), we observed that whole-body net protein 
balance remains negative when only carbohydrate is ingested. To our knowledge 
we are the first to show that muscle protein synthesis is reduced in the elderly in 
practical daily living conditions in which ADL activities are followed by ingestion 
of carbohydrate only.  
Administration of amino acids with or without carbohydrate results in a rapid 
increase in muscle protein synthesis in young adults, whereas protein degradation 
rates are being reduced (10, 11, 20, 24, 25, 29). The latter can be attributed to the 
role of amino acids as precursors for protein synthesis (47), the potential of amino 
acids to stimulate insulin secretion (36) and the proposed property of amino acids, 
and leucine in particular, to stimulate protein synthesis by activating the mRNA 
translational machinery through the mTOR-pathway (19). The latter has been 
reported for leucine administration in vivo in rodents (3-5). Therefore, a mixture 
containing carbohydrate, protein and additional free leucine could therefore likely 
represents an effective nutritional intervention to optimize net muscle accretion. 
Recently, we showed that the combined ingestion of protein and free leucine 
augments skeletal muscle protein synthesis rates in healthy young adults following 
intense resistance exercise when compared with the ingestion of carbohydrate only 
(20). In the present study, we aimed to investigate whether the proposed anabolic 
response to the combined ingestion of protein and leucine would also be present 
in the elderly when compared with the ingestion of carbohydrate only, and we 
questioned whether this response is of a similar or lower magnitude in the elderly.  
In accordance to our earlier findings (20), we observed that whole-body protein 
breakdown rates were significantly suppressed following co-ingestion of leucine 
and protein with carbohydrate, whereas protein synthesis rates were increased 
(figure 6.4). Co-ingestion of protein and leucine with carbohydrate resulted in a 
47±3% and 44±4% increase in whole-body protein synthesis in the young and 
elderly, respectively, when compared with the ingestion of carbohydrate only. As a 
result, whole-body protein net-balance became positive in the CHO+PRO+leu 
trial, which verifies that protein/amino acid ingestion is necessary for net muscle 
anabolism to occur. The co-ingestion of protein and leucine with carbohydrate 
increased FSR compared with carbohydrate ingestion only (figure 6.5). The net 
differences in the mixed muscle protein synthesis rates between the CHO and 
CHO+PRO+leu trials did not differ between the young and elderly subjects. As 
such, our data imply that the combined ingestion of protein and leucine with 
carbohydrate can stimulate muscle protein synthesis to the same extent in young 
and elderly men. This would be in line with more recent observations, showing a 
similar response of muscle protein turnover to an amino acid load in healthy 
elderly and younger adults (25, 37, 39). However, our FSR data seem to be in 
contrast with data presented by Volpi et al (38), who showed that the response of 
muscle protein synthesis to the combined ingestion of amino acids and glucose is 
impaired in the elderly. The latter could be related to the blunted insulin response 
in the elderly compared with the young controls that were reported by Volpi et al 
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(38). In contrast, we observed similar plasma insulin responses in the young and 
elderly volunteers following the co-ingestion of protein and leucine with 
carbohydrate. The observed differences might be attributed to the property of 
leucine to stimulate insulin secretion (36) and/or mRNA translation (3). In this 
study, we investigated the potential differences in the capacity to stimulate muscle 
protein synthesis in the young and elderly following the ingestion of a theoretically 
optimal anabolic nutritional intervention. The latter shows that these properties are 
as effective in the young as in the elderly.  
In conclusion, co-ingestion of protein and leucine improves whole-body protein 
balance when compared with the ingestion of carbohydrate only in young and 
elderly men. Mixed muscle protein synthesis is reduced in the elderly under 
conditions where ADL activities are followed by food ingestion. However, co-
ingestion of protein with leucine substantially increases mixed muscle protein 
synthesis rates to the same extent in the young and the elderly, thereby improving 
whole-body protein balance. 
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Abstract 
To investigate the in vivo effects of resistance exercise on translational control in 
human skeletal muscle, we determined the phosphorylation of AMP activated 
kinase (AMPK), eukaryotic initiation factor 4E-binding protein (4E-BP1), 
p70/p85-S6 protein kinase (S6K1) and ribosomal S6 protein (S6). Furthermore, we 
investigated whether changes in the phosphorylation of S6K1 are muscle fiber-type 
specific. Eight male subjects performed a single high-intensity resistance exercise 
session. Muscle biopsies were collected before, immediately after exercise, and 
following 30 and 120 min of post-exercise recovery. The phosphorylation status of 
AMPK, 4E-BP1, S6K1 and S6 was determined by western blotting with phospho-
specific and pan antibodies. To determine fiber-type specific changes in the 
phosphorylation status of S6K1, immunofluorescence microscopy was applied. 
AMPK phosphorylation was increased ~3 fold immediately following resistance 
exercise, while 4E-BP1 phosphorylation was reduced to 27±6% of pre-exercise 
values. Phosphorylation of S6K1 at Thr421/Ser424 was increased 2-2.5 fold during 
recovery, but did not induce a significant change in S6 phosphorylation. 
Phosphorylation of S6K1 was more pronounced in the type II vs. type I muscle 
fibers. Before exercise, phosphorylated S6K1 was predominantly located in the 
nuclei. After 2h of post-exercise recovery, phospho-S6K1 was primarily located in 
the cytosol of type II muscle fibers. We conclude that resistance exercise 
effectively increases the phosphorylation of S6K1 on Thr421/Ser424, which is not 
associated with a substantial increase in S6 phosphorylation in a fasted state.  
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Introduction 
Skeletal muscle protein turnover has been shown to be stimulated after an acute 
bout of resistance exercise (8, 26). The process of mRNA translation initiation 
forms an important regulatory site in the overall control of muscle protein 
synthesis (5). Recent evidence suggests that the phosphatidylinositol 3-kinase 
(PI3K) signaling pathway plays a key role in this process (18, 28). The activity of 
the signaling cascade controlling muscle protein synthesis is largely determined by 
the phosphorylation of the mammalian target of rapamycin (mTOR) and its 
subsequent activation of the p70/p85 S6 protein kinase (S6K1) and the eukaryotic 
initiation factor 4E-binding protein (4E-BP1) (18).  
Both S6K1 and 4E-BP1 can modulate translation initiation, and control the 
binding of mRNA to the 40S ribosomal subunit (18). 4E-BP1 can bind to the 
initiation factor eIF4E, thereby acting as a translational repressor preventing the 
formation of the eIF4F scaffolding complex, which is necessary for efficient 
binding of the 40S ribosomal subunit to mRNA (1, 14). Activation of the mTOR 
pathway results in 4E-BP1 hyperphosphorylation and a subsequent dissociation of 
the 4E-BP1∙eIF4E complex, allowing it to participate in the translation initiation 
process. Another mechanism regulating the binding of mRNA to the 40S 
ribosomal subunit involves the phosphorylation of ribosomal protein S6, which is 
controlled by the activity of S6K1 (1). S6K1 consist of two isoforms: a 70-kDa 
cytoplasmic isoform (p70-S6K) and an 85-kDa nuclear isoform (p85-S6K) (21). 
The activation of both S6K1 isoforms has been shown to phosphorylate S6 on the 
40S subunit in close proximity of the eIFs and mRNA (21). Phosphorylation of S6 
is thought to alter the interaction of the protein with these components, thereby 
promoting mRNA translation (7). Interestingly, in rodents the phosphorylation 
status of S6K1 following resistance exercise has been reported as an excellent 
marker for the long-term increase in skeletal muscle mass (2).  
It has been speculated that the anabolic response to resistance exercise is muscle 
fiber-type specific. In accordance, it has been shown that human soleus as opposed 
to vastus lateralis muscle is less responsive to resistance exercise (32). In rats, the 
phosphorylation of protein kinase B (PKB or Akt), mTOR and S6K1 following 
resistance exercise has been reported to be more pronounced in muscle tissue 
containing a greater proportion type II muscle fibers (2, 25, 28), as opposed to 
those muscle groups containing more type I fibers (25). Moreover, by applying 
immuno-histochemistry in rat tibialis muscle, it was recently shown that mTOR 
phosphorylation is selectively increased in type IIa fibers for up to several h after 
resistance exercise (25). Data on the activation of the translation initiation 
machinery in human skeletal muscle remain scarce (9, 16). Information on the 
potential muscle fiber-type specific changes in the phosphorylation status of 
proteins involved in translation initiation response to exercise in humans is still 
lacking. 
Both S6K1 and mTOR have been reported to be localized in the cytosol (36). 
However, recent studies have reported these proteins to be localized both in the 
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cytosol as well as in the nuclei of human embryonic kidneys (HEK) 293 cells (17). 
The latter implies that sub-cellular localization of mTOR and/or S6K1 could play 
a functional role. In HEK 293 cells, nuclear import of mTOR has been shown to 
enhance 4E-BP1 phosphorylation and S6K1 activation, whereas nuclear export of 
mTOR attenuated the phosphorylation/activation, suggesting that both activation 
of S6K1 and phosphorylation of 4E-BP1 require nuclear mTOR (17). Similar 
nuclear transport has also been reported for S6K1 (17). These observations suggest 
that the intracellular cytosolic and/or nuclear localization of these key regulatory 
proteins represent a level of control in the regulation of skeletal muscle protein 
synthesis. So far, the sub-cellular localization of S6K1 and the subsequent changes 
that occur in response to resistance exercise have not been studied in human 
muscle. 
The purpose of the present study was to investigate the mode of activation of the 
mRNA translation initiation machinery downstream of mTOR in skeletal muscle 
tissue following a single bout of resistance exercise in vivo in humans. Besides 
measuring the phosphorylation state of S6K1, 4E-BP1 and S6, we aimed to 
investigate whether changes in S6K1 phosphorylation are specific for muscle fiber-
type and/or sub-cellular localization. 
Methods 
Subjects 
Eight healthy male volunteers with no history of participating in any regular 
exercise program were recruited to participate in the present study. Subjects’ 
characteristics are shown in table 7.1. All subjects were informed on the nature and 
possible risks of the experimental procedures, before their written informed 
consent was obtained. This study was approved by the Medical Ethical Committee 
of the Academic Hospital Maastricht. 
Table 7.1 Subjects’ characteristics 
                           Mean ± SEM 
Age (yrs) 22.5 ± 0.9 
Weight (kg) 74.9 ± 2.8 
Height (m) 1.80 ± 0.01 
BMI (kg∙m-2) 23.3 ± 0.7 
% bodyfat (%) 17.8 ± 2.4 
Fat free mass (kg) 61.3 ± 2.1 
Fat mass (kg) 13.6 ± 2.1 
HbA1C (%) 5.3 ± 0.1 
1RM leg press (kg)  198 ± 7 
1RM leg extension (kg)  105 ± 3 
Values are expressed as means±SEM. 
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Pretesting  
Body composition was assessed using the hydrostatic weighing method in the 
morning following an overnight fast. Residual lung volume was measured by the 
helium-dilution technique using a spirometer (Volugraph 2000, Mijnhart, Bunnik, 
The Netherlands). Body weight was measured with a digital balance with an 
accuracy of 0.001 kg (E1200, August Sauter GmbH, Albstadt, Germany). Body fat 
percentage was calculated using Siri's equation (30). Fat free mass (FFM) was 
calculated by subtracting fat mass from total body mass.  
To familiarize subjects with the resistance exercise protocol and the equipment, a 
familiarization trial was performed. Proper lifting technique was demonstrated and 
practiced for each of the 2 lower-limb exercises (leg press and leg extension) and 
for the 3 upper-body exercises (chest press, shoulder press and lat-pulldown). 
Thereafter, maximum strength was estimated using the multiple repetitions testing 
procedure (22).  
In an additional exercise session, at least 1 week before the experimental trial, the 
subjects’ 1 repetition maximum (1RM) was determined (20). After warming up, the 
load was set at 90-95% of the estimated 1RM, and increased after each successful 
lift until failure. A 5 min resting period between subsequent attempts was allowed. 
A repetition was valid if the subject was able to complete the entire lift in a 
controlled manner without assistance.  
Standardization diet and activity prior to testing 
All subjects received a strict standardization diet for 2 days prior to the resistance 
exercise test trial, which was performed in the morning after an overnight fast. 
Subjects were provided with a pre-weighed amount of food products, beverages, 
and instant meals and were allowed to drink water ad libitum. Subjects were 
instructed to take all main meals (breakfast, lunch, and dinner) and between-meal 
snacks at predetermined time intervals during each day. The standardization diet 
provided 0.15 MJ∙kg-1∙day-1 containing 15 Energy% (En%) of protein, 30 En% of 
fat and 55 En% of carbohydrate. All volunteers were instructed to refrain from any 
sort of heavy physical exercise during the 2 days prior to the test-trial. 
Experimental trial 
The day of the test, subjects arrived at the laboratory by car or public 
transportation at 8.00 am, following an overnight fast. After 30 min of supine rest, 
a basal blood sample was collected and a muscle biopsy was taken from the vastus 
lateralis muscle. Thereafter, subjects performed a 5 min low-intensity warm-up on 
a cycle-ergometer, followed by 3 sets of 10 repetitions on 3 resistance exercise 
machines targeting upper-body muscle groups (chestpress, shoulderpress and lat-
pulldown, Jimsa Benelux BV, Rotterdam, The Netherlands). The latter were 
included to provide a whole-body warm-up to reduce the risk of injury. Thereafter, 
subjects performed 8 sets of 10 repetitions on the horizontal leg press machine 
(Technogym BV, Rotterdam, The Netherlands) and 8 sets of 10 repetitions on the 
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leg extension machine (Technogym). Both exercises were performed at 75% of the 
individual 1RM with 2 min rest intervals between sets and required ~45 min to 
complete. All subjects were verbally encouraged during the exercise session to 
complete the entire protocol. Immediately after cessation of exercise, a second 
muscle biopsy sample was taken, after which the subjects rested supine for 2h. 
After 30 min and 2h of post-exercise recovery, additional muscle biopsies were 
taken.  
Muscle biopsies 
Muscle biopsy samples were collected from both legs. The first two biopsies were 
taken from the same incision in one leg; the last two were taken from the same 
incision in the contra-lateral leg. When biopsy samples were taken from the same 
incision, the first sample was taken from a different region (distal of the incision, 
with the needle pointing inwards) than the second (proximal with the needle 
pointing outwards). Muscle biopsies were obtained from the middle region of the 
m. vastus lateralis (15 cm above the patella) and approximately 3 cm below entry 
through the fascia using the percutaneous needle biopsy technique (3).  
Muscle samples were freed from any visible non-muscle material and rapidly 
frozen in liquid nitrogen. Muscle samples (~40 mg) for Western blotting analyses 
were freeze-dried and collagen, blood and other non-muscle fiber material were 
removed from the muscle fibers under a light microscope. The isolated muscle 
fiber mass (6-10 mg) was weighed and 8 volumes (8x dry weight of isolated muscle 
fibers x wet/dry ratio) of ice-cold buffer (20 mmol∙L-1 HEPES (pH 7.4), 100 
mmol∙L-1 KCl, 50 mmol∙L-1 beta-glycerophosphate, mmol∙L-1 NaF, 1 mmol∙L-1 
dithiothreitol, 0.5 mmol∙L-1 Na3VO4, 0.2 mmol∙L-1 EDTA, 0.1 mmol∙L-1 PMSF 
and 1 mmol∙L-1 benzamidine) was added (4). The tissue was then homogenized, 
after which homogenates were centrifuged for 5 min at 1000 g and at 4ºC. 
Thereafter, the supernatant was centrifuged at 10 000 g at 4ºC for 10 min, resolved 
in SDS-buffer and boiled for 5 minutes at 100ºC.  
About 20 mg of each muscle sample were frozen in liquid nitrogen-cooled 
isopentane and embedded in Tissue-Tek for immunohistochemical analysis (Sakura 
Finetek, Zoeterwoude, The Netherlands). 
Muscle sample analysis  
Antibodies 
Polyclonal primary phospho-specific antibodies (anti-phospho S6K1 (Thr421 
/Ser424), anti-phospho S6 (Ser235/236), anti-phospho 4E-BP1 (Thr37) and anti-
phospho AMPK 1,2 (Thr172) and anti-S6K1, anti-S6, anti-4E-BP1 and anti-
AMPK 1,2 were purchased from Cell Signaling Technologies (Beverly, MA, USA). 
Anti-caveolin-3 was from BD biosciences (San Jose, CA USA) and the monoclonal 
antibody raised against adult human slow myosin heavy chain (or A4.951) was 
from Developmental Studies Hybridoma Bank, developed by Dr. Blau. 
Appropriate secondary conjugated antibodies (GARIgGAlexa555 and 
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GAMIgG1Alexa488) were purchased from Molecular Probes (Leiden, The 
Netherlands). 
Western blotting 
Equal amounts of protein (40 µg/lane) were run on either 10% (S6K1 and S6) or 
12% (AMPK and 4E-BP1) SDS-polyacrylamide gels (200 V, mini protein 3 cell, 
Biorad, Hercules, CA) and proteins were transferred (2h 250 mA, Criterion blotter, 
Biorad, Hercules, CA) to 0.45 mm nitrocellulose membranes. After Ponceau S 
staining and de-staining, membranes were blocked in 5% Non Fat Dry Milk 
Powder (NFDM) (Biorad, Hercules, CA) in Tris buffered saline containing 0.1% 
Tween-20 (TBS-T) for 1h. Thereafter, a 1:1000 dilution of the primary (phospho) 
specific antibody (all from Cell Signaling Technology) in 5% NFDM/TBS-T was 
added and incubated overnight at 4ºC on a shaker. After washing the membranes 4 
times 5 min in 15 ml 5% NFDM/TBS-T, the membranes were incubated with a 
1:10 000 dilution of the horseradish peroxidase-conjugated secondary antibody 
(Pierce) in 5% NFDM/TBS-T. Thereafter, the membranes were washed in 25 ml 
of TBS-T for 5, 15, 5 and 5 min. Light sensitive film (CL-Xposure; Pierce) was 
used to detect immunoreactive bands using chemiluminescent substrate 
(SuperSignal CL; Pierce). Autoradiographic film was scanned densitometrically and 
quantification was performed using the program Quantity One version 4.2.1. 
(Biorad). Alpha actin was used to standardize for the amount of protein loaded. 
Phosphorylation of AMPK, 4E-BP1, S6K1 and S6 was expressed relative to the 
total amount of each protein. Data was analyzed as the % change in 
phosphorylation state from pre-exercise values for each subject. 
Immunohistochemistry  
Multiple serial sections (5 µm) from biopsy samples collected before, immediately 
after, 30 and 120 min after exercise were thaw-mounted together on uncoated, pre-
cleaned glass slides for each subject, carefully aligned for cross-sectional analysis. 
Sections were fixed for 5 min in methanol, followed by 1 min in acetone. Slides 
were then incubated overnight at 4 °C with anti-caveolin-3 and anti-phospho S6K1 
antibodies (1:200 and 1:50 in PBS, respectively). Slides were rinsed for 3x 5 min 
with PBS and then incubated for 45 min with appropriate secondary antibodies 
diluted together with 5 µg·ml-1 4',6-Diamidino-2-phenylindole (DAPI; to visualize 
nuclei) in PBS. After several washes with PBS, stained sections were embedded in 
Mowiol® and covered with a coverslip. All muscle cross-sections were stained and 
prepared within a single batch using the same antibody-preparation to minimize 
variability in staining efficiency. Serial sections were stained for slow MHC with 
the monoclonal A4.951 antibody to determine the proportion and cross-sectional 
area of type I and II muscle fibers, which was measured as previously described 
(33). 
After 24h, glass slides were examined using a Nikon E800 fluorescence 
microscope (Uvikon, Bunnik, The Netherlands) coupled to a Basler A113 C 
progressive scan color CCD camera, with a Bayer color filter. Epifluorescence 
signal was recorded using a Texas red excitation filter (540-580 nm) for S6K1, a 
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fluorescein isothiocyanate (FITC) excitation filter (465-495 nm) for caveolin-3, and 
a 4',6-diamidino-2-phenylindole (DAPI) UV excitation filter (340-380 nm) for the 
nuclei.  
Digitally captured images (240x magnification) with five fields-of-view per muscle 
cross-section (12±1 fibers per field-of-view), were processed and analyzed using 
Lucia 4.81 software (Nikon, Düsseldorf, Germany). The phospho-S6K1 specific 
fluorescence signal was quantified for each muscle fiber, resulting in a total of 
60±2 muscle fibers analyzed for each muscle cross-section (32±2 type I and 27±2 
type II muscle fibers) and for each muscle nuclei, resulting in a total of 117±7 
muscle fiber nuclei analyzed for each muscle cross-section (58±5 nuclei of type I 
and 59±5 nuclei of type II muscle fibers). Muscle nuclei were selected based on the 
DAPI staining. An intensity threshold representing minimal intensity values 
corresponding to nuclear phospho-S6K1 was set manually and uniformly used for 
all images. Phospho-S6K1 content of muscle nuclei was expressed as the 
percentage of the nuclear area that was stained. Intracellular phospho-S6K1 
content was expressed as mean staining intensity.  
Statistics 
All data are expressed as means±SEM. Analyses of variance (ANOVA) for 
repeated measures were applied to determine differences in phosphorylation status 
in the protein of interest over time. In case of a significant F-ratio, a Scheffé post-
hoc test was applied to locate the differences. AMPK phosphorylation status 
before and after exercise were compared using a paired t-test. Statistical 
significance was set at P<0.05. 
Results 
Resistance exercise 
Mean 1 repetition maximum (1RM) measured during the pre-test was 198±7 kg on 
the horizontal leg press and 105±3 kg on the leg extension exercise. Therefore, 
average weight lifted during the resistance exercise was set at 148±5 and 79±3 kg 
for the leg press and leg extension respectively. All subjects completed 8 sets with 
10 repetitions on the leg press. One subject was unable to finish 10 repetitions 
during the 6th set, after which resistance was reduced to 65% of the individual 
1RM. All subjects completed 8 sets of 10 repetitions on the leg extension machine. 
Western blotting results 
Western blotting with phospho-specific antibodies showed that AMPK 
phosphorylation was increased 3-fold following resistance exercise (P<0.05). Thr172 
phosphorylation of AMPK assessed with western blotting is shown in figure 7.1. 
Thr37 phosphorylation of 4E-BP1 assessed with western blotting is presented in 
figure 7.2. 4E-BP1 phosphorylation was reduced immediately after resistance 
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exercise (P<0.05), after which they returned to baseline values after 30 min of 
recovery. After 120 min of post-exercise recovery, 4E-BP1 phosphorylation was 
significantly reduced compared to resting values (P<0.05).  
Figure 7.1 AMPK phosphorylation at Thr172 in vastus lateralis muscle at rest, immediately post-exercise and after 
30 and 120 min of post-exercise recovery. Representative immunoblots are shown (top). Values are means+SEM; 
* significantly different from resting values. 
 
Figure 7.2 4E-BP1 phosphorylation at Thr37 in vastus lateralis muscle at rest, immediately post-exercise and after 
30 and 120 min of post-exercise recovery. Representative immunoblots are shown (top). Values are means+SEM; 
* significantly different from resting values; # significantly different from values observed after 30 min of post-
exercise recovery. 
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Thr421/Ser424 phosphorylation of S6K1 assessed with western blotting is shown in 
figure 7.3. Following resistance exercise, S6K1 phosphorylation was increased and 
was significantly higher 30 min post-exercise compared to basal resting values 
(P<0.05). Ser235/236 phosphorylation of S6 assessed with western blotting is 
presented in figure 7.4. No significant differences in S6 phosphorylation were 
observed following exercise. 
Figure 7.3 S6K1 phosphorylation at Thr421/Ser424 in vastus lateralis muscle at rest, immediately post-exercise and 
after 30 and 120 min of post-exercise recovery. Representative immunoblots are shown (top). Values are 
means+SEM; * significantly different from resting values.(P<0.05). 
 
Figure 7.4 S6 phosphorylation at Ser235/236 in vastus lateralis muscle at rest, immediately post-exercise and after 30 
and 120 min of post-exercise recovery. Representative immunoblots are shown (top). Values are means+SEM. No 
differences were observed over time. 
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Figure 7.5 Immunofluorescent images (360x magnification) of muscle nuclei (A) and S6K1 (Thr421/Ser424) (B) in 
the pre-exercise muscle biopsies showing nuclear localization of phospho-S6K1 (C). The nuclei were stained using 
DAPI. 
Immunohistological analyses 
Western blotting with phospho-specific antibodies showed that Thr421/Ser424 
phosphorylation of S6K1 was increased following resistance exercise and was 
significantly higher 30 min post-exercise compared to the observed resting values. 
Using immuno-histochemical techniques we were able to quantify changes in 
localization and phosphorylation of S6K1 in a fiber-type specific manner. To 
determine the cellular localization of S6K1 in muscle fibers, we used immuno-
fluorescence staining of the muscle membrane, nuclei and S6K1 (Thr421/Ser424). As 
presented in figure 7.5, staining for phospho-specific S6K1 in the pre-exercise 
muscle biopsies shows a predominant localization of phospho-S6K1 in the nuclei. 
However, after 2h of post-exercise recovery we show a marked increase in 
phosphorylated S6K1 present in the cytosol (figure 7.6). In figure 7.6, images of 
representative cross-sections of vastus lateralis muscle obtained before and 120 
min after exercise with sections stained for phospho-S6K1 are presented. 
Phosphorylation of S6K1 was increased following resistance exercise in both the 
type I and type II fibers (figure 7.7; P<0.05). However phosphorylation of S6K1 
increased to a greater extent in the type II fibers compared to the type I fibers 
(figure 7.7; P<0.05). At 30 min after the resistance exercise session nuclear 
phospho-S6K1 content was increased in the type II fibers only (P<0.05). 
On average, muscle samples taken from the vastus lateralis muscle consisted for 
53±2% of type I and 47±3% of type II muscle fibers. Type II muscle fibers had a 
significantly greater cross sectional area compared to the type I fibers (5243±331 
vs. 4668±240 µm2, P<0.05). No differences between fiber-types were observed in 
average number of myonuclei per muscle fiber cross-section (2.1±0.3 vs. 2.3±0.2 
nuclei per fiber for type I and II muscle fibers, respectively; NS). In addition, 
nuclei area did not differ between type I and II muscle fiber (31.8±0.9 vs. 31.7±1.0 
µm2, respectively).  
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Figure 7.6 Images (240x magnification) of representative cross-sections of vastus lateralis muscle showing 
primarily nuclear localization of phospho-S6K1 in muscle samples obtain before exercise (A). Phospho-S6K1 is 
primarily located in the cytosol of type II muscle fibers after 2h of post-exercise recovery (B). Staining for 
caveolin-3 and nuclei are shown in panel C and D (showing the cell membranes in green and nuclei in blue). The 
muscle fibers are labeled as type I and type II. 
Discussion 
In the present study, we show that a single bout of resistance exercise leads to the 
phosphorylation of S6K1 in human skeletal muscle in a fiber-type-dependent 
manner, with the most pronounced phosphorylation being observed in the type II 
muscle fibers. The phosphorylation of S6K1 observed following exercise was not 
accompanied by a substantial activation of S6K1. The latter could, in part, be 
attributed to the observed immediate exercise induced increase in AMPK 
phosphorylation, which has been shown to induce reductions in 4E-BP1 
phosphorylation and S6K1 activation (4). 
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Figure 7.7 The effect of resistance exercise on the phosphorylation status of S6K1 in the cytosol (A) and nuclei 
(B). Mean fiber-type-specific intramyocellular phospho-S6K1 (expressed as staining intensity) and mean fiber-
type-specific nuclear phospho-p70/p85-S6K (expressed as % area stained) before, immediately after exercise and 
following 30 and 120 min of post-exercise recovery as determined by fluorescence microscopy on stained muscle 
cross-sections. Data provided are means+SEM. * significantly different from pre-exercise values (P<0.05); # 
significantly different from values observed in type I fibers (P<0.05). 
Though the metabolic response to resistance exercise has not been studied 
extensively, it has been shown that muscle lactate concentrations quickly increase 
up to ~17 mmol·kg-1 wet muscle weight, during a single session of resistance 
exercise training in vivo in humans (12, 31). Furthermore, we observed that skeletal 
muscle fiber glycogen content declines substantially in both type I and II muscle 
fibers following resistance type exercise tasks (19). In line with these findings, we 
observed a marked increase in the phosphorylation of AMP-activated protein 
kinase (AMPK) in the present study (figure 7.1). This indicates that resistance 
exercise leads to a reduction in the energy status of the muscle fiber, thereby 
stimulating the phosphorylation of skeletal muscle AMPK. As far as we know, this 
is the first study to report an increase in AMPK phosphorylation following 
resistance type exercise activities. In accordance, earlier studies have reported that 
high-intensity endurance exercise (6, 37) but not low or moderate intensity exercise 
(6, 34) augments AMPK activation. The latter requires AMPK phosphorylation on 
Thr172 by an AMPK kinase. The major AMPK kinase in skeletal muscle is LKB1 
(29). In addition, AMPK phosphorylation has been associated with the 
concomitant decline in muscle glycogen content, as AMPK has been suggested to 
have a glycogen-binding domain (29), which would explain the observation that 
AMPK is activated to a greater extent when muscle glycogen concentrations are 
low (37). Though AMPK is generally regarded as a main energy sensor in the cell, 
being responsible for the regulation of skeletal muscle glucose and fatty acid 
uptake and oxidation (18, 27), it was recently proposed that the AMP-activated 
protein kinase might also play an important role in the regulation of muscle protein 
synthesis and/or degradation (4, 7). 
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Bolster and co-workers (4) were the first to show that AMPK activation in skeletal 
muscle tissue, by 5-aminoimidazole-4-caroxamide 1- -D-ribonucleoside (AICAR) 
administration in rats, reduces protein synthesis rates. The latter was associated 
with a reduced phosphorylation state of mTOR at Ser2448, S6K1 at Thr389 and 4E-
BP1 at Thr37 (4). More recently, it was proposed that activation of AMPK results 
in mTOR phosphorylation at Thr2446 (7), which decreases mTOR phosphorylation 
at Ser2448, thereby diminishing the ability of insulin (and other growth factors) to 
phosphorylate S6K1 (7). These observations are indicative of the presence of 
another metabolic master switch mechanism in which AMPK plays a key role by 
integrating signals associated with the energy state of the cell and growth factors 
associated with protein translation.  
The present study shows that a single session of high-intensity resistance exercise 
in vivo in humans significantly increases AMPK phosphorylation and reduces the 
phosphorylation status of 4E-BP1 in skeletal muscle tissue immediately after 
cessation of exercise (figure 7.2). The exercise bout did not significantly increase S6 
phosphorylation (figure 7.4), indicating that S6K1 activity was not substantially 
increased. The latter is in close agreement with observations in vitro in H2K 
myotubes (7) and in vivo in rats (4) showing AMPK phosphorylation to suppress 
S6K1 activity. The kinase activity of S6K1 is controlled by a series of 
phosphorylation steps at several Ser/Thr residues (11, 35). Phosphorylation of 
S6K1 in the carboxy terminal auto-inhibitory domain (at Ser411, Ser418, Thr421 and 
Ser424) results in a conformational change in the protein allowing the 
phosphorylation of Ser404, Thr389 in the linker domain and Thr229 in the catalytic 
domains, which activates the kinase (27, 35). Consequently, the ribosomal protein 
S6 on the 40S subunit is phosphorylated, which is thought to alter the interaction 
of the protein with the eIFs and the mRNA (7).  
In the present study, we show that a single session of high-intensity resistance 
exercise was not sufficient to fully activate S6K1. The exercise effect of S6K1 was 
likely to be limited to Thr421/Ser424, as we did not observe a significant increase in 
the phosphorylation of S6. The extracellular signal-regulated kinase-1/2 (ERK1/2) 
has been suggested to play an important role in phosphorylation of S6K1 on 
Thr421/Ser424. In accordance ERK1/2 phosphorylation has been shown to be 
substantially increased immediately following exercise (16, 24). Our observations 
are in agreement with data reported by Karlsson et al. (16), showing that a single 
session of resistance exercise (4 sets, 10 repetitions of leg extension) does not fully 
activate S6K1. However, they showed that post-exercise ingestion of branched 
chain amino acids has a striking effect on S6K1, which was evident by site-specific 
phosphorylation at Thr389 (16). These data indicate that intake of an ample amount 
of protein/amino acids is needed to fully activate skeletal muscle translation 
initiation. In contrast to these and our observations, there are some studies in 
rodents that have reported an increase in S6K1 activity in response to either 
isometric or eccentric contractions (2, 15, 23). The apparent contradictory findings 
are attributed to the fact that maximal muscle contraction was induced through 
electrical stimulation of the nerve at 100 Hz. The latter results in the recruitment of 
all motor units (including all fast and slow twitch fibers), which is quite different 
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from voluntary muscle contraction in vivo (13). Therefore, in the present study we 
also aimed to study muscle fiber-type specific effects of resistance exercise on 
S6K1 phosphorylation.  
Using immuno-histochemical techniques, we were able to quantify changes in 
phosphorylation of S6K1 at Thr421/Ser424 in a fiber-type specific manner. 
Phosphorylation of S6K1 was increased following resistance exercise in both the 
type I and type II fibers (figure 7.6). However, phosphorylation of S6K1 increased 
to a greater extent in the type II fibers compared to the type I fibers (P<0.05). In 
accordance, the phosphorylation of PKB (or Akt), mTOR and S6K1 following 
resistance exercise in rats has been reported to be more pronounced in muscle 
groups containing a greater proportion type II vs. type I muscle fibers (e.g. m. 
tibialis anterior vs. m. soleus) (2, 25, 28). Moreover, by the application of immuno-
histochemistry in rat m. tibialis anterior, it has recently been shown that mTOR 
phosphorylation is selectively increased in type IIa fibers several hours after a bout 
of resistance exercise (25). These observations are most likely due to specificity in 
muscle fiber-type recruitment. Interestingly, we have recently shown that a single 
session of resistance exercise results in a substantial reduction in muscle fiber 
glycogen content. Moreover, these changes are fiber-type specific and are closely 
related to fiber-type oxidative capacity. As such, net changes in muscle fiber 
glycogen content were more pronounced in type II fibers compared to type I 
muscle fibers, which can be attributed to the greater recruitment of these fibers 
during high-intensity resistance exercise (13). One could, therefore, speculate that 
AMPK phosphorylation will increase to a greater extent in these fibers, 
phosphorylating mTOR on Thr2446, thereby decreasing the capacity of the kinase 
to phosphorylate S6K1 at Thr389. This could explain why we did not observe a 
substantial increase in S6 phosphorylation during the 2h of post-exercise-recovery, 
while phosphorylation of S6K1 on Thr421/Ser424 was increased. 
The localization of proteins involved in the regulation of translation initiation is 
thought to play an important role in the modulation of protein synthesis (17). 
Proteins like mTOR and S6K1 have been reported to be localized both in the 
cytosol as well as in the nuclei of human embryonic kidneys (HEK) 293 cells (17). 
Interestingly, it has been demonstrated that in vitro nuclear import of mTOR 
enhances 4E-BP1 phosphorylation and S6K1 activation, whereas nuclear export of 
mTOR attenuated the phosphorylation/activation, suggesting that both activation 
of S6K1 and phosphorylation of 4E-BP1 require nuclear mTOR (17). Similar 
nuclear transport has also been reported for S6K1 (17). In the light of these 
observations, the present study also examined the sub-cellular location of S6K1, 
using immuno-fluorescence staining of the muscle membrane, nuclei and S6K1 
(Thr421/Ser424). In the pre-exercise muscle biopsies we show a predominant nuclear 
localization of phospho-S6K1 (figure 7.5, 7.6 A/C), while following the resistance 
exercise session, phosphorylated S6K1 is primarily located in the cytosol (figure 7.6 
B/D), especially in type II fibers. Interestingly, we show that 30 min after cessation 
of exercise nuclear phospho-S6K1 content was increased in the type II fibers. The 
latter could imply that the nucleus plays a key role in the activation of S6K1 
and/or that S6K1 functions as a transcription factor. However, as the antibody 
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that was used recognizes both p70 and p85-S6K, we cannot differentiate between 
nuclear import of S6K1 and phosphorylation of p85-S6K, the latter of which is 
known for its unique nuclear localization (10, 21). More research is warranted to 
determine the role of sub-cellular location of S6K1 and its potential regulatory 
role. 
We conclude that a single bout of resistance exercise in vivo in humans activates 
skeletal muscle AMPK, resulting in a decrease in the phosphorylation state of 4E-
BP1. During recovery S6K1 phosphorylation is increased, and showed to be fiber-
type specific, indicating that the signaling response to S6K1 is muscle fiber-type 
specific. However, in the absence of food intake, the phosphorylation status of 
S6K1 on Thr421/Ser424 is not accompanied by a substantial increase in the 
phosphorylation of S6 under fasting conditions. As such, in the absence of food 
intake, exercise does not fully activate the translation initiation process in skeletal 
muscle tissue.  
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Skeletal muscle plays a central role in the regulation of whole-body glucose 
metabolism. By virtue of its mass, skeletal muscle is the primary tissue responsible 
for insulin-dependent glucose clearance, accounting for up to 80% of whole-body 
glucose uptake after meal ingestion. In addition, the total amount of muscle mass 
is also one of the main determinants of basal metabolic rate (BMR). Aging is 
accompanied with a substantial loss of muscle mass, which consequently leads to 
muscle weakness and major disabilities in every day life. The latter is accompanied 
by a reduction in BMR, the loss of functional capacity and an increased likelihood 
of developing chronic metabolic diseases like obesity, type 2 diabetes and 
osteoporosis.  
Various interventions have been proposed to reduce or reverse the loss of muscle 
mass and function. It has been suggested that physical activity (i.e. resistance 
exercise) and nutritional interventions (i.e. protein, amino acids) could represent 
effective strategies to reduce, or counteract the loss of muscle tissue that occurs 
with aging and disease. In this thesis we focus on the beneficial effects of 
resistance exercise and the potential of dietary supplementation with carbohydrate, 
protein and/or specific amino acids to enhance muscle protein anabolism. In 
chapter 2 we first show that resistance exercise is as powerful as endurance 
exercise in enhancing post-exercise insulin sensitivity. Both the amount of lipid and 
glycogen stored in muscle have been shown to play a role in the exercise induced 
increase in muscle insulin sensitivity. We, therefore, have investigated the use of 
intramuscular lipid and glycogen stores during resistance exercise in chapter 3. In 
chapter 4-6 the use of insulinotropic protein/amino acid mixtures to accelerate 
post-exercise (total muscle) protein synthesis has been investigated. In chapter 7, 
we looked at changes in the phosphorylation of 4E-BP1 and S6K1 following 
resistance exercise to get a better understanding of the upregulation of the 
molecular signaling mechanisms that control muscle protein synthesis.  
In this final chapter, we will elaborate on some of the reported findings by 
discussing their significance and clinical relevance in the elderly population. In 
addition, we will discuss specific methodological issues that need to be considered 
in future studies. In the last paragraph, important aims for future research will be 
defined. 
 
Resistance exercise and insulin sensitivity 
Most exercise intervention programs solely use endurance exercise because of its 
acute enhancing effect on insulin stimulated glucose clearance. Interestingly, we 
have shown that a single bout of resistance exercise also improves whole-body 
insulin sensitivity by ~15% when measured 24h after cessation of exercise (chapter 
2). This seems to be of a similar magnitude as the ~20% improvement that has 
been reported following an acute (~60 min) bout of endurance exercise (51, 59). 
As such, there should be no restriction in combining the benefits of both types of 
exercise in future lifestyle intervention programs. This could be of significant 
importance in frail and/or type 2 diabetic elderly, who are often in such a physical 
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state that generally does not allow them to perform endurance exercise. In that 
case, it would be helpful to first gain muscle strength and mass through resistance 
training. 
The mechanisms by which resistance exercise stimulates insulin sensitivity have not 
yet been fully elucidated. It seems likely to assume that resistance exercise is 
followed by an attenuated muscle GLUT-4 translocation (78) and/or elevated 
GLUT-4 expression (45). Factors thought to play a major regulatory role in this 
process include AMPK activation (26, 28, 35, 101), Ca2+/calmodulin-dependent 
kinases (108, 109), muscle glycogen content and subsequent activation of glycogen 
synthase activity (11, 23, 29, 55, 59, 102, 103). Prolonged moderate intensity 
endurance exercise does not seem to increase AMPK phosphorylation (20, 90) and 
does not affect signaling through the insulin signaling pathway (102). The latter is 
evidenced by unchanged phosphorylation of insulin receptor tyrosine kinase, Akt 
and GSK-3 (102). It is therefore thought that activation of Ca2+/calmodulin-
dependent kinases (22, 68) and the reduction in muscle glycogen content and 
subsequent activation of glycogen synthase are the main regulatory factors that 
modulate glucose uptake following endurance exercise (55). Interestingly, in 
contrast to moderate intensity endurance exercise, resistance exercise has been 
reported to lead to an increase in AMPK phosphorylation (chapter 7) and to 
activate signaling through the PI-3 kinase/mTOR pathway (36). Prolonged (16-
24h) activation of PI-3 kinase, and several downstream effectors like S6K1 (36, 
46), 4E-BP1 (46) and S6 (46) have been reported in rat skeletal muscle following 
resistance exercise (36). The reported activation of the PI-3 kinase/mTOR 
pathway is likely to play an important role in the augmented glucose uptake and 
protein synthesis rates following resistance exercise. Increased Akt signaling has 
been shown to inhibit GSK3, which leads to the activation of glycogen synthase 
and to GLUT4 translocation (71). In addition, resistance exercise can also 
substantially reduce muscle glycogen content (chapter 3, (24, 77)). This implies that 
resistance exercise has the ability to enhance muscle insulin sensitivity via several 
other potential mechanisms and might therefore represent a more powerful means 
to increase the blood glucose clearance capacity when compared to endurance 
exercise (18). 
In contrast to endurance exercise, information on the metabolic demands imposed 
upon by resistance exercise (i.e. muscle glycogen and IMTG utilization) is scarce. 
Early reports suggested that the energy needs during resistance exercise are 
provided with only a minimal activation of glycogenolysis or lipolysis (39). In 
chapter 3 we, therefore, investigated fiber-type specific changes in skeletal muscle 
glycogen and lipid content following resistance exercise and subsequent recovery 
using histological techniques. The use of (immuno)histochemistry on skeletal 
muscle cross-sections prepared from muscle biopsy samples represent an effective 
strategy to assess fiber-type specific changes in intramyocellular lipid and/or 
glycogen content, without the methodological limitations generally associated with 
biochemical extraction analyses on skeletal muscle samples, like the contamination 
of skeletal muscle tissue with extramyocellular fat (37). In 2001, we introduced an 
optimized lipid staining protocol, permitting automated quantification of 
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intramyocellular lipid depositions in skeletal muscle sections together with 
immuno-localization of other myocellular elements by fluorescence microscopy. 
Lipid droplets were detected in skeletal muscle by oil red O (ORO) staining, which 
was modified to diminish background staining, to prevent crystallization of ORO 
and to optimize lipid retention in cryosections (43). Since then we have 
implemented this method in several studies to investigate the effects of exercise 
and dietary interventions on muscle fiber-type specific lipid content (85, 87, 89, 
90). Moreover, we recently reported a good correlation between IMTG content as 
determined by 1H-magnetic resonance spectroscopy (MRS) and fluorescence 
microscopy (86). The conventional periodic acid-Schiff reagent (PAS) reaction to 
stain for muscle glycogen content has been optimized in a similar manner as the oil 
red O staining (74). Strong correlations between data on (mixed-muscle) glycogen 
content obtained by the use of both biochemical and histochemical methods have 
recently been reported (74). These observations indicate that semi-quantitative 
microscopy on PAS or ORO-stained muscle cross-sections represent valid 
methods to determine fiber-type-specific changes in muscle glycogen and lipid 
content and can be used to create insight in differences between fuel storage 
between the different muscle fiber-types and, as such, in their subsequent role in 
skeletal muscle metabolism. 
Figure 8.1 Correlation between the degree of glycogen depletion and the insulin-stimulated glucose uptake in 
thigh muscles of healthy men. Adapted from Richter et al. (66). 
The applied methodology clearly shows that mixed muscle glycogen content is 
substantially decreased following resistance exercise, which is in line with previous 
studies applying biochemical analysis on mixed muscle tissue (24, 77). We extend 
on the earlier findings by showing that these changes in muscle glycogen content 
are fiber-type specific, and more pronounced in type IIx fibers when compared to 
type I muscle fibers. This is in contrast to observations following endurance 
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exercise, where glycogen stores are primarily reduced in type I fibers (unpublished 
observations, L. van Loon & R. Koopman). This apparent difference may be the 
result of the high rate of ATP production per second necessary to sustain the high 
power output during resistance exercise in type II fibers. Due to the observed low 
mitochondrial content in type IIx fibers, they must rely for the greater part on 
anaerobic glycogenolysis for ATP generation. 
The exercise-induced reduction in skeletal muscle glycogen content has been 
associated with an increase in insulin sensitivity (11, 59, 102, 103) as shown in 
figure 8.1. In fact, skeletal muscle glucose uptake and glycogen synthase activity 
have been shown to strongly depend on muscle glycogen availability (56, 104). 
Interestingly, not only muscle substrate utilization has been shown to be fiber-type 
specific. AMPK activation, induced by AICAR, increases glucose uptake in rat 
fast-twitch muscle (109), but not in slow twitch soleus muscle (108). There are also 
indications that the activation of the insulin signaling cascade following resistance 
exercise is fiber-type specific. In chapter 7, we show that S6K1 phosphorylation 
following resistance exercise in humans is more pronounced in type II, compared 
to type I muscle fibers. In addition, the phosphorylation of PKB (or Akt), mTOR 
and S6K1 following resistance exercise in rats has been reported to be more 
pronounced in muscle tissue containing a greater proportion of type II muscle 
fibers (5, 58, 70), as opposed to those muscle groups containing more type I fibers 
(58). Moreover, by applying immunohistochemistry in rat tibialis muscle, it was 
recently shown that mTOR phosphorylation is selectively increased in type IIa 
fibers for up to several h after resistance exercise (58). This selective activation of 
the signaling through mTOR in fast-twitch muscle fibers may in part explain why 
endurance exercise, in contrast to resistance exercise, does not affect signaling 
through the insulin signaling pathway. 
We have recently demonstrated a substantial (~60%) net reduction in type I 
muscle fiber lipid content following 2h of moderate intensity endurance exercise 
(86, 90). Moreover, it has been reported that it takes ~48h to fully replenish the 
IMTG stores following a 3 h endurance exercise bout (89). Interestingly, in chapter 
3 we report a net decline (~27%) in IMTG content following resistance exercise in 
type I muscle fibers. Nevertheless, this effect was only temporary and not evident 
after 2h of post-exercise recovery. The absence of a prolonged net reduction in 
skeletal muscle lipid content implies that the reported stimulating effects of 
resistance exercise on whole-body insulin sensitivity are unlikely to be attributed to 
a reduction in intramuscular lipid content. However, it has been suggested that not 
IMTG content per se, but fatty acid intermediates like fatty acyl-CoA, ceramides 
and/or diacylglycerol modulate skeletal muscle insulin signaling. Increased 
intracellular concentrations of such fatty acid intermediates have been shown to 
increase PKC activation and enhance serine phosphorylation of the insulin 
receptor substrate-1 (IRS-1). The latter reduces its tyrosine phosphorylation, 
thereby suppressing PI-3 kinase activity, leading to a reduced GLUT-4 
translocation to the sarcolemma. It could be speculated that acute changes in 
muscle fatty acyl-CoA, ceramides and diacylglycerol concentrations following 
resistance exercise are (partly) responsible for the observed effects of resistance 
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training on skeletal muscle insulin sensitivity (84, 85). However, more research is 
warranted to address the proposed relationship between exercise, fatty acid 
intermediates and skeletal muscle insulin sensitivity. 
Nutritional interventions to promote muscle protein synthesis 
Endurance athletes optimize carbohydrate availability before, during and after 
prolonged endurance exercise to replenish muscle and liver glycogen stores and, as 
such, to optimize endurance performance capacity. In addition, it has been 
suggested that the ingestion of carbohydrate reduces protein degradation (69). In 
line with these findings, we demonstrate in chapter 4 that net protein degradation 
does not increase during moderate intensity endurance exercise when carbohydrate 
is ingested. This implies that net protein breakdown and oxidation is of minor 
magnitude during endurance type activities, like (ultra)marathons and prolonged 
cycling races. However, when only carbohydrate is ingested during and after 
exercise, whole-body protein balance remains slightly negative during exercise and 
subsequent recovery (42). The latter indicates that the ingestion of protein/amino 
acids is needed to obtain a positive net protein balance. In accordance, we show 
that the combined ingestion of protein and carbohydrate improves net protein 
balance at rest, during prolonged moderate intensity exercise and subsequent 
recovery in elite endurance athletes. The latter may well play an important role in 
the facilitation of specific muscle adaptation following endurance exercise training. 
Specific muscle adaptation includes the increased expression of proteins 
instrumental in the processes involved in the mobilization and oxidation of 
endogenous fat and carbohydrate stores.  
Optimizing protein metabolism following resistance exercise 
In contrast to endurance exercise, resistance exercise training can result in 
profound increases in skeletal muscle mass and strength (25, 67, 99). Interestingly, 
after a single session of resistance exercise, both muscle protein synthesis and 
degradation rates are strongly elevated (60). As a result, net muscle protein balance 
will remain negative in the absence of food intake. The latter implies that skeletal 
muscle hypertrophy can only occur under conditions where food is ingested during 
the early phases of post-exercise recovery. Therefore, the combined ingestion of 
protein and carbohydrate represents an effective strategy to promote net muscle 
protein accretion, as it can stimulate protein metabolism in several ways. Besides 
providing amino acids as precursors for protein synthesis, combined ingestion of 
carbohydrate and protein/amino acids has been shown to elevate plasma insulin 
levels (41, 46, 63, 65, 66), which could further augment protein anabolism (6, 10, 
27, 31, 32). Interestingly, a growing body of evidence indicates that amino acids 
can also function as potent nutritional signaling molecules, with an active 
regulatory function in muscle protein metabolism. It has been suggested that all 
essential amino acids (EAA) are responsible for the amino acid induced stimulation 
of muscle protein synthesis (92). Their presence stimulates protein synthesis, most 
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likely through stimulation of multiple steps in the mRNA translation process (3, 4). 
The branched-chain amino acids (30), and leucine in particular (3, 4), seem to have 
the highest potential to promote protein anabolism, by decreasing the rate of 
protein degradation and increasing muscle protein synthesis rates (54). The latter 
could partly be attributed to the insulinotropic potential of leucine, and the 
subsequent phosphorylation of key regulatory proteins that modulate protein 
synthesis (38, 48, 62). However, the anabolic effects of leucine have also been 
reported in the absence of elevated insulin concentrations. As such, leucine seems 
to be able to stimulate skeletal muscle protein synthesis through both insulin-
dependent as well as insulin-independent mechanisms (3), which involve signaling 
through the mammalian target of rapamycin or mTOR (41). Despite many 
speculations and promising results from recent animal studies, there is hardly any 
evidence showing leucine supplementation to improve protein balance in vivo in 
humans. 
Therefore, in chapter 5 and 6 we have investigated the potential of co-ingestion of 
leucine and protein with carbohydrate following resistance exercise or activities of 
daily living (ADL) to stimulate protein anabolism. Co-ingestion of leucine resulted 
in lower whole-body protein breakdown and oxidation rates and increased protein 
synthesis. The latter could partly be attributed to the higher plasma insulin 
concentrations following leucine co-ingestion. In line with previous studies (47, 52, 
64), we showed that net protein balance can be improved by the ingestion of 
protein and carbohydrate in the post-exercise/ADL period. Moreover, in chapter 5 
we have shown that the co-ingestion of leucine and protein with carbohydrate 
following resistance exercise resulted in higher muscle protein synthesis rates, 
compared to the ingestion of carbohydrate only. In addition, a greater whole-body 
protein balance was observed when compared to the ingestion of carbohydrate 
only and carbohydrate with protein (44). Nonetheless, muscle protein synthesis 
rates were similar with and without leucine when added to protein and 
carbohydrate. Although this study does not clearly demonstrate that leucine 
stimulates muscle protein synthesis in vivo in humans following resistance exercise, 
it demonstrates that protein anabolism following resistance exercise can be 
augmented with the ingestion of the leucine, protein and carbohydrate mixture. 
As there is an overwhelming interest in the effects of leucine on muscle protein 
metabolism, numerous studies have been performed to investigate the pathways 
involved in (amino acid induced) protein synthesis and degradation. With the 
identification of leucine as a potent nutritional signaling molecule, most studies 
have focused on the effects of leucine to modulate these signaling events. 
However, it would be naive to assume that the regulatory role of leucine in protein 
metabolism is unique. Even though leucine seems to be most effective in 
stimulating protein anabolism (17), we hypothesize that most essential amino acids 
are likely to play a regulatory role in protein metabolism and that these are likely to 
be mutually synergistic in stimulating protein anabolism. Future research should 
define the most important essential amino acids with such a regulatory potential. 
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Optimizing protein anabolism in the elderly 
Aging is associated with the progressive decline in skeletal muscle mass and 
function. The age-related changes in skeletal muscle mass are attributed to a 
disturbance in the regulation of muscle protein turnover, which results in a chronic 
imbalance between muscle protein synthesis and degradation. In chapter 6, we 
investigated the anabolic response to carbohydrate (CHO) ingestion following 
simulated ADL type activities in vivo in young (~20 y) and elderly men (~75 y). 
Consequently, we show that muscle protein synthesis rates are significantly lower 
in the elderly (~75 y) compared with the young (~20 y) under such conditions. 
The observed mixed muscle fractional synthetic rate (FSR) values following ADL 
activities were ~30% lower in the elderly compared with the young subjects. These 
observations are similar to previous reports showing muscle protein synthesis rates 
to be 20-30% lower in elderly humans (60-84 yrs) than in young adults in a basal, 
fasted state (34, 75, 100). Our findings on the muscle level are in line with our 
observations using the whole-body tracer methods showing whole-body 
phenylalanine and tyrosine turnover to be 20-25% lower in the elderly compared 
with the young. Thus, on a whole-body level, protein synthesis, oxidation and 
breakdown are reduced in the elderly compared with the young subjects. The 
reduction in whole-body protein turnover may indicate that tissue remodeling is 
impaired in the elderly. Muscle tissue remodeling, which involves the up- and/or 
down-regulation of specific sets of proteins (72, 73), is necessary to optimize 
muscle function for a new type of activity. The lower protein turnover rate in the 
elderly could indicate that the adaptive response to training is impaired. 
Consequently, it would be interesting to investigate whether there are differences 
in the specific sets of proteins that are up and/or down-regulated after exercise in 
young and elderly humans. 
In accordance to our earlier findings (44), we observed that whole-body net 
protein balance remains negative when only carbohydrate is ingested. To our 
knowledge we are the first to show that muscle protein synthesis is reduced in the 
elderly under practical daily living conditions in which ADL activities are followed 
by ingestion of carbohydrate only. Interestingly, co-ingestion of protein and 
leucine stimulates muscle protein synthesis rates to the same extent in young and 
elderly men (chapter 6). This is in line with more recent observations, showing a 
similar response of muscle protein turnover to an amino acid load in healthy 
elderly and younger adults (57, 91, 94). However, our FSR data seem to be quite 
the opposite from data presented by Volpi et al (93), who showed that the 
response of muscle protein synthesis to the combined ingestion of amino acids and 
glucose is impaired in the elderly. The latter could be related to the blunted insulin 
response in the elderly compared with the young controls that were reported by 
Volpi et al (93). In contrast, we excluded subjects with impaired insulin 
sensitivity/glucose tolerance and we observed similar plasma insulin responses in 
the young and elderly volunteers following the co-ingestion of protein and leucine 
with carbohydrate. The observed differences might be attributed to the property of 
leucine to stimulate insulin secretion (88) and/or mRNA translation (2). In this 
study, we investigated the potential differences in the capacity to stimulate muscle 
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protein synthesis in the young and elderly following the ingestion of a theoretically 
optimal anabolic nutritional intervention strategy. The latter shows that the 
response to the intervention is of a similar magnitude in the young and elderly. 
However, our study does not demonstrate that leucine stimulates muscle protein 
synthesis in vivo in elderly humans. Whether additional leucine ingestion is more 
effective in promoting muscle anabolism than protein and carbohydrate only 
remains to be established in the elderly population. The latter will be addressed in 
one of our future studies. 
Amino acids tracer considerations 
Stable isotope amino acid tracers are widely used to study protein metabolism (96). 
With the continuous intravenous infusion of these tracers, and repeated sampling 
from the plasma pool, whole-body amino acid kinetics can be determined (i.e. the 
rate of appearance (Ra) and the rate of disappearance (Rd) of the amino acid of 
interest). In this model amino acid Rd from the blood compartment equals the rate 
of oxidation + protein synthesis, whereas amino acid Ra equals the rate of protein 
breakdown + the rate of appearance of amino acids from dietary protein from the 
gut (105).  
The use of the (whole-body) tracer balance methodology to investigate the effect 
of post-exercise nutrition on protein metabolism has some important limitations as 
it is based on a few important assumptions. Two important assumptions include: 
1) tissue amino acid pool size and enrichment are constant and 2) the amino acid 
tracer used is representative for the metabolism of the other amino acids. The first 
assumption indicates that the whole-body method (or any other compartmental 
analyses) is only valid when a steady state is present in the concentration and 
enrichment of the tracer amino acid in the plasma and muscle pool. However, after 
the oral ingestion of amino acids, it has been shown that amino acid 
concentrations increase substantially in the muscle free amino acid pool (15). The 
latter indicates that a significant portion of the plasma amino acid Rd results in 
muscle amino acid pool extension. This results in an overestimation of whole-body 
protein synthesis rates. Consequently, methods were introduced to measure tissue 
or protein-specific synthesis rates. In chapter 5 and 6, we have measured tracer 
incorporation in muscle protein as a means to directly measure mixed muscle 
protein synthesis rates. 
The second assumption indicates that the whole-body method can only provide 
useful information upon whole-body protein turnover, when the applied amino 
acid tracer is a valid representative for the metabolic fate of all other amino acids. 
In early amino acid tracer studies, leucine was generally applied as a tracer (49, 53, 
65, 76, 100, 106, 107). However, in chapter 4 we stress that care should be taken 
with the use of the leucine tracer to study protein metabolism during exercise. 
Leucine metabolism during exercise is not generally representative of the fate of 
the other amino acids that are present in proteins. During exercise, uptake (1, 82) 
and oxidation (82, 97, 98) of branched chain amino acids (leucine, isoleucine and 
valine) increase several fold in contracting muscle. The latter means that the 
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stochastic leucine model of whole-body protein metabolism (50) becomes invalid 
during exercise and cannot be used to estimate qualitative or quantitative changes 
in whole-body protein synthesis and/or degradation. Therefore, more recent 
studies from our (42, 44) and other laboratories (12, 60, 64, 80, 95) have used 
phenylalanine as a tracer to study protein metabolism. It has been shown that 
phenylalanine is not oxidized in rat skeletal muscle (19), which would mean that all 
phenylalanine that enters the muscle is used for muscle protein synthesis (7). This 
is one of the other basic assumptions of the three compartment model as 
proposed by Biolo et al (7). Interestingly, in chapters 5 and 6 we provide data that 
tend to proof this assumption wrong. In these chapters we infused labeled 
phenylalanine and measured phenylalanine and tyrosine enrichment in plasma and 
free muscle amino acid pool. Consequently, we observed ~60% higher tyrosine 
enrichments in the free muscle amino acid pool compared to values observed in 
plasma. This seems to suggest that phenylalanine is converted to tyrosine in 
skeletal muscle. The latter is in line with observations by van Hall et al. (83), 
showing that during one-legged exercise, tyrosine is released from the muscle in 
larger amounts than its relative occurrence in muscle protein and phenylalanine in 
smaller amounts. These and our findings may have major implications for the 
published data to date, as most tracer models are based on the assumption that 
phenylalanine is not broken down in the muscle. Consequently, these studies are 
likely overestimating muscle protein synthesis, and care should be taken with the 
interpretation of these data. The latter will be investigated in detail in future 
studies. 
Regulation of protein synthesis: effects of exercise and nutrition 
It has been shown that both muscle protein synthesis (8, 60, 79) as well as protein 
breakdown rates (8, 60) are accelerated following resistance exercise. Resistance 
exercise exerts its effect either via the increased local production of muscle specific 
IGF-1 or MGF (33) and/or other contraction induced signaling events. These 
factors can increase signaling of the PI-3 kinase/mTOR pathway resulting in an 
increase in muscle protein synthesis rates and glucose uptake. However, food 
intake is an essential factor to fully stimulate the activity of this signaling pathway. 
Although muscle protein synthesis is stimulated during the post-exercise recovery 
phase (60), net muscle protein balance remains negative in the absence of food 
intake (8, 60, 61). It has been shown that the administration of protein/amino 
acids with carbohydrate results in a rapid increase in muscle protein synthesis rates 
(chapter 5 and 6), whereas (whole-body) protein degradation rates are decreased (9, 
15, 64, 79, 81).  
Recent evidence suggests that the phosphatidylisositol 3-kinase (PI3-K) signaling 
pathway plays a key role in the integration of contraction mediated signaling (for 
example MGF) and signaling from nutritional factors (40, 70). The activity of the 
signaling cascade controlling muscle protein synthesis is largely determined by the 
phosphorylation of the mammalian target of rapamycin (mTOR) and its 
subsequent activation of the 70-kDa S6 protein kinase (p70-S6K) and the 
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eukaryotic initiation factor 4E-binding protein (4E-BP1) (40). In chapter 7, we 
report a marked increase in the phosphorylation of AMP-activated protein kinase 
(AMPK), indicating that resistance exercise leads to a reduction in the energy status 
of the muscle fiber, thereby stimulating the phosphorylation of skeletal muscle 
AMPK. AMPK activation in skeletal muscle tissue has been associated with a 
reduced phosphorylation state of mTOR at Ser2448, p70-S6K at Thr389 and 4E-BP1 
at Thr37 (13). More recently, it was proposed that activation of AMPK results in 
mTOR phosphorylation at Thr2446 (21), which decreases mTOR phosphorylation 
at Ser2448 (figure 8.2), thereby diminishing the ability of insulin (and other growth 
factors) to phosphorylate p70-S6K (21) during exercise. These observations are 
indicative of the presence of a metabolic switch mechanism in which AMPK plays 
a key role by integrating signals associated with the energy state of the cell and 
growth factors associated with protein translation.  
 
Figure 8.2 The integration of signals from exercise and nutritional factors. PI3-K, phosphatidylinositol-3 kinase; 
Akt, protein kinase B; AMPK AMP-activated kinase; mTOR, mammalian target of rapamycin protein kinase; 
eIF4E, eukaryotic initiation factor 4E; 4E-BP1, eIF4E binding protein 1; S6K1; p70/p85 ribosomal protein S6 
protein kinase; eIF4F, eukaryotic initiation factor 4F; S6, ribosomal protein S6; GSK-3, glycogen synthase kinase 
3; eIF2B, eukaryotic initiation factor 2B; eIF2∙GDP, inactive eukaryotic initiation factor 2; eIF2∙GTP, activated 
eukaryotic initiation factor 2. 
 
Chapter 7 shows that a single session of high-intensity resistance exercise in vivo in 
humans significantly increases AMPK phosphorylation and reduces the 
phosphorylation status of 4E-BP1 in skeletal muscle tissue immediately after 
cessation of exercise. The exercise bout did not substantially increase S6 
phosphorylation, indicating that p70-S6K activity was not increased to a large 
extent. Similar results were reported following resistance exercise in rats (14), and 
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S6K1 phosphorylation at Thr389 was shown to be unchanged. Our observations are 
also in agreement with data reported by Karlsson et al. (38), showing that a single 
session of resistance exercise (4 sets, 10 repetitions of leg extension) does not fully 
activate p70-S6K. However, they showed that post-exercise ingestion of branched 
chain amino acids has a striking effect on p70-S6K, which was evident by site-
specific phosphorylation at Thr389 (38). These data indicate that intake of an ample 
amount of amino acids is essential to activate skeletal muscle translation initiation. 
Though translation initiation is likely to represent a main regulatory factor in 
modulating muscle protein synthesis, Proud and colleagues (16, 63) have shown 
that also the translation elongation process is under regulatory control by nutrients 
and hormones. The latter suggests that the anabolic response to exercise and/or 
nutrient intake can be controlled at various different levels (i.e. mRNA translation 
initiation, elongation, termination and post-translational modification). The 
relationship between activation of the molecular signaling pathways and in vivo 
muscle protein synthesis rates in response to exercise and nutrition clearly remains 
to be assessed in vivo in human studies. 
In chapter 5 and 6 we investigated the effect of post-exercise intake of 
carbohydrate, protein and free leucine and showed that muscle protein synthesis 
rates were substantially increased when leucine was co-ingested with protein and 
carbohydrate when compared with the ingestion of carbohydrate only. Although 
these studies do not demonstrate that leucine specifically stimulates muscle protein 
synthesis in vivo in humans following resistance exercise/ADL activities, it 
demonstrates that protein anabolism following resistance exercise can be 
augmented with the ingestion of a leucine, protein and carbohydrate mixture. 
Studies in rats have increased the understanding of the mechanisms of nutritional 
regulation of protein synthesis at the molecular level and indicate that leucine 
ingestion could stimulate muscle anabolism in several ways, as it can further 
increase plasma insulin concentrations and also directly stimulate protein synthesis 
in an insulin independent manner. The stimulatory effect of leucine on protein 
synthesis occurs at the level of translation initiation and involves signaling through 
mTOR (41, 62), and subsequent phosphorylation and activation of 4E-BP1, S6K1 
and ribosomal protein S6 (figure 8.2). The protein kinase mTOR is thought to 
serve as a convergence point for leucine- and insulin-mediated effects on 
translation initiation (41, 62). Furthermore, leucine has been shown to have the 
potential to affect muscle protein metabolism by decreasing the rate of protein 
degradation (54), most likely via an increase in circulating insulin (38, 48, 62). 
However, not only leucine has the potential to stimulate muscle protein synthesis, 
as intramuscular and plasma essential amino acid availability has been shown to 
play an important regulatory role in protein anabolism (12, 92). In addition to 
increased signaling through mTOR, an increase in essential amino acid availability 
results in a decreased phosphorylation of the eukaryotic initiation factor 2 (eIF2). 
The phosphorylation of the eIF2 ( -subunit) is mediated by the mammalian 
ortholog of the yeast general control nonderepressing kinase 2 (mGCN2), which 
responds to changes in (essential) amino acid availability. Decrease in 
phosphorylation of eIF2  leads to the dissociation and activation of the eukaryotic 
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initiation factor 2B (eIF2B), thereby increasing the translation of most mRNAs 
(Fig 2).  
Data provided in chapters 4-6 in this thesis, show that the combination of exercise 
and nutrition can effectively stimulate (muscle) protein synthesis. There is an 
increasing body of evidence showing that the PI3-Kinase signaling pathway is 
likely to play a key role in the integration of contraction mediated signaling and 
signaling from nutritional factors. Most of the research has been performed using 
in vitro and in vivo animal models. In these models, exercise or electrical stimulation 
have been shown to increase signaling through the PI3-kinase/mTOR pathway 
resulting in increases in protein synthesis and glucose uptake. In addition to 
exercise, ingestion of amino acids, and leucine in particular, has been shown to 
effectively increase mTOR phosphorylation and the activation of translation. For 
now, there is no human data available to assess the proposed stimulating effects of 
leucine on skeletal muscle protein synthesis.  
General conclusions 
In this thesis, we focused on the beneficial effects of resistance exercise and the 
potential of dietary supplementation with carbohydrate, protein and leucine to 
enhance muscle protein anabolism. Resistance exercise was shown to be as 
powerful as endurance exercise in enhancing post-exercise insulin sensitivity. In 
addition, we reported that a single resistance exercise session substantially reduced 
intramyocellular glycogen content in a muscle fiber-type specific manner. The 
latter suggests that the acute improvements in whole-body insulin sensitivity 
following resistance exercise could, at least partly, be attributed to the net 
reduction in skeletal muscle glycogen content. Additionally, we showed that 
immediately after resistance exercise AMPK phosphorylation is increased. This 
could be the initial trigger to increase glucose uptake and to simultaneously inhibit 
mRNA translation initiation (and thus protein synthesis). Although S6K1 
phosphorylation was increased in a muscle fiber-type specific manner following 
resistance exercise, the phosphorylation of S6 was not substantially increased under 
fasting conditions.  
As such, in the absence of food intake, exercise does not fully activate the 
translation initiation process in skeletal muscle tissue. Therefore, the combined 
ingestion of protein and carbohydrate has been suggested as a more effective 
strategy to promote net muscle protein accretion, as it can stimulate protein 
metabolism by providing amino acids as precursors for protein synthesis and 
further elevate plasma insulin levels and reduce protein breakdown. We showed 
that prolonged exhaustive moderate intensity endurance exercise does not result in 
increased protein degradation and/or a decrease in protein synthesis compared 
with resting situations when carbohydrates are ingested. However, protein intake is 
necessary to increase protein synthesis and further decrease protein breakdown, 
resulting in a positive net protein balance.  
Amino acids have more metabolic roles than to merely serve as building blocks for 
proteins. They function as potent nutritional signaling molecules, and have an 
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active regulatory role in modulating muscle protein metabolism. The branched-
chain amino acid leucine seems to have the potential to promote protein 
anabolism. Despite many speculations and promising results from recent animal 
studies, there is hardly any evidence showing leucine supplementation to improve 
protein balance in vivo in humans. Therefore, we investigated the effect of post-
exercise intake of leucine and showed that muscle protein synthesis rates were 
substantially increased when leucine was co-ingested with protein and carbohydrate 
compared with the ingestion of carbohydrate only.  
These observations have lead to the hypothesis that physical activity followed by 
the ingestion of leucine with protein and carbohydrate could represent an effective 
strategy to reduce or counteract the loss of muscle tissue that occurs with aging. 
Consequently, we demonstrated that co-ingestion of protein and leucine with 
carbohydrate improves whole-body protein balance when compared with the 
ingestion of carbohydrate only in young and elderly men. Mixed muscle protein 
synthesis was shown to be reduced in the elderly when only carbohydrate was 
ingested. However, co-ingestion of protein and leucine substantially increases 
mixed muscle protein synthesis rates to the same level in the young and elderly, 
thereby improving whole-body protein balance. The present data indicate that the 
combined ingestion of carbohydrate, protein and leucine represents an effective 
strategy to increase muscle anabolism following resistance exercise or ADL 
activities in young and elderly humans. 
Future research 
The studies described in this thesis provide novel information on the beneficial 
effects of resistance exercise and the use of dietary supplements containing 
carbohydrate, protein and/or leucine as means to optimize post-exercise muscle 
protein anabolism in vivo in humans. However, there are many questions that still 
need to be addressed in future research: 
 
 Is the combined ingestion of leucine and protein with carbohydrate more 
effective in stimulating protein synthesis compared to carbohydrate and 
protein ingestion only? 
 Is phenylalanine converted to tyrosine in human skeletal muscle? 
 Which proteins are synthesized at a higher rate following exercise and are 
there differences in the specific sets of proteins that are synthesized after 
resistance and endurance exercise as well as between young and elderly 
humans? 
 What is the effect of protein ingestion following exercise on the specific 
sets of proteins that are synthesized and are there differences between 
young and elderly humans? 
 Do different types of proteins differ in ability to stimulate muscle protein 
anabolism? 
 What is the relationship between the activation of intracellular signaling 
and in vivo muscle protein synthesis? 
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 What signaling pathways that regulate muscle protein synthesis are 
impaired in the elderly? 
 What is the time course of activation of the key kinases leading to protein 
anabolism and remodeling and does the activation window depend on the 
timing of nutrient intake and composition? 
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Skeletal muscle is one of the major organs involved in metabolism. Aging and 
chronic metabolic diseases, like type 2 diabetes, are generally associated with a 
significant loss of skeletal muscle mass. Muscle wasting eventually leads to muscle 
weakness and major disabilities in day-to-day life. Therefore, various interventions 
have been proposed to reduce or reverse the loss of muscle mass and function. 
Most attention so far was paid to endurance type of exercise. In this thesis we 
focus on the beneficial effects of resistance exercise and the proposed importance 
of the ingestion of carbohydrate, protein and/or specific amino acids as a means to 
augment muscle protein anabolism. 
In chapter 2, we report that a single resistance exercise session can improve 
whole-body insulin sensitivity by as much as 15% when measured 24h after 
cessation of exercise. The latter tends to be of a similar magnitude as the ~20% 
improvement that has been reported in literature following an acute (~60 min) 
bout of endurance exercise. The presented data indicate that there should be no 
restriction in combining the benefits of both types of exercise in future lifestyle 
intervention programs. The greater whole-body insulin sensitivity following 
endurance exercise has been associated with the reduction of muscle substrate 
sources following exercise. However, information on the metabolic demands of 
resistance exercise is scarce. In chapter 3, it is shown that mixed muscle glycogen 
content is substantially decreased following a single resistance exercise session. 
These changes in muscle glycogen are shown to be fiber-type specific, and tend to 
be more pronounced in type IIx muscle fibers compared to type I muscle fibers. 
Furthermore, intramyocellular lipid content is reduced in the type I muscle fibers 
only and returns to baseline values within 2h of post-exercise recovery. The 
absence of a prolonged net reduction in skeletal muscle lipid content implies that 
the reported stimulating effects of resistance exercise on whole-body insulin 
sensitivity is unlikely to be attributed to a temporary reduction in intramyocellular 
lipid content. 
In chapters 4, 5 and 6 the effects of exercise or activities of daily living and 
nutrition on protein metabolism are evaluated. In these studies, continuous 
infusions of labeled amino acids are applied to measure their rate of appearance 
and/or disappearance in blood. With this method we can estimate protein 
breakdown, synthesis, oxidation and net-balance on a whole-body level. In 
chapters 5 and 6 we also measure the rate of incorporation of a labeled amino acid 
into skeletal muscle protein to directly assess mixed muscle protein synthesis rates. 
In chapter 4, different tracer methods are compared with the intention to assess 
whole-body protein turnover, during and following 6h of prolonged endurance 
exercise when carbohydrate or carbohydrate and protein are ingested. 
Discrepancies are shown when applying [2H5]phenylalanine and/or [15N]urea and 
the [1-13C]leucine tracer methods during exercise. These discrepancies are likely 
attributed to the fact that during exercise the uptake and oxidation of leucine is 
increased several fold. Therefore, leucine is likely not representative of the fate of 
the other essential amino acids during exercise. With phenylalanine and urea as 
tracers it is demonstrated that net protein degradation does not increase during 
moderate intensity exercise when carbohydrate is ingested. However, under these 
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conditions, protein net balance remains negative. The combined ingestion of 
carbohydrate and protein is shown to improve net protein balance at rest, during 
exercise and post-exercise recovery. 
In chapters 5 and 6 the effects of amino acid and/or protein (hydrolysate) 
ingestion on muscle protein synthesis are investigated. The combined ingestion of 
carbohydrate, protein and leucine stimulates protein anabolism in several ways. It 
provides amino acids as precursors for protein synthesis and elicits a strong 
insulinotropic response. In addition, in animal models, leucine has been shown to 
stimulate protein synthesis by an insulin-independent mechanism. In chapter 5, it 
is shown that the combined ingestion of carbohydrate (0.3 g∙kg-1∙h-1), protein 
hydrolysate (0.2 g∙kg-1∙h-1) and leucine (0.1 g∙kg-1∙h-1) following resistance exercise 
substantially augments the plasma insulin response. The combined ingestion of this 
mixture reduces whole-body protein breakdown and oxidation rates and increases 
protein synthesis rates. The net protein balance is negative when only carbohydrate 
is ingested, positive with carbohydrate and protein and improves further following 
the combined ingestion of carbohydrate, protein and leucine. In addition, muscle 
protein synthesis rates are shown to be significantly higher when carbohydrate, 
protein and leucine are ingested. These data suggest that the additional ingestion of 
free leucine in combination with protein and carbohydrate likely represents an 
effective strategy to increase muscle protein anabolism following resistance 
exercise. 
The progressive loss of skeletal muscle mass with aging, or sarcopenia, is partly 
attributed to a disruption in the regulation of skeletal muscle protein turnover. The 
anabolic effect of food intake on muscle protein synthesis seems to be blunted in 
the elderly. The latter has been proposed to play a key-role in the etiology of 
sarcopenia. In chapter 6, potential differences in the response to the ingestion of 
carbohydrate (0.49 g∙kg-1∙h-1) with or without protein hydrolysate (0.16 g∙kg-1∙h-1) 
and free leucine (0.03 g∙kg-1∙h-1) following simulated activities of daily living (ADL) 
on whole-body protein balance and mixed muscle protein synthesis rates are 
investigated in both young and elderly men. Whole-body phenylalanine and 
tyrosine fluxes are shown to be significantly higher in the young versus the elderly, 
indicative of a slower protein turnover rate in the elderly. Protein balance is shown 
to be negative when only carbohydrate is ingested, but positive when both protein 
and leucine are co-ingested in both groups. Muscle protein synthesis rates are 
shown to be substantially lower in elderly compared with young adults when only 
carbohydrates are ingested. Combined ingestion of protein hydrolysate and leucine 
with carbohydrate increases muscle protein synthesis rates and improves net 
protein balance to the same extent in young and elderly men. These data indicate 
that the anabolic properties of this nutritional intervention are equally effective in 
young and elderly men. 
The rate of muscle protein synthesis is regulated in part by the process of mRNA 
translation initiation. The latter has been shown to be regulated by the 
posphatidylinositol 3 kinase signaling pathway, with major regulatory roles for the 
mammalian target of rapamycin (mTOR), S6 protein kinase 1 (S6K1) and the 
eukaryotic initiation factor 4E-binding protein (4E-BP1). In chapter 7, the effects 
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of a single session of resistance exercise on the phosphorylation status of several 
proteins involved in the regulation of muscle protein synthesis are assessed. In 
addition, it is observed that changes in the phosphorylation status are muscle fiber-
type specific. Resistance exercise results in a strong activation of AMP activated 
kinase (AMPK), while 4E-BP1 phosphorylation is reduced, suggesting that 
translation initiation is blunted immediately following resistance exercise. During 
recovery, S6K1 phosphorylation increases but this is shown to occur 
predominantly in the fast twitch type II muscle fibers. The observation that S6 
phosphorylation does not substantially change when subjects remain fasted implies 
that the ingestion of protein/amino acids is essential to fully activate the 
translational machinery. 
In the final chapter, the significance and clinical relevance of the acquired data are 
discussed and important aims for future research are defined. In addition, specific 
methodological issues that need to be considered in future studies are also 
mentioned. 
 
In summary, resistance exercise reduces muscle glycogen stores in a fiber-type 
specific manner, which could partly be responsible for the observed increase in 
insulin sensitivity following exercise. Although resistance exercise increases S6K1 
phosphorylation in a fiber-type specific manner, S6 phosphorylation does not 
increase under fasting conditions. The latter indicates that food intake following 
exercise is needed to fully activate mRNA translation initiation and muscle protein 
synthesis. In contrast to common belief, endurance exercise does not increase 
protein degradation and oxidation when only carbohydrates are ingestion. 
However, the intake of protein/amino acids is necessary to attain a net positive 
protein balance. Amino acids do not only serve as building blocks for de novo 
protein synthesis. Amino acids, and leucine in particular, seem to be able to 
function as signaling molecules with an important regulatory role in muscle protein 
metabolism. The combined intake of leucine and protein hydrolysates with 
carbohydrate following resistance exercise can effectively stimulate muscle protein 
synthesis. These observations have lead to the hypothesis that physical activity 
followed by the ingestion of leucine with protein hydrolysate and carbohydrate 
could represent an effective strategy to reduce or counteract the loss of muscle 
tissue that occurs with aging. Co-ingestion of protein hydrolysate and leucine 
substantially increases mixed muscle protein synthesis rates to the same level in the 
young and elderly, thereby improving whole-body protein balance. The present 
data indicate that the combined ingestion of carbohydrate, protein and leucine 
represents an effective strategy to increase muscle protein anabolism following 
resistance exercise or ADL activities in young and elderly humans. 
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De skeletspier is één van de belangrijkste organen die betrokken is bij de regulatie 
van het metabolisme. Veroudering en chronische metabole ziekten zoals diabetes 
zijn geassocieerd met een sterk verlies aan spiermassa. Dit heeft tot gevolg dat 
spierkracht en uithoudingsvermogen afneemt, waardoor de functionele capaciteit 
van de patiënt achteruit gaat. Om deze afname van de spiermassa tegen te gaan zijn 
verschillende interventies voorgesteld. Tot nu toe is er vooral aandacht geweest 
van de effecten van duurtrainingen. In dit proefschrift wordt aandacht besteed aan 
de voordelen van het uitvoeren van krachttraining en de mogelijkheden van de 
gecombineerde inname van koolhydraten, eiwithydrolysaten en leucine om de 
spieraanwas te stimuleren. 
In hoofdstuk 2 wordt aangetoond dat de insuline gevoeligheid, 24 uur na één 
enkele krachttraining met ongeveer 15% kan worden verbeterd. Dit is vergelijkbaar 
met de resultaten die gerapporteerd worden na het uitvoeren van één enkele 
duurtraining. De uitkomsten van deze studie geven dus aan dat er geen beperking 
behoeft te bestaan in het implementeren van beide vormen van inspanning in 
toekomstige interventieprogramma’s. De verbeterde insuline gevoeligheid na 
inspanning wordt vaak geassocieerd met het gebruik van substraatvoorraden in de 
spier tijdens inspanning. Echter, er is eigenlijk nauwelijks iets bekend over hoeveel 
van die voorraden tijdens krachttraining gebruik wordt. In hoofdstuk 3 wordt 
aangetoond dat de spierglycogeen voorraad sterk gedaald is na een krachttrainings-
sessie. De verlaging in glycogeen voorraad blijkt daarnaast spiervezelspecifiek te 
zijn. De daling is namelijk groter in de snelle type IIx vezels in vergelijking met de 
langzamere type I vezels. Verder daalt ook de vetvoorraad in de spiervezels. Dit 
gebeurt echter selectief in de langzame vezels (type I) en 2 uur na inspanning is de 
vetvoorraad alweer aangevuld tot basale hoeveelheden. Het feit dat de 
vetvoorraden in de spier na krachttraining niet verlaagd worden voor langere tijd, 
geeft aan dat de gerapporteerde toename in insuline gevoeligheid na dit soort 
inspanning niet kan worden toegeschreven aan een daling in vetvoorraden in de 
spier. 
In de hoofdstukken 4, 5 en 6 zijn de effecten van fysieke inspanning en 
voedingsinterventies op het eiwitmetabolisme bestudeerd. In deze studies worden 
proefpersonen geïnfuseerd met gelabelde aminozuren. Op de wijze kan bepaald 
worden hoe snel aminozuren in het bloed verschijnen en hoe snel ze in weefsels 
verdwijnen. Met behulp van deze techniek kan op heel lichaamsniveau de 
eiwitaanmaak, afbraak, oxidatie en de netto balans uitgerekend worden. In 
hoofdstuk 5 en 6 is ook nog gemeten hoe snel het gelabelde aminozuur wordt 
ingebouwd in spierweefsel om op die manier de snelheid te kunnen bepalen 
waarmee spiereiwit wordt aangemaakt. 
In hoofdstuk 4 worden verschillende gelabelde aminozuren (tracers) gebruikt om 
het eiwitmetabolisme voor, tijdens en na een 6 uur lange duurtraining in kaart te 
kunnen brengen terwijl de proefpersonen continue koolhydraten of koolhydraten 
en eiwitten innamen. Er bestaan duidelijke verschillen in de uitkomsten die 
verkregen zijn met de [2H5]phenylalanine en [15N]ureum tracer vergeleken met de 
[1-13C]leucine tracer tijdens inspanning. Dit verschil wordt waarschijnlijk 
veroorzaakt door het feit dat de leucine opname en oxidatie tijdens inspanning 
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sterk verhoogd wordt, terwijl dat met andere aminozuren niet gebeurd. Hierdoor is 
leucine niet representatief voor het lot van de andere essentiële aminozuren tijdens 
inspanning. Met de phenylalanine en ureum tracers is aangetoond dat tijdens ultra 
lange duurinspanning de eiwitafbraak en oxidatie niet verhoogd is wanneer 
koolhydraten worden ingenomen gedurende de inspanning. Echter onder deze 
condities is de netto eiwitbalans negatief. Uit deze studie blijkt dat de inname van 
een koolhydraat en eiwitmengsel ervoor zorgt dat de netto eiwitbalans sterk 
positief wordt. 
In de hoofdstukken 5 en 6 wordt het effect van de inname van eiwit/aminozuren 
op de spiereiwitsynthese bepaald. Deze inname van een mengsel met koolhydraten, 
eiwithydrolysaten en leucine kan op verschillende manieren de eiwitaanmaak 
stimuleren. Het levert bouwstenen (aminozuren) voor de aanmaak van eiwit en kan 
de insuline afgifte door de alvleesklier sterk verhogen. Verder blijkt uit 
dierenonderzoek dat het essentiële aminozuur leucine de unieke eigenschap heeft 
om direct de eiwitsynthese te stimuleren via een insuline onafhankelijk 
mechanisme. In hoofdstuk 5 wordt aangetoond dat de gecombineerde inname van 
koolhydraten (0.3 g/kg/u), eiwit (0.2 g/kg/u) en leucine (0.1 g/kg/u) na een 
krachttraining leidt tot een sterke stijging in de plasma insuline concentratie, 
wanneer deze wordt vergeleken met de inname van koolhydraat met of zonder 
eiwit. De eiwitafbraak en oxidatie wordt verlaagd terwijl de eiwitaanmaak wordt 
verhoogd na de inname van de koolhydraat, eiwit en leucine drank. De netto 
eiwitbalans op heel lichaamsniveau is negatief wanneer alleen koolhydraten worden 
ingenomen, positief wanneer eiwithydrolysaat aan de drank wordt toegevoegd en 
nog verder verhoogd wanneer ook leucine wordt toegevoegd. De 
spiereiwitsynthese is significant hoger wanneer koolhydraat, eiwithydrolysaat en 
leucine wordt ingenomen vergeleken met de inname van koolhydraten alleen. Deze 
data lijkt te suggereren dat de inname van eiwithydrolysaat en leucine met 
koolhydraten een effectieve strategie is om de spiereiwitaanmaak te verhogen na 
krachttraining. 
Het verlies van spiermassa dat optreedt naarmate men ouder wordt, ook wel 
sarcopenie genoemd, wordt gedeeltelijk veroorzaakt door een verstoorde regulatie 
van de spiereiwitsynthese en afbraak. Bijvoorbeeld, het stimulerende effect van 
voedselinname op de spiereiwitsynthese lijkt bij ouderen verminderd te zijn. Dit 
wordt gezien als een van de belangrijkste factoren in de etiologie van sarcopenie. 
In hoofdstuk 6 wordt gekeken of er verschillen zijn in eiwit balans en 
spiereiwitsynthese na normale dagelijkse activiteiten met de inname van 
koolhydraten (0.49 g/kg/u) met of zonder eiwithydrolysaat (0.16 g/kg/u) en vrije 
leucine (0.03 g/kg/u) tussen oudere (± 75 jaar) en jongere (± 21 jaar) mensen. De 
flux van phenylalanine en tyrosine blijkt lager te zijn in de ouderen wat impliceert 
dat de eiwitturnover (aanmaak en afbraak) lager is in de oudere proefpersonen. 
Wanneer alleen koolhydraten worden ingenomen is de eiwitbalans op heel-
lichaamsniveau negatief, terwijl hij positief is na de inname van leucine en eiwit met 
koolhydraten. De spiereiwitsynthese is significant lager in de oudere personen in 
vergelijking met de jongeren. De gecombineerde inname van eiwit en leucine met 
koolhydraten verhoogt de eiwitsynthese snelheid in zowel de jongeren als de 
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ouderen. Sterker nog, de spiereiwitaanmaak wordt net zo sterk gestimuleerd door 
de inname van deze drank in de ouderen als in de jongeren. Dit betekent dat de 
anabole capaciteit van deze voedingsinterventie net zo groot is in ouderen als in 
jongeren. 
De snelheid van spiereiwitaanmaak wordt gereguleerd door een proces genaamd 
translatie initiatie dat ervoor zorgt dat begonnen kan worden met het aflezen van 
mRNA en daarna eiwit gevormd kan worden. Dit proces wordt gereguleerd door 
de phophatidylinositol-3 kinase signaalcascade. De belangrijkste enzymen/kinases 
in deze keten zijn de proteïne kinase mTOR, S6 proteïne kinase 1 (S6K1) en 
eukaryotische initiatie factor 4E-bindingsproteïne (4E-BP1). In hoofdstuk 7 wordt 
het effect van één enkele krachttraining op de fosforylatiestatus van verschillende 
eiwitten gemeten die betrokken zijn in de regulatie van de spiereiwitsynthese 
snelheid. Het blijkt dat veranderingen in fosforylatie van S6K1 spiervezeltype 
afhankelijk zijn. Deze fosforylatie treedt vooral op in snelle type II spiervezels. De 
krachttraining resulteert in een sterke activering van de AMP geactiveerde kinase 
(AMPK), terwijl 4E-BP1 fosforylatie verlaagd is. Dit impliceert dat direct na 
inspanning translatie initiatie geremd is. Gedurende het herstel neemt de mate van 
S6K1 fosforylatie toe, terwijl de fosforylatie van S6 niet verandert wanneer 
proefpersonen nuchter blijven. Deze data suggereert dat de inname van voldoende 
eiwitten nodig is om de translatie initiatie optimaal te laten verlopen. 
In het laatste hoofdstuk wordt het belang van de behaalde onderzoeksresultaten 
besproken en hun klinische relevantie voor de oudere populatie bediscussieerd. 
Verder worden belangrijke doelen voor toekomstig onderzoek gedefinieerd. Ook 
worden specifieke methodologische problemen waarmee rekening moet worden 
gehouden in toekomstig onderzoek aangehaald.  
  
Samenvattend, krachttraining leidt tot een spiervezelspecifieke verlaging van de 
glycogeenvoorraad in de spier, wat gedeeltelijk verantwoordelijk is voor de 
verhoogde insuline gevoeligheid na inspanning. Hoewel krachttraining de 
fosforylatie van S6K1 verhoogt op een spiervezelspecifieke manier, blijft de 
fosforylatie van S6 onveranderd wanneer men gevast blijft. Dit geeft aan dat de 
inname van voedsel na het sporten essentieel is om de mRNA translatie initiatie en 
de aanmaak van spiereiwit volledig te activeren. Hoewel over het algemeen gedacht 
wordt dat duurtraining leidt tot een toegenomen eiwit afbraak en oxidatie, blijkt dit 
niet het geval te zijn wanneer koolhydraten worden ingenomen. Om een positieve 
netto eiwitbalans te verkrijgen moet men naast koolhydraten echter ook 
eiwitten/aminozuren innemen. Aminozuren vormen niet alleen de bouwstenen 
voor nieuwe eiwitten, ze kunnen ook functioneren als signaal moleculen die een 
belangrijke regulerende rol in het eiwitmetabolisme kunnen spelen. Dit geldt vooral 
voor het aminozuur leucine. De gecombineerde inname van leucine, 
eiwithydrolysaat en koolhydraten na een krachttraining blijkt effectief in het 
stimuleren van de spiereiwitsynthese. Deze observatie heeft tot de hypothese geleid 
dat fysieke activiteit gevolgd door de inname van leucine, eiwit en koolhydraten 
een effectieve strategie kan zijn om het verlies van spiermassa bij ouderen te 
verminderen of te voorkomen. Het blijkt dat de gecombineerde inname van 
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leucine, eiwit en koolhydraten de spiereiwit-aanmaak in jongeren en ouderen in 
dezelfde mate stimuleert, wat leidt tot een verbeterde netto eiwit balans. Deze data 
geven aan dat de gecombineerde inname van leucine, eiwit en koolhydraten een 
effectieve strategie is om de spiereiwit-aanmaak te stimuleren in de eerste uren na 
een krachttraining of in de periode na een verhoogd dagelijkse activiteiten patroon 
in jonge en oudere mensen. 
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Als allerlaatste schrijf ik nu dit dankwoord. Dit kleine stukje tekst zal waarschijnlijk 
toch het meest gelezen deel van dit proefschrift worden. Om een beetje op gang te 
komen zal ik maar beginnen met een enorm cliché: “Een proefschrift schrijven 
kun/kan/ken je niet alleen”. Daarom wil ik iedereen bedanken die in de afgelopen 
jaren een bijdrage heeft geleverd. Een aantal mensen wil ik hierbij in het bijzonder 
benadrukken. 
Allereerst wil ik natuurlijk Luc, mijn co-promotor, en Ton en Wim, mijn 
promotoren, bedanken. Luc, een betere begeleider dan jij kan een AIO zich niet 
wensen. Door jou is het voor mij mogelijk geweest om de afgelopen 4 jaar het 
maximale uit mezelf te halen. Door jou heb ik geleerd dat grenzen er zijn om 
overwonnen te worden (op naar de 170). Het uitgebreid met jou bediscussiëren 
van data en artikelopzetten heeft het schrijven voor mij een stuk makkelijker 
gemaakt. De zaken die me het meest bij zijn gebleven zijn natuurlijk allereerst, de 
tick dat ik voor, tijdens en na een testdag de neiging heb om alles 4 keer te 
controleren. Verder zijn de bemoedigende woorden: when does the hurting stop??? of 
natuurlijk at least things can’t get any worse… gedenkwaardig. Het ziet er gelukkig naar 
uit dat we als team voorlopig nog even door kunnen blijven gaan. Ton, dank je 
voor het feit dat je mij de mogelijkheid hebt gegeven om AIO te worden. De vele 
uren met uitleg over de aminozuur-tracermethodologie zullen me bijblijven. Ik 
vond het jammer dat je naar B’ham vertrok, maar dit geeft natuurlijk wel de 
mogelijkheid voor extra buitenlandse reisjes! Wim, dankzij jou heb ik de studie uit 
1996 kunnen opschrijven. Verder was je veelal op de achtergrond, maar je wist me 
te motiveren wanneer dat nodig was. Ik heb wel het idee dat we elkaar in de 
toekomst nog wel eens in een vergaderzaal zullen tegenkomen. 
Further, I would like to thank all members of the reviewing committee, Arie 
Nieuwenhuijzen Kruseman, Yves Boirie, Arie Kies, Annemie Schols en Coen 
Stehouwer for their critical evaluation of my thesis. Kevin Tipton and Harm 
Kuipers, thank you for accepting the invitation to be part of the corona during my 
thesis defense.  
Onder de bezielende begeleiding van Luc werk ik natuurlijk samen met 
verschillende werkpaarden uit de M3-groep (in wisselende samenstelling): Lex, 
Richard (macro-man), Joan, Antoine, Bart, Milou, Trent, Maurice, Hanneke en 
Stephan. Natuurlijk ook mijn 2 paranimfen Ralph en Kristof; dank jullie wel dat 
jullie mijn paranimfen willen zijn. Ralph, een betere collega en koffieleut kan een 
mens zich niet wensen, jouw levensmotto: it never hurts to help… Bedankt voor je 
hulp de afgelopen jaren! Kristof, al jaren zijn wij kamergenoten en wij hebben in de 
afgelopen tijd al veel kamergenoten versleten (Erwin, Kaatje, Hanneke, Githa en 
Anneke). In die tijd was je altijd het luisterende oor als er weer eens iets aan de 
hand was. Verder hebben mijn stagiaires Tjieu, Rudy, Marcel en Nico natuurlijk 
veel werk uit handen genomen waardoor ik me op het schrijven kon storten, 
jongens bedankt!!! Niet direct M3, maar Erik en Harm, dank jullie wel voor jullie 
support.  
Zonder proefpersonen begin je als onderzoeker vrij weinig, of eigenlijk niks! Dus 
mannen, dank jullie wel dat ik bij jullie zoveel bloed en spierbiopten heb mogen 
verzamelen! In veel van mijn studies heb ik gebruik gemaakt van stabiele isotopen. 
Dankwoord 
185 
Zonder de dames van het SIRC (Annemie, Anita, Hanne, Mia) en de mannen in de 
apotheek van het AZM (Eugene en Wil) waren de analyses/studies niet zo van de 
grond gekomen. Gert, bedankt voor de wijze lessen (samen met Matthijs) omtrent 
het Fingerspitzengefühl dat nodig is bij het uitvoeren van histochemische 
bepalingen. Jos en Wendy bedankt voor jullie inzet bij mijn verschillende studies 
qua analyses en Gabby voor het zetten van infusen. Ik heb ze eigenlijk nog nooit in 
een dankwoord terug zien komen, maar de mannen van de centrale 
sterilisatie/spoel-ruimte verdienen een bedankje voor het kunnen bijbenen van de 
snelheid waarmee ik in de afgelopen jaren bioptnaalden gebruikt heb.  
Arie, Marian en Luc van DSM Food Specialties en Marchel en Ardy van Numico 
Research, bedankt voor onze (vaak urenlange) discussies over het project. Jullie 
hebben me een goede kijk gegeven over hoe mooi, maar soms ook hoe moeilijk 
het kan zijn om in de industrie te werken. 
Samenwerkingen met andere labs zijn ook belangrijk en moeten daarom ook niet 
vergeten worden: Stephan en Thorsten (the Germans), Dominique en Dr Dendale 
(Hasselt), Hidde en Frits (AMC), Asker, Kevin, Chris and Carl (Birmingham), Olav 
(Stockholm) and David (Melbourne).  
Yves and Stephane, I am looking forward to spend some time in Clermont-
Ferrand next year. 
Vrienden die collega’s worden en andersom: Joost en Joris, buiten het werk, 
komen we elkaar vooral in de sportschool tegen waar jullie de sfeer altijd was losser 
weten te krijgen (ik weet niet of dit de prestaties altijd ten goede komt). Gijs, we 
zijn ongeveer gelijk begonnen aan het AIO-avontuur en zijn ook ongeveer gelijk 
klaar. Ik ben er dan ook trots op dat ik een kleine week na mijn eigen promotie, als 
paranimf achter je mag staan! Niels, trainingsbeest, bedankt voor alle 
fietstrainingstips, maar ik zal wel nooit een geweldige coureur worden. Dank ook 
aan alle overige collega’s van Humane Biologie en Bewegingswetenschappen die 
het werken de afgelopen jaren aangenaam hebben gemaakt. 
Bryan, mijn trainingsmaat, dank je voor je luisterend oor en voor het helpen bij alle 
laatste herhalingen zodat ik er nog net eentje extra kan doen. 
Mijn familie, schoonfamilie en vrienden van boven de rivieren verdienen ook een 
bedankje. Pa en ma (of beter Kees en Elly), bedankt voor het feit dat jullie me 
hebben gestimuleerd te gaan studeren en voor getoonde steun en interesse 
gedurende de studie en het promoveertraject. Zie hier het resultaat! Monique en 
Marcel (en natuurlijk Ilan), onverwacht word ik toch ook nog een docent… Nico 
en Mariet, dank jullie wel voor Anouk en samen met Joyce en Guy voor de 
gezelligheid (en biertjes) de laatste jaren. Jaco, Wendy, Willem en Jacqueline, we 
zien elkaar te weinig, maar we zijn al jaren bezig om daar verandering in te 
brengen… 
 
Tenslotte blijft er natuurlijk nog één persoon over, Anouk!!! Ik blijf het geweldig 
vinden je mijn vrouw te mogen noemen. Aan jou heb ik heel veel te danken. Je 
staat altijd voor me klaar en je geeft me de ruimte en tijd om uit te zoeken waar ik 
nu uiteindelijk naar toe wil. Mijn eeuwige dank voor al je liefde en geduld en ik 
hoop in de toekomst nog veel dingen met jou te mogen delen. 
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René Koopman was born on February 9th 1979 in Rotterdam, the Netherlands. In 
1997, he completed his pre-university education at the Rijks Scholengemeenschap 
in Middelharnis. He started his study Health Sciences at Maastricht University in 
1997. He graduated in the field of Movement Sciences in 2001 after an internship 
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he worked as a research assistant at the Department of Human Biology, Maastricht 
University. During this period he acquired practical experience with the use of 
(immuno)histochemical analyses. 
In Februari 2002, he started as a PhD student at the department of Human 
Biology at Maastricht University. In 2005, he was awarded by the Nutrition 
Interest Group of the American College of Sports Medicine with the international 
research award for his work on nutritional interventions to promote post-exercise 
protein synthesis. In 2005 he was awarded with an International Training 
Fellowship Grant from the Nutricia Research Foundation to visit the Human 
Nutrition Laboratory (CRNH/INRA) in Clermont-Ferrand, France. There he will 
have the opportunity to acquire expertise in the use and application of molecular 
biology techniques and measurement of protein synthesis rates in different muscle 
protein fractions. 
René Koopman is now appointed as a staff member at the Department of 
Movement Sciences. He continues his work on the stimulation of protein 
anabolism in the young and elderly by nutrition. Changes in protein metabolism 
are investigated on a whole-body, tissue and cellular level, with skeletal muscle as 
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